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Presented herein is the development and application of palladium-catalyzed methods for 
allylation, propargylation and 1,3-dienylation of acetonitrile pronucleophiles. The developed 
methods focus on optimizing both atom- and step-economy during product formation thus 
resulting in a minimal production of waste. Further, ligand-controlled regiodivergent strategies 
are also presented which provide efficient access to various functionalities through a change in 
reaction mechanism controlled by the denticity of the coordinating ligand. 
In regards to the developed methods for the propargylation and 1,3-dienylation of 
acetonitrile pronucleophiles, the presented work provides access to these functionalities using 
propargylic electrophiles that were rarely observed using previously known methods. In chapter 
1, a brief review of commonly employed propargylation methods is presented which often occur 
under harsh reaction conditions or result in a large amount of byproduct formation. Further, few 
exceedingly difficult palladium-catalyzed propargylation strategies are also reported that 
overcome the large bias for the allenyl isomer or products arising from dinucleophilic addition.   
Alternatively, in chapter 2, we present our ligand-controlled regiodivergent strategy for 
the propargylation and 1,3-dienylation of acetonitrile pronucleophiles. Specifically, we report the 
first palladium-catalyzed coupling of a butadiene synthon to generate 1,3-dienylated products. 
Further, each method provides significant advantages over commonly employed strategies to 
access such functionalities such as optimizing step-economy and avoiding the necessity for 
prefunctionalized starting materials.  
 iv 
In chapter 3 of this dissertation, we present our ongoing efforts to expand the substrate 
scope of the developed regiodivergent method to nitriles possessing a pKa >17. To achieve this 
goal, decarboxylative cross-coupling is employed to access the reactive intermediate in situ via 
irreversible decarboxylation thus generating CO2 as the only byproduct. Once again, selective 
propargylation or 1,3-dienylation is ligand-controlled and can occur though changing the ligand 
from monodentate to bidentate, respectively.    
Lastly, in chapter 4 we present a method for the in situ activation of allylic alcohols using 
CO2 for the allylation of nitroalkanes, nitriles, and aldehydes. The developed method provides 
several advantages over commonly employed allylation strategies: (a) avoids the pre-activation of 
allylic electrophiles for successful cross-coupling, (b) avoids the use of additives for allylic 
alcohol activation, and (c) generates base in situ for pronucleophile activation thus providing an 
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Chapter 1. Synthetic Methods for Propargylation and Propargylic Carbonate 
Reactivity. 
 
1.1 Introduction to Propargylation Methods 
The alkyne functional motif lies at the center of many synthetic efforts due to its ability to 
serve as a precursor to a diverse variety of functional group transformations.1,2 This characteristic 
leads to the broad application of alkynes as synthetic intermediates in both the development of 
synthetic methods and syntheses of biologically active compounds.3,4 Further, alkynes themselves 
are prevalent in many natural products, pharmaceuticals, and fine chemicals, which contributes to 
their overall chemical significance.5,6 
Electrophilic propargylation is one highly utilized method for alkyne incorporation into 
molecular scaffolds. In the most straightforward transformation, direct electrophilic 
propargylation can be achieved via SN2 substitution of a propargylic halide.7 ,8  Although this 
method can be attractive in terms of simplicity, it often suffers from some inherent drawbacks 
such as low regioselectivity, poor reagent availability, toxicity of propargylic halides, and the lack 
of potential for an asymmetric variant.7,8,9  As an alternative, less reactive but more readily 
available propargyl alcohols, acetates, and carbonates can be employed in the presence of 
transition metals to promote selective propargylation while minimizing reagent toxicity. Further, 
transition metal controlled propargylation would also allow the use of chiral, non-racemic ligands 
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Scheme 1.1: Regioselective Nucleophilic A ttack of Propargylic E lectrophiles
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Unlike addition into allylic electrophiles, which yield alkene products, 10  transition metal-
catalyzed additions to propargylic electrophiles are much more complex since they can result in 
alkyne, allene, or cyclized products and therefore have been underdeveloped in comparison.11 As 
alluded to previously, one characteristic that significantly contributes to the complexity of these 
reactions is the issue of regioselectivity. Similar to a transition metal-catalyzed allylation reaction, 
nucleophilic attack of a propargylic electrophile has the potential to occur at the α-carbon to the 
leaving group, to yield propargyl products, or at the γ-carbon, to yield allenyl products (Scheme 
1.1). However, unlike allylation reactions that proceed through a similar metal-bound 
intermediate, propargylic electrophiles have the potential to generate numerous types of metal-
bound intermediates, which substantially increases the difficulty in controlling product 
selectivity.     
1.2 Lewis and Brønsted Acid Catalyzed Propargylation Reactions 
Classically, the Nicholas reaction has been highly utilized as a reliable method to control 
regioselective addition to the α-carbon of propargyl alcohols (Scheme 1.2).12 , 13  Compatible 
nucleophiles include: alcohols, amines, thiols, ketones, silyl enol ethers, and electron-rich 
aromatic rings.13 However, the reaction lacks both step and atom-economy with the requirement 
of preformed, organometallic reagents using Co2(CO)6, Lewis or Brønsted acid additives, and the 
need for a subsequent oxidative demetallation to obtain the desired propargylated product. 
























Scheme 1.2: C lassic Nicholas Reaction Sequence .
 3 
Alternatively, in attempt to provide a “greener” and more cost effective propargylation 
method, recent attention has focused on the development of Lewis or Brønsted acid catalysis to 
activate propargyl alcohols directly for SN1 propargylic substitution and avoid the necessity for 
preformed organometallic compounds. For example, in 2007 Sanz and coworkers reported the use 
of p-toluenesulfonic acid monohydrate (PTS) in the Brønsted acid-catalyzed propargylation of 
1,3-dicarbonyl compounds with internal propargylic alcohols resulting in water as the only 
byproduct (Scheme 1.3). 14  Under the optimized reaction conditions, acyclic β-diketone 
nucleophiles underwent successful propargylation at room temperature and resulted in moderate 
isolated yields of the propargylated product. However, a decrease in yield was observed when the 
nucleophile was altered to cyclic β-diketones and even more so when β-ketoesters were 
employed. Further, the reaction was only tolerant of mono-substitution at the propargylic position 
of the starting propargyl alcohols. For tertiary alkynols, selective formation of the allenylated 
products was observed. Lastly, refluxing reaction conditions were required for the propargylation 
of 1,3-dicarbonyl compounds using singly activated, terminally unsubstituted propargyl alcohols.  
 
Shortly after Sanz’s report in 2007, Zhou and coworkers reported the use of Yb(OTf)3 in 
the Lewis acid-catalyzed propargylation of 1,3-dicarbonyl compounds at room temperature 
(Scheme 1.4).15  In addition to successful propargylation of acyclic β-diketones with internal 
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terminal propargylic alcohols under the optimized reaction conditions without a significant 
decrease in product yield. However, the reaction remained intolerant of disubstituted alkynols, 
which again resulted in selective formation of the allenyl isomers. Further, in the report by Sanz, 
propargylic alcohol starting materials were still limited to those with aryl substitution at the 
propargylic position presumably to stabilize the forming cation and facilitate ionization for SN1 
substitution.   
 
Recently, in 2015, Díez-González and coworkers reported the use of inorganic acid HBF4 
in the propargylation of oxygen-, nitrogen-, and carbon- nucleophiles with propargylic alcohols at 
room temperature (Scheme 1.5).16 Contrary to Lewis or organic Brønsted acid catalysts, inorganic 
Brønsted acids can be easily removed from the reaction media and are typically more stable to air 
and reagent-grade solvents. Despite being successful for the propargylation of oxygen-, nitrogen-, 
and carbon- nucleophiles using both terminal and internal propargylic alcohols, the developed 
method was restricted to electron-rich 1-aryl propargyl alcohols. However, when the reaction 
temperature and catalyst loading were both increased, the reaction scope could be expanded to a 
few substrates with alkyl or electron-poor aryl substituents and products were obtained in 
moderate yield. Surprisingly, a similar increase in reaction temperature and catalyst loading also 
lead to the successful propargylation from tertiary alkynols, which under the previously discussed 




































Scheme 1.4: Lewis A cid-C ataly zed Propargylation of 1,3-Dicarbonyl C ompounds
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scope of carbon nucleophiles was extended to both electron rich aryl and heteroaryl moieties to 
yield the products of Friedel-Crafts –type substitution.        
 
As illustrated above, both Lewis and Brønsted acid-catalysis can be a highly efficient 
method for the propargylation of various nucleophiles. However, the current methods are largely 
dependent on both the electronic and steric environment surrounding the starting materials. 
Further, the extended application of Lewis or Brønsted acid catalysis in larger, more structurally 
complex systems can lead to complications with chemoselectivity with other sensitive 
functionalities.17 As an alternative, transition metal-catalyzed propargylation methods have been 































































































Scheme 1.5: Inorganic Bronsted A cid-C atalyzed Propargylation Reactions .
 6 
develop more generalized reaction methods. For conceptual simplicity, the following transition 
metal-catalyzed propargylation methods have been divided into sections according to the metal 
catalyst.18,19  
 
1.3 Ruthenium-Catalyzed Propargylation Reactions 
Beginning in 2000, Nishibayashi, Hidai, Uemura and coworkers began developing 
methods for the propargylation of various nucleophiles with propargylic alcohols using thiolate-
bridged ruthenium (III,III) dimers. 20  Over the course of their studies, methods have been 
developed for the propargylation of carbon-,21,22,23 oxygen-, phosphonate-, thiols-, and nitrogen- 
nucleophiles.20, 24 , 25 , 26  Following initial coordination, rearrangement and dehydration, 
regioselective nucleophilic addition is reportedly controlled through formation of cationic 
ruthenium allenylidene intermediates, which undergo selective nucleophilic attack at the γ-carbon 


















































Scheme 1.6: Mechanism of Diruthenium-C atalyzed Propargylation
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Prior investigation of ruthenium allenylidene complexes conducted by Valerga, 27 
Esteruelas and López28 have demonstrated that cationic ruthenium allenylidene complexes are 
highly electrophilic in contrast to their neutral counterparts. Further, the allenylidene ligand itself 
has unique characteristics including electrophilic character at Cα and Cγ and nucleophilic 
character at Cβ of monometallic species (Scheme 1.7). By tuning the basicity of the metal center 
through the choice of coordinating ligands, regioselective nucleophilic addition could favor either 
the Cα (weakly basic metal centers) or Cγ (strongly basic metal centers) position. However, when 
the cationic monometallic complexes were applied to selective propargylation in the presence of 
propargylic alcohols, the complexes were found to be inactive.27,28,29 This observation motivated 
Nishibayashi, Hidai, Uemura and coworkers to evaluate other types of ruthenium catalysts 
(beyond monometallic species) for the activation of propargylic alcohols. Specifically, thiolate-
bridged diruthenium catalysts were screened based on prior observations of their success in 
catalyzing the head-to-head dimerization of terminal alkynes30 and ability to promote selective 
propargylation of various nucleophiles without any allene formation. However, due to the 
requirement of a ruthenium-allenylidene intermediate, the substrate scope and overall synthetic 




 In attempt to overcome the restricted synthetic application to terminal propargylic 
electrophiles using diruthenium catalysts, some attention has been devoted toward the 
development of a mononuclear variant. Unfortunately, the developed methods continue to suffer 
from severe drawbacks. For example, in 2002 Mitsudo and coworkers were able to demonstrate 
that thio- nucleophiles underwent successful propargylation when propargylic carbonates were 
employed in the presence of 10 mol % CpRuCl(cod) (Scheme 1.8).31 However, the reaction was 
only successful in the presence of N-methylpiperidine as a solvent (necessary to retain catalyst 
activity) and at elevated reaction temperatures of 100 oC. Further, terminal propargylic 
electrophiles were unsuccessful and the reaction was intolerant of substitution at the propargylic 
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Scheme 1.8: Mononuclear Ruthenium C atalyzed Propargylation of Thiols .
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1.4 Copper-Catalyzed Propargylation Reactions 
 Similarly, a number of groups including Hennion and Hanzel,32 Murahashi,33 Caporusso34 
and van Maarseveen35  have developed methods for the copper(I)-catalyzed propargylation of 
various nucleophiles in which the regioselectivity determining step is proposed to occur through 
nucleophilic attack of a copper allenylidene intermediate (Scheme 1.9).36 However, contrary to 
the diruthenium-catalyzed rearrangement and subsequent condensation of propargylic alcohols to 
generate a ruthenium-acetylidene intermediate, the use of copper(I) catalysts requires a 
stoichiometric or super stoichiometric amount of base to deprotonate the alkyne proton and 
generate a copper-acetylide or copper acetylidene intermediate. This mechanistic requirement of a 
metallic-acetylidene intermediate once again limits the synthetic utility of the copper(I)-catalyzed 
method to terminal propargylic electrophiles.     
 
 Despite the synthetic limitation of copper(I)-catalyzed propargylations using terminal 
propargylic electrophiles, Hu and coworkers were recently able to expand the scope of carbon 
nucleophiles to β-ketoesters which had only been mildly successful under previously developed 































Scheme 1.9: C opper(I)-C atalyzed Propargylation of 2o-A mines
 10 
their source of the propargylic electrophile allowed for in situ generation of ketone enolate 
equivalents rather than requiring preformation prior to subjection to the propargylation reaction 
conditions.  
As an alternative to copper(I)-catalyzed propargylations, Zhan37,38 and coworkers have 
also explored the use of copper(II) in the SN1 substitution of propargyl acetates (Scheme 1.11). 
However, similar to the substrate restrictions found in section 1.1.2, the developed reaction was 
sensitive to substitution on the starting propargylic electrophile. As typically found in the 
transition metal-catalyzed reactions covered thus far, an aryl substituent was required at the 1-
position of the starting propargyl alcohol, but 1,1-diaryl substituted alcohols were found to 





















































1.5 Rhenium-Catalyzed Propargylation Reactions  
 In order to avoid the formation of metal allenidene intermediates and bypass the 
limitation of terminal propargylic electrophiles, Toste39,40 ,41  and Takai42  reported the use of a 
rhenium metal-oxo complex to promote the propargylation of carbon-, oxygen- and nitrogen 
nucleophiles (Scheme 1.12).18 The mechanism by which propargylation occurs, utilizes a known 
[3,3]-rearrangement of the metal-oxo species to form an allenolate intermediate. Next, SN2' 




















R1, R2, R3 propargyl:allene
Ph, H, Ph 88% : 0%
Ph, H, H 84% : 0%
Ph, Ph, Ph 38% : 52%



























Scheme 1.12: Rhenium-Oxo-Catalyzed Propargylation Reactions.
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 The use of a rhenium metal-oxo complex as a catalyst was found to produce moderate to 
good yields of the propargylated nucleophiles from secondary propargylic alcohols, although 
there was again a requirement for an aryl moiety at the propargylic position. Further, tertiary 
propargylic alcohols were unsuccessful, presumably due to steric hindrance between to the two 
allenyl substituents and the incoming nucleophile in the transition state. Importantly, 
propargylation reactions with the rhenium-oxo catalyst were successful for alkyl, aryl and silyl 
terminally substituted propargylic alcohols without any effect on product yield.       
 
1.6 Palladium-Catalyzed Reactions with Propargylic Electrophiles  
 Despite significant contributions involving transition metal-catalyzed propargylation 
reactions by other metals, palladium-catalyzed reactions with propargylic electrophiles possess 
unique reactivity owed to its ability to yield several different types of products. Bias toward 
formation of a specific product is known to arise through the tuning of various palladium-
coordinated intermediates and the hard/soft character of the active nucleophile. Both will be 
discussed in the following. 
In 1999, Tsutsumi, Ogoshi, Kurosawa and coworkers conducted thorough studies on the 
synthesis and characterization of various palladium complexes resulting from the reaction of 
propargylic halides with Pd(PPh3)4.43  It was observed that when Pd(PPh3)4 was added in a 
stoichiometric amount to either a propargyl halide or an allenyl halide, two isomeric products 
formed following initial oxidative addition of the halide—carbon bond: the η1-allenylpalladium 
complex and the η1-propargylpalladium complex. Preference for either of the η1-palladium-
coordinated intermediates was dependent on competitive steric hindrance at the internal and 
terminal positions of the starting material (Scheme 1.13) however; both starting materials 
generated the same palladium-bound intermediates. It is important to realize that the nature of the 
 13 
counterion on the palladium complex significantly contributes to its preferred configuration. For 
example, when both the η1-allenyl and η1-propargylpalladium complex were simultaneously 
treated with silver tetrafluoroborate, ligand exchange between the coordinating chloride ligand 
and the non-coordinating BF4- counterion lead to exclusive formation of a cationic η3-
propargylpalladium complex (Scheme 1.14).  
 
 
Further, when the cationic η3-propargylpalladium complex was subjected to a series of NMR 
solvent studies, it was found that the polarity of the solvent also had a significant effect on the 
preferred coordination mode of the palladium-bound complex (Scheme 1.15).43 When polar 
solvents were employed, such as CDCl3 or DMF-d7, the cationic η3-propargylpalladium complex 
was largely favored over the neutral η1-allenylpalladium complex. In contrast, when non-polar 
C6D6 was used, exclusive formation of the neutral η1-allenylpalladium complex was observed. 
Therefore, the η1-allenylpalladium complex is preferred in the presence of coordinating 
counterions, such as chloride ions as well as in non-polar, aprotic solvents. Alternatively, in 
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Scheme 1.14: h1- h3-Propargylpalladium Interconversion B ased on C ounterion
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complex is preferred in the presence of bidentate phosphine ligands, hard or non-coordinating 
counterions, and in polar solvents.43,44,45,46 
 
In addition to the evaluation of reaction conditions that favor either a neutral η1-
palladium or cationic η3-palladium complex, a large amount of work has been conducted by 
Chen, 47  Kurosawa, 48 , 49  Ogoshi,48,49 Wojcicki, 50  and Tsuji11 that has provided invaluable 
information regarding the reactivity of these palladium-bound intermediates with various 
nucleophiles. For the purpose of this review, only carbon nucleophiles will be discussed. In 
general, palladium-catalyzed nucleophilic substitution of propargylic electrophiles can be 
categorized into four different types (Scheme 1.16).11,51 Typically, when considering nucleophilic 
additions of type I or type II, an η1-allenylpalladium complex is generated (largely biased through 
the lack of steric hindrance at the terminal position of the propargylic electrophile along with the 
soft-character of the palladium-catalyst). The intermediate complex can then undergo either 
insertion with a compatible alkene (type I) or transmetallation with an organometallic carbon 
nucleophile (type II), both of which result in allene products. Alternatively, soft-carbon 
nucleophiles (type III) are known to regioselectively attack the center carbon of a cationic η3-
propargylpalladium complex. After subsequent protonation to yield a π-allyl palladium 



















3 Cl C6D6 0/100
4 Br CDCl3 68/32
a) Ratios of 7 and 8 calculated by integrations of respective 1H NMR 
signals at 25 oC.
7a: X = Cl
7b: X = Br
8a
8b
Scheme 1.15: Solvent E ffe cts on Palladium-C omplexes
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product, or intramolecularly to yield a cyclization product and regenerate the active palladium(0) 
complex. Lastly, although very rare, type IV nucleophilic additions arise from the formation of an 
η1-propargylpalladium complex. In general, the η1-propargylpalladium complex can be biased 
when a bulky substituent is located at the terminal position of the allene thus promoting the 
palladium catalyst to proceed via oxidative addition of the carbon—halide bond rather than SN2' 
displacement of the leaving group to generate the η1-allenylpalladium complex. Similar to the 
type I and type II additions, once the η1-propargylpalladium complex is formed, either insertion 
of an alkene or nucleophilic attack of an organometallic carbon nucleophile could occur to yield 






















































































































   




























































































































































































































































1.7 Reactivity of η3-Propargylpalladium Complexes 
 As mentioned in the previous section, addition to an η3-propargylpalladium complex has 
been shown to occur exclusively at the center carbon.52 In 1995, Ogoshi and Kurosawa reported 
that a phenyl substituted η3-propargyl ligand on palladium was not linearly coordinated to 
palladium with an angle of 154o.53  Further, the η3-propargylpalladium ligand was located in 
approximately the same plane as the monodentate phosphine ligands to form a planar 
tetracoordinate palladium complex.53,54 Additional studies contributed by Delbecq and Sinou,54 
along with previous reports,52 revealed that in the η3-propargylpalladium, palladium is bound to 
the terminal carbons of the propargyl moiety through orbital overlap analysis. However the bond 
distances are not equal. A slightly longer bond distance exists between palladium and the 
substituted carbon (in this case 2.35 Å) compared to the unsubstituted terminal carbon (2.19 Å). 
Although no overlap population exists between C2 and palladium (indicating no bond), the 
distance from the palladium center was found to be short (2.19 Å). Importantly, DFT calculations 
have suggested that the central carbon is positively charge whereas the terminal carbons of the 
propargyl ligand are negatively charged.54 Further examination of orbital overlap populations 
were found to be highest at the center carbon of the propargyl ligand when NH3 or MeO- were 
employed as nucleophiles. Therefore, selective nucleophilic attack the center carbon of η3-
propargylpalladium complexes is proposed to occur under both orbital and charge-control at the 
central carbon.  
Of additional importance are the characteristics of the phosphine ligand. Specifically, the 
P-Pd-P angle55 which has a direct affect on the bent angle of the η3-propargyl ligand. In 2014, 
Anderson and Paton reported that the charge distribution on each of the carbon atoms of the η3-
propargyl moiety are not affected with an increase or decrease in the bite angle of the phosphine 
ligand.56  However, the energy of the molecular orbitals changes significantly. Through DFT 
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calculations it was found that bidentate ligands with larger bite angles cause an elongation, or 
bond lessoning, between palladium and the terminal carbons of η3-propargyl ligand. As a result, a 
flattening of the η3-propargyl moiety occurs which lowers the LUMO of the terminal carbons to 
resemble an allenyl cation. The lowered LUMO orbitals promote favored attack at the 
unsubstituted terminal carbon as opposed to the center carbon of the η3-propargyl moiety as is 
commonly observed. Therefore, bidentate ligands possessing small bite angles are optimal for 
regioselective nucleophilic attack at the center carbon of η3-propargylpalladium complexes. 
 
1.8 Palladium-Catalyzed Propargylation Reactions from Propargylic Electrophiles 
 As discussed in sections 1.1 – 1.5 of this chapter, current methods for selective 
propargylation of carbon nucleophiles often suffer from poor atom-economy, reagent toxicity, or, 
most importantly, selectivity among a diverse class of propargylic electrophiles or nucleophiles. 
Further, despite the advantages of palladium-catalyzed reactions with propargylic electrophiles, 
section 1.6 demonstrated that soft carbon nucleophiles most commonly lead to products of 
dinucleophilic addition or cyclization as opposed to propargyl products. Therefore, development 
of a palladium-catalyzed method that selectively yields propargylated soft carbon nucleophiles 
would significantly advance the realm of palladium-catalyzed reactions with propargylic 
electrophiles. However, reactions of this type remain scarce to date.  
  In 2015, Iazzetti and coworkers reported the successful propargylation of Meldrum’s 
acid derivatives in the presence of 5 mol% Pd(OAc)2, 20 mol% P(2-furyl)3, in refluxing THF 
(Scheme 1.17).57 It was found that both alkyl and aryl substitution was tolerated at the terminal 
and internal position of the propargyl carbonate starting materials without a significant effect 
yield. However, nucleophiles were strictly limited to highly stabilized, monosubstituted 
Meldrum’s acid derivatives. When 2-methylcyclohexandione was employed instead, exclusive 
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formation of the dinucleophilic addition product was observed, clearly displaying the limitation 
of this method (Scheme 1.18).    
  
 
 Due to the difficulty associated with direct nucleophilic addition of palladium-bound 
intermediates to yield propargyl products, Morken and coworkers designed a palladium-catalyzed 
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propargylated product (Scheme 1.19).58 Upon optimization of reaction conditions, it was found 
that allylation of various propargyl acetates proceeded stereospecifically with respect to the 
starting propargyl acetate. Further, mono- and disubstitution was tolerated at the propargylic 
position of the starting acetate materials, without a significant effect on product yields or 
contamination by the allene isomer. However, the reaction was intolerant of substitution at the 
terminal position of the propargyl acetate starting materials and also required three equivalents of 
CsF as an additive. Lastly, due to the mechanistic constraints of the developed reaction, only allyl 
moieties were sufficient coupling partners to obtain the propargylated products.      
 
 As one last alternative, in 2011, Álvarez de Cienfuegos and Cuerva reported a dual-
catalytic system consisting of palladium and titanium for the nucleophilic propargylation of 
aldehyde and ketone moieties (Scheme 1.20).59 As found in typical palladium-catalyzed reactions 
with propargylic electrophiles, the first suggested step in the mechanistic sequence was the 
oxidative addition of propargyl carbonate to palladium(0) will undergo oxidative addition into the 
propargyl carbonate to yield an η1-allenylpalladium complex (in equilibrium with the η1-
propargyl and η3-propargylpalladium complexes). Subsequent fragmentation of the palladium(II) 
complex is then promoted by a single-electron transfer (SET) from the super-stoichiometric 
addition of Cp2TiCl to yield an allenyltitanocene intermediate. Next, coordination of the 
electrophilic carbonyl compound occurs which undergoes regioselective nucleophilic attack to 
yield the resulting propargyl alcohol after an acid work-up. Although this method utilized a 
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Scheme 1.19: Palladium-C atalyzed Cross-C oupling of A llyl B oronates
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drawbacks include the requirement of super-stoichiometric amounts of titanium and the limitation 
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Scheme 1.20: Titanium/Palladium-Mediated Propargylation of K etones
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1.9 Conclusion: 
 Throughout chapter 1, numerous methods have been presented that catalyze the 
propargylation of carbon-centered nucleophiles including the Nicholas reaction, Lewis acids, 
Brønsted acids, and transition metal catalysis. However, known propargylation methods still 
suffer from a limited substrate scope of substituted propargylic electrophiles and lack generality 
for a diverse class of carbon-centered nucleophiles.  Additionally, in regard to palladium-
catalyzed reactions, only a handful of methods exist that are able to override the large bias for the 
allenyl isomer or products arising from dinucleophilic addition to palladium-bound intermediates 
in favor of propargylation. Therefore, a more generalized atom-economical propargylation 
method would significantly advance the field of propargylation chemistry. Specifically, the 
method should expand the scope of carbon nucleophiles and provide access to propargylation 
reactions using substituted propargylic electrophiles.   
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Chapter 1 of this dissertation was a review of electrophilic propargylic substitution to yield 
propargylated carbon-centered nucleophiles. Specifically, attention was focused on methods such 
as the Nicholas reaction or those mediated by, Lewis acids, Brønsted acids, and catalysts using 
various transition metals. However it was stated that, in general, the developed methods suffer 
from detrimental drawbacks that prevent their widespread application including: (a) limited 
substrate scope, (b) limit to highly stabilized carbon-centered nucleophiles, or (c) production of a 
large amount of waste.      
Chapter 1 also covered the unique reactivity of palladium-catalyzed substitutions of 
propargylic electrophiles and it was demonstrated that palladium has the potential to generate 
structurally diverse metal-bound intermediates (Scheme 2.1). As a result, various products can be 
selectively accessed by altering the reaction conditions to favor one of the metal-bound 
intermediates, along with judicious choice of the activated nucleophile. However, palladium-
catalyzed propargylation of carbon-centered nucleophiles is rare.  
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To briefly reiterate the typical reaction patterns of palladium-catalyzed substitutions of 


















































































































   



























































































































































































































































products (Scheme 2.2). In contrast use of stabilized nucleophiles, such as malonates, commonly 
leads to bis-addition products, while selectivity for propargylic substitution is much more 
rare.1,2,3,4 Additionally, only under select circumstances, primarily controlled through cyclization, 
have diene products arisen from the substitution of propargyl electrophiles.  
 
 Based on the material presented above, palladium-catalyzed substitution of propargylic 
electrophiles offer the potential to develop a regiodivergent strategy to access functionally diverse 
products from a single class of starting materials. Chapter 2 of this dissertation will detail our 
contribution toward the development of a palladium-catalyzed, ligand-controlled, regiodivergent 
strategy to access both the rarely observed propargyl and dienyl isomers resulting from 
palladium-catalyzed propargylic substitution (Scheme 2.3). Further, in order to optimize the atom 
efficiency of the reaction, propargylic carbonates were employed as the electrophilic propargyl 






























Pd2(dba)3 (5 mol %)
ligand (10 mol %)












Scheme 2.3: Regiodivergent Substitution of Propargylic Carbonates.
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2.2 Ligand-Controlled Regiodivergent Strategies: 
A major endeavor in the development of transition metal-catalyzed reactions typically 
entails the mass screening of various ligands for optimized reaction selectivity. Although 
effective, this protocol usually results in the optimized formation of one product class or bond-
type. Occasionally, however, regiodivergent strategies arise in which orthogonal selectivity is 
observed for two or more products simply by changing the characteristics of the metal-
coordinated ligand. Such examples optimize method development through production of various 
products with minimal reaction modification. However, development of ligand-controlled 
regiodivergent strategies is difficult since they must circumvent both steric and electronic 
properties of the substrate that typically govern product regioselectivity. In the following, a brief 
summary of recent regiodivergent strategies will be presented.              
 In 2016, Jiang and coworkers reported the gold-catalyzed, ligand-controlled 
regiodivergent hydroarylation of alkynes to access both ortho- and para-substituted cyclized 
products (Scheme 2.4).5 Selectivity was controlled through electronic variations at the gold-center 
through employment of either electron-deficient tris(2,4-di-tert-butylphenyl)phosphine or 
electron-rich XPhos as the ligand source. When electron-deficient tris(2,4-di-tert-
butylphenyl)phosphine was employed, selective formation of the ortho-substituted product was 
observed. Due to the electron-deficient metal center, along with the weakly coordinating -OTs 
counterion, it was proposed that the gold catalyst would “pull” the coordinated alkyne toward the 
methoxyl amide directing-group resulting in the ortho-cyclized product. 6 , 7 , 8  Alternatively, 
employment of bulky, electron-rich XPhos would disfavor amide coordination through 
unfavorable steric interactions and “push” the coordinated alkyne away from the directing group 
resulting in the para-cyclized product.    
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Alternatively, in regards to palladium-catalyzed regiodivergent methods, Cárdenas and 
coworkers reported the selective synthesis of allylboronates and alkenylboronates controlled by 
the coordinating strength of the employed ligand (Scheme 25).9 It was proposed that cyclization 
to generate the alkenylboronate could be favored with weaker, more labile trialkylphosphine 
ligands (path a) that enable a free coordination site on the metal center upon dissociation. The 
empty coordination site could allow coordination of the alkyne followed by transmetalation and 
reductive elimination to yield the alkenylboroante product. Alternatively, more strongly 
coordinating, non-labile NHC ligands prevent cyclization by perturbing alkyne coordination and 





























DCE (0.1 M), 80 oC
8 h
DCE (0.1 M), 80 oC
8 h
Scheme 2.4: Au(I)-Catalyzed, Ligand Controlled Regiodivergent Cyclization.
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 In 2014, and subsequent reports in 2015, Hall and coworkers reported a regiodivergent 
Suzuki-Miyaura cross-coupling to produce 2- and 4-substituted dihydropyrans and 
dehydropiperidines (Scheme 2.6).10,11 As reported by Cárdenas, regioselective product formation 
was again attributed to the strength and steric environment about the coordinating ligand. For 
phosphine-based ligands, it was previously reported that the SE' pathway is favored to generated 
intermediate 2.2 B.12,13 Further, use of more weakly coordinating tria lkylphosphine ligands was 






Pd(OAc)2 (5 mol %)
B2(pin)2 (1.2 equiv.)
t-BuOK (5 mol %)
Pd(OAc)2 (5 mol %)
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xylene, 50 oC, 8 h






































Scheme 2.5: Palladium-Catalyzed Regiodivergent Synthesis of Allylboronates and Alkenylboronates.
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heteroatom conjugated σ-bond palladium(II) species 2.2 D prior to reductive elimination to form 
the α-arylated product.10 In contrast, more electron-rich and sterically bulky SPhos promotes 
rapid reductive elimination of the arylated palladium intermediate 2.2 B to yield the γ-arylated 
product.    
 
 Lastly, most recently in 2016, Buchwald further expanded the known methods of 
regiodivergent Suzuki-Miyaura cross-coupling reactions to yield both substituted linear and 
branched prenyl functionalities (Scheme 2.7). 14  Initially, it was proposed, and eventually 
supported, that optimal product selectivity could be achieved by minimizing the σ-π-σ 
interconversion of palladium-bound intermediates through the employment of strongly 
coordinating ligands. Further, bias for a 6-membered transition-state could be favored with 
smaller ligands to yield the branched product while more sterically bulky ligands would disfavor 




















































[(allyl)PdCl]2 (1.5 mol %)
(4-CF3C6H4)3P (6 mol %)
ArX (1 equiv.)
[(allyl)PdCl]2 (1.5 mol %)
SPhos (6 mol %)
K3PO4 (4 equiv.)
CH3CN, 85oC, 12 h
K3PO4 (4 equiv.)














 The above examples display methods in which both steric and electronic characteristics 
of the ligand are utilized to promote selective product formation. Such strategies can be 
invaluable to further predict substrate reactivity and potentially reveal alternative reaction 
pathways for new product formations.         
 
2.3 Synthetic Significance and General Synthetic Methods that Yield 1,3-Butadiene Motifs: 
Conjugated butadiene motifs are highly valuable synthetic targets for organic chemists. Much 
of their significance stems from their use as functional handles in total syntheses,15,16 syntheses of 
biologically active compounds17 and complex molecule syntheses.18 ,19  Specifically, conjugated 
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[(allyl)PdCl]2 (1.5 mol %)
L6 (6 mol %)
K3PO4 (aq.),
CH3CN, 70oC, 12 h
K3PO4 (aq.),
THF, 40oC, 12 h
[(allyl)PdCl]2 (1.5 mol %)





Scheme 2.7: Palladium-Catalyzed, Regiodivergent Suzuki-Miyaura Cross-Coupling.
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inter- and intramolecular Diels-Alder reactions, 20,21 ,22,23  cycloadditions,24,25 ,26  hydrogenations,27 
Sharpless epoxidation,28,29 etc. Further, 1,3-dienes themselves are prevalent sub-structural motifs 
in natural products,30,31,32 biologically active pharmaceuticals,33 and materials.34  
In general, current synthetic methods to synthesize 1,3-dienes rely heavily on transition 
metal-catalyzed cross-coupling reactions,35 transformations from allene derivatives,36 olefination 
reactions, 37  or cyclization reactions. 38  However, very few methods utilize the direct cross-
coupling of butadiene synthons for diene incorporation. Furthermore, methods that report direct 
butadiene cross-coupling often require pre-formed organometallic or organoborane reagents and 
produce a large amount of waste. A brief summary of butadiene coupling methods will be 
presented in the following.  
In 1981, Nunomoto, Kawakami, and Yamashita reported the dienylation of aryl and alkyl 
iodides with palladium tetrakis and copper iodide respectively (Scheme 2.8).35g However, the 
presented method suffered from a very limited substrate scope of both alkyl and aryl iodides. 
Further, the method also suffered from low to moderate isolated yields and some substrate 
dependent polymerization was also reported. Lastly, the presented methods were limited to aryl 
or alkyl-iodides and were incompatible with bromo- and chloro- derivatives.      
 
 Two-years later in 1983, Shea and Pham reported an expansion of the substrate scope of 
1,3-dienylation to selective 1,4-addition of α,β-unsaturated ketones along with cross-coupling of 














Scheme 2.8: Pd(0) and Cu(I)-Catalyzed Dienylation.
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report that selective dienylation occurred without contamination by the allene isomer. However, 
in general, product yields remained low to moderate and extended reaction times of 24-48 hours 
were required for successful 1,3-dienylation of alkyl bromides or tosylates.    
 
 Alternatively, in 1999, Hatakeyama and coworkers reported the use of 
tributylstannylbuta-1,3-diene in the dienylation of aldehyde derivatives (Scheme 2.10).35i 
Although the reaction appeared to be selective, high yielding and could be conducted at room 
temperature, a stoichiometric amount of SnCl4 was required to generate the homoallenyl 
intermediate required for subsequent 1,3-dienylation. Further, along with the narrow scope of 
alkyl and aryl aldehydes, tin reagents are toxic which promotes the development of more amiable 
reaction conditions.  
 
As an alternative, subsequent studies conducted by Venturello revealed that 1,3-
dienylboronate esters could be used in the Suzuki cross-coupling of aryl or alkenyl iodides, 
bromides, chlorides and triflates (Scheme 2.11).35d In general, the developed method produced the 
1,3-dienylated aryl species in moderate yields except for reactions of aryl chlorides which 










Scheme 2.9: Copper-Catalyzed 1,4-Addition of 1,3-Butadiene.
Bu3Sn
SnCl4 (1 equiv.)
CH2Cl2 (0.13 M), -78 oC
then, DMF (3 equiv.)





Scheme 2.10: Buta-1,3-Dienylation of Aldehydes.
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Similarly, Sherburn and Paddon-Row reported the utility of both the Kumada-Tamao-Corriu 
reaction and the Negishi reaction in the coupling of 1,3-dienes to efficiently synthesize 
dendralene hydrocarbons (Scheme 2.12).35f Specifically, these coupling methods provided a 
synthetic route to produce branched hydrocarbons in moderate yields and high selectivity as 
opposed to previously utilized methods. However, despite the obvious importance of these 
coupling reactions, one drawback lies in the production of a stoichiometric amount of metal waste 


























(Ph3P)2PdCl2 (5 mol %)





Scheme 2.11: Suzuki Cross-Coupling of 1,3-dienylboronate Esters:
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 In attempt to circumvent the requirement of preformed organometallic compounds and 
expand the functional group tolerance of 1,3-dienylation methods, Connell and coworkers 
reported the asymmetric 1,3-dienylation of aldehyde derivatives from propargylic halides 
(Scheme 2.13).36a However, the method suffers from numerous inefficiencies compared to the 
previous presented methods. Although it does not require preformed organometallic compounds, 
successful dienylation occurs over a two-step process in which stoichiometric and super-
stoichiometric amounts of numerous additives are employed. Further, attempts to develop a one-

























Scheme 2.12: 1,3-Butadiene Coupling to Yield Branched Hydrocarbons.
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 Alternatively, in 2013 Yu and coworkers reported the use of cyclopropylmethyl N-
tosylhydrazones as butadiene surrogates in the palladium(0)-catalyzed 1,3-dienylation of aryl and 
heteroaryl motifs (Scheme 2.14).35c Their protocol bypasses the need for pre-formed 
organometallic species and occurs in one-step with moderate to high overall yields of the desired 
product. However, the method is limited to unsubstituted cyclopropyl rings and requires super-






CrCl2 (10 mol %), Mn0 (2 equiv.)












Scheme 2.13: One-Pot Asymmetric 1,3-Dienylation of Aldehydes.
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2.4 Development of Regiodivergent Synthesis of 1,3-Dienes  
Current synthetic methods that achieve the direct cross-coupling of butadiene synthons 
rely heavily on pre-formed organometallic or organoborane reagents. Consequently, these 
methods lack step-economy and produce a significant amount of waste. Therefore, it would be 
useful to develop alternative methods to cross-couple 1,3-dienyl motifs via reaction of readily 
available starting materials under mild reaction conditions, while minimizing overall byproduct 
formation. To address this need, we hypothesized that propargyl carbonates could serve as diene 
electrophiles if, after mono-substitution to generate a palladium π-allyl intermediate, 39 ,40 ,41 
elimination occurred instead of the more common attack by a second nucleophile (Scheme 


























PdCl2(MeCN)2 (5 mol %)
XPhos (10 mol %)
LiOt-Bu (2.2 equiv.)




Scheme 2.14: Cross-coupling of Cyclopropylmethyl N-Tosylhydrazones as a Source 
of 1,3-Butadiene
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fashion via the formal coupling of an electrophilic 1,3-diene synthon. To the best of our 
knowledge, the use of a propargyl carbonate as a source of butadiene electrophile for cross-
coupling has not been reported.43 
 
 Given our experience with allylic alkylations of acetonitriles,44 our optimization studies 
began by examining the effects of palladium catalyst, ligand, and solvent on the cross-coupling of 
methyl propargyl carbonate with commercially available diphenyl acetonitrile (Table 2.1). 
Initially, reaction conditions that previously provided high yields for allylation of tertiary 
acetonitriles with allylic alcohols were employed (entry 1).44b Under these conditions, GC/MS 
analysis revealed the formation of three isomeric products. Upon isolation and characterization of 
each product, it was confirmed that the major products were the 1,3-dienyl and propargyl 
isomers, with only minor formation of the allene. In order to optimize reaction conversion, we 
next conducted a solvent screen, which revealed that polar, aprotic solvents provided optimal 
conversion (entry 1, 3) compared to non-polar solvents (entries 2, 17, 18). In an attempt to 
determine the ligand effect on product ratios, several bidentate ligands were examined (entries 4-
9). Excitingly, (diphenylphosphino)ethane (dppe) displayed optimal selectivity for the 1,3-diene 
product (entry 5). This result was in sharp contrast to previous accounts that report cyclization,43 
bis-addition,42 or allenylation 45  as the major products arising from palladium-catalyzed 


















 With the optimized reaction conditions established for 1,3-dienylation of 
diphenylacetonitrile, we next evaluated the scope of DD-diaryl acetonitrile derivatives in the 
substitution of methyl propargyl carbonate to synthesize 1,3-dienes (Scheme 2.16).47 A variety of 
unsymmetric diarylacetonitrile reactants with electron-donating or withdrawing substituents 
provided product in good to excellent yields (3b, 3c, 3h, 3m). Further, meta-chloro and para-
bromo substituted arenes, which can be prone to other coupling reactions, were well tolerated (3g, 
















4 dppm CH3CN 28 4 42 27
5 dppe CH3CN 3 0 94 3
6 dppp CH3CN 5 0 87 8
7 dppb CH3CN 2 0.2 85 13
8 dppf CH3CN 1 0.5 74 24
10 rac-BINAP CH3CN 4 0.5 70 24
11c JohnPhos CD3CN 45 20 2 33
12c tBu-MePhos CD3CN 22 29 2 47
13c Cy-JohnPhos CD3CN 56 4 15 25
14c MePhos CD3CN 11 3 19 67
15c MePhos DMSO-d6 51 5 9 35
16c MePhos d-DMF 43 3 7 47
17c MePhos toluene-d8 87 6 0.3 6
18c MePhos 1,4-dioxane 87 5 1 8
1
catalyst
Pd(PPh3)4 -- DMSO 26 3 40 31
2 Pd(PPh3)4 -- THF 62 1 15 22















19 Pd2(dba)3 MePhos DMF 10 3 6 81
20 Pd2(dba)3 dppe DMF 3 0 95 2
21 Pd2(dba)3 MePhos DMF 10 3 6 81
22d Pd2(dba)3 dppe DMF 9 0 91 0
23e Pd2(dba)3 dppe CH3CN 3 0 95 2
24f Pd2(dba)3 dppe CH3CN 1 0 98 1
25g Pd2(dba)3 MePhos DMF 1 3 6 90
26f,g Pd2(dba)3 -- DMF -- -- -- --
9 Pd2(dba)3 XantPhos CH3CN 1 11 7 31
1a 2a
Table 2.1: Optimization of Reaction Conditions:
a) diphenylacetonitrile (0.3 mmol), carbonate (0.3 mmol), catalyst (2.5 mol %), ligand (5 
mol%), 0.15 M, 90 °C, 14 h. b) % conv. determined by GC/MS. c) diphenylacetonitrile 
(0.1 mmol), carbonate (0.1 mmol), reaction monitored by 1H NMR spectroscopy. d) 
isolated yield 24%. e) 0.3 M f) 80 °C g) 0.6 mmol carbonate
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3e). Notably, a variety of substitution patterns were tolerated and even increased steric bulk at the 
ortho-position did not hinder product formation (3c, 3f, 3h). Unfortunately, basic heteroaryl 
moieties, while requiring reduced reaction time, lead to poor isolated yields (3i, 3j). In contrast, 
the non-basic heteroaromatic 1,5-(dimethyl)pyrrole reactant provided product in good yield, as 
did arene substituents that contained extended conjugation (3d, 3f, 3k). Lastly, styrene and 
benzoxazole derivatives were unsuccessful and only degradation of the starting material was 
observed (3n, 3o).  
 
 
Pd2(dba)3 (5 mol%) 
dppe (10 mol%)


































































a) nitrile (0.3 mmol), carbonate (0.6 mmol), palladium (5 mol %), dppe (10 mol%), DMF 
(2 mL), 80 oC, 1 h. Isolated yields are reported.
Scheme 2.16: Acetonitrile Scope of 1,3-Diene
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  With the functional group tolerance evaluated for the acetonitrile reaction component, 
other propargylic carbonates were examined to see if they could be used to form substituted diene 
products (Scheme 2.17). It was found that nucleophilic substitution of a terminally substituted 
ethyl or heptyl propargylic carbonate resulted in decreased isolated yields (4b, 4c) compared to 
the model substrate 3a. However, terminally substituted benzyl propargylic carbonate produced 
the substituted 1,3-diene product in moderate yield (4d). In attempt to access more intricate triene 
functionalities, an allyl substituent was utilized at the terminus of the propargylic carbonate, and 
the resulting triene was isolated in good yield (4e). Unfortunately, both terminal carbocyclic 
substituents along with internal alkyl substituents on the propargylic carbonate significantly 
hindered product formation (4f-4g).  
 46 
 
 Fueled by the selective formation of the terminal 1,3-diene analogues, we next examined 
the potential pathways that could give rise to dienylation. It has been reported that palladium 
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dppe (10 mol%)





















































a) nitrile (0.3 mmol), carbonate (0.6 mmol), palladium (5 mol %), dppe (10 mol%), DMF 
(2 mL), 80 oC, 1 h, isolated yields are reported. b) isolated yield. c) determined by 1H 
NMR spectroscopy. d) determined by GC/MS
Scheme 2.17: Scope of Substituted 1,3-Dienes.
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palladium intermediate.41,48 Further, outer-sphere nucleophilic attack of η3-propargyl palladium 
species often occurs exclusively at the center carbon. 49  Therefore, we envisioned that 1,3-
dienylation could arise via two potential mechanistic pathways (Figure 2.1). In both cases, initial 
oxidative addition of the propargylic carbonate and subsequent loss of CO2 would yield an η3-
propargyl palladium intermediate along with methoxide. Next, deprotonation of the 
pronucleophile would promote nucleophilic attack at the center carbon of the palladium 
intermediate to generate the corresponding palladacyclobutene (B).50 If the mechanism proceeds 
via path a, protonation could occur from either methanol or nitrile, leading to π-allyl palladium 
intermediate C. Base-induced elimination would regenerate the palladium(0) catalyst and yield 
the 1,3-diene product. 51 , 52  Alternatively, β-hydride elimination from the palladacycle B could 

















































Figure 2.1. Potential Pathways for 1,3-Dienylation.
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 To determine which pathway is more likely, two isotopic labeling experiments were 
performed (Scheme 2.18). The terminally deuterated propargylic carbonate produced product 
with an 8.1:1.0 H/D ratio at the internal carbon of the diene as determined by 1H NMR 
spectroscopy (Scheme 2.18a). A similar reaction that coupled deuterated diphenyl acetonitrile 
with protio methyl propargyl carbonate resulted in an H/D ratio of 1.2/1.0 (Scheme 2.18b). The 
differing ratios result from a primary KIE for protonation combined with the competitive 
protonation from nitrile and liberated methanol. These results are inconsistent with a mechanism 
involving β-hydride elimination/reductive elimination. Thus, we favor path a which involves 
protonation of the palladacyclobutene to form S-allyl palladium intermediate C.  
 
In attempt to trap a putative S-allyl intermediate, the palladium-catalyzed acetonitrile 
cross-coupling was performed with a propargylic carbonate that was unable to undergo 
elimination (Scheme 2.19). The observation of bis-substituted 1,3-diene product in 93% yield 
supports the kinetic feasibility of the formation of a π-allyl palladium intermediate required for 
path a.  
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2.5 Development of Regiodivergent Synthesis of Propargylated Diaryl Acetonitrile Derivatives  
As discussed previously, palladium-catalyzed substitution of methyl propargyl carbonate 
with DD-diaryl acetonitrile pronucleophiles selectively forms 1,3-dienyl products in the presence 
of bidentate ligand dppe. During our reaction optimization studies, a change from bidentate 
(dppe) to monodentate (MePhos) ligand was accompanied by a switch in selectivity from the 1,3-
dienyl isomer to the propargyl isomer under otherwise identical reaction conditions (Table 2.1). 
The development of palladium-catalyzed substitution of propargylic carbonates to selectively 
yield propargylated nucleophiles would not only expand on the limited strategies known for 
catalytic propargylation from internal propargylic electrophiles, 53  but also allow for a 
regiodivergent synthesis of 1,3-dienyl and propargyl acetonitrile derivatives solely by altering the 
denticity of the coordinating ligand. 
Classically, the Nicholas reaction has been utilized as a method for propargylation 
utilizing propargylic alcohol reactants. Despite this, its utility has been limited by the requirement 
for stoichiometric organometallic reagents. 54  Recent focus on propargylation has been 
concentrated on the development of alternative methods using catalytic transition metals.  For 
example, propargylic alkylation using internal propargylic carbonates was only recently reported 
by Iazzetti in 2015. 55 However, the reaction is limited to highly stabilized Meldrum’s acid-like 























Scheme 2.19: Trapping of Palladium p-Allyl Intermediate.
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propargylic carbonates that result in cycloaddition42b,56 or formation of allene45 derivatives. The 
method outlined herein aims to expand the scope of palladium-catalyzed propargylation to 
weakly acidic DD-diaryl acetonitrile motifs that give rise to functionalized quaternary 
diarylmethane products.  
Beginning with the same optimized reaction conditions developed for the 1,3-dienylation 
method, we merely changed the coordinating ligand from bidentate dppe to monodentate MePhos 
and evaluated the scope of diarylacetonitriles that undergo propargylation (Scheme 2.20). 
Analogous to results of 1,3-diene syntheses, the propargylation of acetonitriles containing 1-
naphthyl, 2-naphthyl and para-substituted biphenyl derivatives provided very good yields without 
being influenced by steric hindrance (5a, 5d, 5f, 5l). When para-methoxy, ortho-fluoro and meta-
chloro-substituted phenyl rings were screened, all corresponding products were obtained in 
moderate-good isolated yields (5b, 5c, 5g). Altering the ortho-substituent to a nitro moiety 
resulted in an excellent isolated yield of 94% (5h). In contrast to their poor reactivity for 
dienylation, heterocyclic pyridine and pyrimidine derivatives were tolerated under the general 
reaction conditions and resulted in good isolated yields (5i, 5j). However, when the heterocycle 
was changed to a benzoxazole functionality, a dramatic decrease in yield was observed (5o, 
Scheme 8). A styrene derivative proceeded smoothly to the propargylated product albeit slightly 
lower yield compared to the polycyclic and bicyclic analogues (5n). Lastly, a para-morpholine 
substituted acetonitrile failed to undergo reaction (5m). 
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 With the propargylation of various diaryl acetonitrile substrates examined, we next 
sought to apply our propargylation method to substituted propargylic carbonates (Scheme 2.21). 
Nucleophilic substitution of terminally substituted ethyl or heptyl propargylic carbonates was 
well tolerated (6b, 6c). However, a decrease in isolated yield was observed with using a benzyl 
propargylic carbonate (6d). Gratifyingly, excellent isolated yields were obtained from propargylic 
carbonates that are terminally substituted by carbocycles (6e-6g). Further, allyl and internally 
substituted methyl and ethyl propargylic carbonates resulted in moderate-high isolated yields of 
Pd2(dba)3 (5 mol%) 
 MePhos (10 mol%)




































































a) nitrile (0.3 mmol), carbonate (0.6 mmol), palladium (5 mol %), MePhos (10 mol%), 
DMF (2 mL), 80 oC, 1 h, isolated yields are reported. b) isolated with 10% allene and 
7% bis addition product.
Scheme 2.20: Propargylation of Acetonitrile Derivatives.
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the propargylated products (6h, 6i, 6j, 6k). Unfortunately, vinyl and phenyl propargylic 
carbonates were not well-tolerated under the standard reaction conditions (6l, 6m). 
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a) diphenylacetonitrile (0.3 mmol), carbonate (0.6 mmol), palladium (5 mol %), 
MePhos (10 mol%), DMF (2 mL), 80 oC, 1 h. Isolated yields are reported.
Scheme 2.21: Propargylation with Substituted Carbonates.
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Having studied the synthetic scope of the dienylation and propargylation reactions, we 
aimed to convert our observation of denticity-dependent regioselectivity into a more formal 
mechanistic hypothesis. Beginning with Pd(0) and monodentate MePhos, we propose that 
oxidative addition of the propargylic carbonate would initially favor a cationic η3-propargyl 
palladium intermediate E similar to intermediate A in the dienylation pathway (Figure 2.22). 
Contrary to bidentate ligand dppe, which forces outer-sphere nucleophilic attack of the activated 
nitrile, we propose that the mono-coordination of the MePhos ligand provides an open 
coordination site for binding of the activated nitrile.44a,57 Binding of an anionic ligand has been 
observed to typically favor the η1-allenyl species (in this case G).41,48,52 Subsequent inner-sphere 






 In conclusion, we report the regiodivergent synthesis of substituted 1,3-dienyl and 
propargyl quarternary diaryl methanes. We propose that regioselective nucleophilic substitution to 
palladium-bound intermediates occurs through two distinct reaction mechanisms that are 
controlled by the denticity of the ligand. Bidentate ligands block coordination of the nitrile 
nucleophile, favoring outer-sphere attack of the nucleophile, leading to dienylation. In contrast, a 
monodentate ligand allows coordination of the nucleophile to palladium, resulting in 
propargylation via inner sphere nucleophilic attack. 
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Purified compounds, unless otherwise stated, were obtained by column chromatography using 60 
Å porosity, 230 x 400 mesh standard grade silica gel from Sorbent Technologies. TLC analysis 
was preformed on silica gel HL TLC plates w/UV254 from Sorbent Technologies. Gas 
chromatography/mass spectrometry data was obtained using a Shimadzu GCMS-QP2010 SE. 
NMR spectra were obtained on a Bruker Advance 500 DRX equipped with a QNP cryoprobe. 1H 
and 13C spectra were normalized using residual undeuterated solvent signals as a reference (CDCl3 
= 7.28 ppm for 1H and 77.36 ppm for 13C).1 19F NMR spectra were referenced to α,α,α-
trifluorotoluene (purchased from Sigma Aldrich) at -62.7 ppm.   
 
N,N-Dimethylformamide (DMF) and nitromethane were purchased from Sigma Aldrich and stored 
in a glove box. Dichloromethane (DCM), tetrahydrofuran (THF), and toluene were either purified 
by an Innovative Technology Pure SolvTM solvent purification system or purchased from Sigma 
Aldrich and stored in a glove box. Tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) was 
purchased from Strem as were ethylenebis(diphenylphosphine) (dppe) and 2-
dicyclohexylphosphino-2’-methylbiphenyl (MePhos). All were stored in a glove box. 










Synthesis of Starting Materials  
Acetonitrile 2.1b,2,3 2.1c, 2.1d,4 2.1e,2 2.1f, 2.1g and 2.1l: 
 
General Procedure for direct cyanation of benzylic alcohols in the  synthesis of diaryl nitriles 
2.1b-2.1g and 2.1i2: In a glove box under an argon atmosphere, an oven or flame dried 20 mL 
Biotage microwave vial (#355458) equipped with a magnetic stir bar was charged with benzylic 
alcohol (2 mmol), Zn(OTf)2 (0.11 g, 0.3 mmol, 15 mol %), and CH3NO2 (20 mL, 10 M) then 
sealed and removed. TMSCN (0.24 g, 2.4 mmol, 1.2 eq) was then added using a syringe before 
heating the vessel at 100 oC overnight. The mixture was diluted with distilled water (100 mL) and 
extracted into ethyl acetate (50 mL x 2) and washed with brine (20 mL). The organic layer was 
dried over sodium sulfate and concentrated before purification by column chromatography in a 







Characterization of 2.1c: 
 
Yield: .36 g, 1.7 mmol, 85%  
Appearance : off-white solid   
1H NMR Spectra (500 MHz, CDCl3): δ 7.77 (td, J = 7.6, 1.8 Hz, 1H), 7.68 (m, 6H), 7.51 (td, J = 
7.5, 1.2 Hz, 1H), 7.42 (ddd, J = 9.7, 8.2, 1.2 Hz, 1H), 5.77 (s, 1H).  
13C NMR Spectra (126 MHz, CDCl3): δ 160.00 (d, J = 248.5 Hz), 135.01, 130.72 (d, J = 8.2 Hz), 
129.60 (d, J = 2.7 Hz), 129.55, 128.70, 127.83 (d, J = 1.3 Hz), 125.28 (d, J = 3.6 Hz), 123.78 (d, J 
= 13.9 Hz), 119.19, 116.37 (d, J = 21.2 Hz), 36.42 (d, J = 4.0 Hz). 
19F NMR Spectra (376 MHz, CDCl3): δ -117.2 (s, 1F).     
HRMS: [M-H]- calcd for C14H10FN: 210.0719. Found: 210.0740. 
IR: 3087, 3064, 3031, 2246, 1589, 1492, 1456, 1236, 1093, 1031, 804, 756, 725, 696cm-1 
 
Characterization of 2.1f: 
 
ref. 5 
Yield: 0.48 g, 1.97 mmol, 98% 
Appearance: white solid 
1H NMR Spectra (500 MHz, CDCl3): δ 7.92 (m, 3H), 7.66 (m, 1H), 7.53 (m, 3H), 7.36 (m, 5H), 
5.86 (s, 1H).   
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13C NMR (126 MHz, CDCl3): δ 135.58, 134.47, 131.11, 130.64, 129.89, 129.53, 129.49, 128.61, 
128.12, 127.51, 127.38, 126.56, 125.77, 123.38, 120.08, 77.61, 40.25. 
HRMS: [M]+calcd for C18H13N: 243.1048. Found: 243.1052. 
IR: 3085, 3062, 2962, 2927, 2904, 2632, 2416, 2358, 2331, 2241, 1681, 1650, 1625, 1598, 1512, 
1494, 1454, 1396, 1159, 1029, 862, 796, 775, 750, 725, 696, 642, 561 cm-1 
Characterization of 2.1g: 
 
ref. 6 
Yield: 26 mg, 1.12 mmol, 28% 
Appearance: dark yellow oil 
1H NMR Spectra (500 MHz, CDCl3): δ 7.37 (m, 9H), 5.13 (s, 1H). 
13C NMR Spectra (126 MHz, CDCl3): δ 137.82, 135.18, 130.54, 129.46, 128.66, 128.65, 127.98, 
127.79, 125.98, 119.15, 42.30. 
HRMS: [M+H]+ calcd for C14H10ClN: 228.0580. Found: 228.0598.  
 
Characterization of 2.1l: 
 
Yield: 0.38 g, 1.4 mmol, 48% 
Appearance: white solid 
1H NMR Spectra (500 MHz, CDCl3): δ 7.60 (m, 4H), 7.43 (m, 10H), 5.21 (s, 1H).  
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13C NMR (126 MHz, CDCl3): δ 141.61, 140.49, 136.16, 135.16, 129.60, 129.20, 128.66, 128.48, 
128.24, 128.09, 128.00, 127.44, 119.99, 42.66. 
HRMS: [M+H]+ calcd for C20H15N: 270.1283. Found: 270.1307.  
Preparation 2.1h:7 
 
To a 50 mL round bottom flask equipped with a magnetic stir bar, 1-fluoro-2-nitrobenzene (0.7 g; 
5 mmol), benzyl cyanide (0.6 g; 5 mmol), tetrabutylammonium bromide (1.6 g; 5 mmol), and 
toluene (21 mL) were added and allowed to stir for 10 min. Next, 50% w/w NaOH (2 mL, 2.5 M) 
was added to the solution and the mixture was stirred overnight at 50 oC. The mixture was diluted 
with toluene (15 mL) and washed with distilled water (50 mL x 3) and brine (20 mL) then dried 
using Na2SO4. The purified product was obtained after column chromatography in 10 % - 20% 
ethyl acetate:hexane. Yield 0.42 g (35%). 1H NMR (500 MHz, CDCl3): δ 8.09 (dd, J = 8.2, 1.4 Hz, 
1H), 7.74 (m, 2H), 7.58 (m, 1H), 7.37 (m, 5H), 6.20 (s, 1H). 13C NMR (126 MHz, CDCl3): δ 










Synthesis of 2.1i,8,9 2.1j,9 and 2.1o:10 
 
General procedure for aryl chloride coupling with benzyl cyanide in the synthesis of 2.1i, 
2.1j, 2.1o:6 In a 10 mL oven or flame dried Schlenk flask purged with argon, potassium hydroxide 
(KOH) (1.2 g, 20 mmol) and dimethyl sulfoxide (DMSO) (2.5 mL) were added and stirred for 30 
minutes. In a separate flask, benzyl cyanide (7.5 mmol, 0.89 g) was diluted with DMSO (1 mL) 
and the solution was added dropwise via syringe to the KOH mixture then stirred for 30 minutes. 
Aryl chloride was then added in portions and the mixture was stirred at room temperature 
overnight. Upon reaction completion, the vessel contents were poured into ice water (20 mL) and 
extracted into ethyl acetate (20 mL x 2) and washed with brine. The organic layer was dried over 
sodium sulfate and concentrated before purification by column chromatography with a gradient of 












Synthesis of 2,5-dimethyl-α-phenyl-1H-Pyrrole-1-acetonitrile:11  
 
In a 50 mL round bottom flask, 2-amino-2-phenylacetonitrile (2.6 mmol, 0.34 g), hexane-2,5-
dione (3.1 mmol, 0.35 g), and THF (13 mL) were added and stirred at room temperature for 5 
minutes. Iodine (0.26 mmol, 0.076 g) was added to the solution and stirred overnight. The mixture 
was then diluted with ethyl acetate (30 mL) and washed with saturated Na2S2O3 (20 mL) then 
NaHCO3 (20 mL) and brine. The organic layer was then dried over sodium sulfate and 
concentrated. The crude product was purified by column chromatography in a gradient of 5% - 
10% ethyl acetate:hexanes. Yield 77% (0.42 g). 1H NMR (500 MHz, CDCl3): δ 7.41 (m, 3H), 7.17 
(m, 2H), 6.35 (s, 1H), 5.90 (s, 2H), 2.19 (s, 6H). 13C NMR (126 MHz, CDCl3): δ 133.82, 129.62, 
129.37, 128.80, 125.80, 166.61, 108.05, 48.72, 13.30. HRMS: [M+H]+ calcd for C14H14N2: 












General procedure for the synthesis of Acetonitrile 2.1m and 2.1n:3 
 
In an oven or flame dried 25 mL Schlenk flask a solution of indium(III) bromide (0.17 mmol, 0.06 
g) and TMSCN (3.4 mmol, 0.33 g) in DCM (4 mL) was stirred for 30 minutes. In a separate flask, 
the alcohol (1.7 mmol) was diluted with DCM (4 mL) and the solution was added dropwise to the 
InBr3 mixture and stirred overnight. The reaction was quenched with distilled water (20 mL) and 
diluted with DCM (20 mL). The organic layer washed with distilled water (2 x 20 mL) then brine 
(20 mL). The crude product was dried over sodium sulfate and concentrated before purification by 
column chromatography in 5%, 10%, 15% ethyl acetate:hexane.  
Characterization of 2-(4-morpholinophenyl)-2-phenylacetonitrile 2.1m: 
 
Yield: 53% (25 mg).     
Appearance : orange solid 
1H NMR (500 MHz, CDCl3): δ 7.37 (m, 5H), 7.25 (m, 2H), 6.90 (m, 2H), 5.10 (s, 1H), 3.87 (m, 
4H), 3.17 (m, 4H). 
13C NMR (126 MHz, CDCl3): δ 151.34, 136.65, 129.45, 128.94, 128.43, 127.98, 127. 13, 120.30, 
116.13, 67.14, 49.21, 42.14, 
HRMS: [M+H] calcd for C18H18N2O: 279.1497. Found: 279.1498. 
IR: 2966, 2856, 2835, 2358, 1643, 1596, 1446, 1284, 1118, 923, 833, 740, 703, 644 cm-1 
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Synthesis and Characterization of Propargyl Carbonates: 
 
 
A 200 mL flame dried Schlenk flask was placed under an argon atmosphere and charged with 
propargyl alcohol (20 mmol) and DCM (100 mL) then stirred for 5 minutes at room temperature. 
Next, pyridine (3.3 mL, 40 mmol) was added to the solution and the mixture was stirred for 15 
minutes. The solution was then cooled to 0 oC using an ice water bath followed by the dropwise 
addition of methyl chloroformate (3.3 mL, 40 mmol) over ten minutes. The resulting mixture was 
allowed to stir for 1 hour at 0 oC then warmed to room temperature and stirred for an additional 
hour. The reaction was quenched with a saturated solution of ammonium chloride (50 mL) and 
extracted into DCM (100 mL) and washed with water (50 mL x 3) then brine (100 mL x 1). The 
crude product was dried over sodium sulfate and concentrated before purification by column 











    ref. 16 
Yield: 0.25 g, 1.2 mmol, 60% 
Appearance: clear liquid 
1H NMR (500 MHz, CDCl3): δ 4.74 (t, J = 2.2 Hz, 2H), 3.82 (s, 3H), 2.23 (tt, J = 7.3, 2.2 Hz, 
2H), 1.53 (m, 2H), 1.32 (m, 8H), 0.90 (t, J = 6.9 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 155.66, 88.96, 73.64, 56.65, 55.36, 32.05, 29.13, 29.12, 28.67, 
22.97, 19.09, 14.44. 
GC/MS: m/z [M+H]+ calcd for C12H20O3: 213.1; found: 213.1.  
IR: 2956, 2929, 2858, 2235, 1755, 1444, 1377, 1261, 1151, 950, 790 cm-1 
 
 
Yield: 18 mg, 1 mmol, 33%  
Appearance: clear liquid 
1H NMR (500 MHz, CDCl3): δ 7.35 (m, 4H), 7.27 (m, 1H), 4.82 (t, J = 2.2 Hz, 2H), 3.83 (s, 3H), 
3.67 (t, J = 2.2 Hz, 2H).  
13C NMR (126 MHz, CDCl3): δ 155.51, 136.14, 128.74, 128.08, 126.93, 85.98, 75.83, 56.31, 
55.24, 25.25. 
GC/MS: m/z [M]+ calcd for C12H12O3: 204.1; found 204.1. 
IR: 3062, 3029, 3008, 2956, 2235, 2202, 1747, 1731, 1703, 1600, 1583, 1494, 1444, 1421, 1377, 




Yield: 0.77g, 5 mmol, 45% 
Appearance: clear liquid 
1H NMR (500 MHz, CDCl3): δ 4.71 (d, J = 2.1 Hz, 2H), 3.82 (s, 3H), 1.28 (m, 1H), 0.76 (m, 4H), 
13C NMR (126 MHz, CDCl3): δ 155.63, 91.92, 69.00, 56.64, 55.34, 8.62, -0.22. 
GC/MS: m/z [M]+ calcd for C8H10O3: 154.1; found: 154.1.  
 
 
Yield: 55 mg, 3 mmol, 60% 
Appearance: clear liquid 
1H NMR (500 MHz, CDCl3): δ 4.75 (d, J = 2.1 Hz, 2H), 3.82 (s, 3H), 2.64 (qt, J = 7.6, 2.1 Hz, 
1H), 1.93 (m, 2H), 1.73 (m, 2H), 1.60 (m, 4H). 
13C NMR (126 MHz, CDCl3): δ 155.64, 93.01, 73.13, 56.74, 55.34, 33.85, 30.40, 25.31. 
GC/MS: m/z [M]+ calcd C10H14O3: 182.1; found: 182.1.  
 
 
Yield: 1.76 g, 9.0 mmol, 83% 
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Appearance: clear liquid  
1H NMR (500 MHz, CDCl3): δ 4.76 (d, J = 2.1 Hz, 2H), 3.82 (s, 3H), 2.41 (m, 1H), 1.80 (m, 2H), 
1.70 (m, 2H), 1.47 (br m, 3H), 1.30 (m, 3H). 
13C NMR (126 MHz, CDCl3): 155.63, 92.81, 73.54, 56.70, 55.33, 32.63, 29.38, 26.12, 25.14. 
GC/MS: m/z [M]+ calcd for C11H16O3: 196.1; found: 196.1. 
IR: 2931, 2854, 2235, 1755, 1446, 1375, 1265, 1157, 1020, 948, 900, 790 cm-1 
 
Yield: 2 g, 13 mmol, 70% 
Appearance: clear liquid 
1H NMR (500 MHz, CDCl3): δ 5.81 (m, 1H), 5.33 (dq, J = 17.1, 1.8 Hz, 1H), 5.14 (dq, J = 10.0, 
1.6 Hz, 1H), 4.78 (t, J = 2.2 Hz, 2H), 3.83 (s, 3H), 3.03 (dp, J = 6.0, 2.0 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 155.63, 132.02, 116.86, 85.19, 76.09, 56.43, 55.40, 23.38. 
GC/MS: m/z [M]+ calcd for C8H10O3: 154.1: found: 154.1. 
IR: 3016, 2983, 2958, 2358, 2341, 1747, 1714, 1444, 1421, 1377, 1263, 1149, 1107, 1020, 993, 
950, 919, 900, 790, 648 cm-1 
 
 
Yield: 1.7 g, 10.1 mmol, 56% 
Appearance: clear liquid  
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1H NMR (500 MHz, CDCl3): δ 5.00 (br m, 1H), 4.86 (br m, 1H), 4.78 (t, 2H), 3.83 (s, 3H), 2.96 
(m, 2H), 1.80 (m, 3H). 
13C NMR (126 MHz, CDCl3): δ 155.64, 140.14, 112.36, 85.65, 76.03, 56.47, 55.40, 27.82, 22.40. 
GC/MS: m/z [M]+ calcd for C9H12O3: 168.1; found: 168.1. 
IR: 2958, 2887, 2858, 2235, 1755, 1652, 1444, 1375, 1261, 1228, 1149, 948, 900, 790 cm-1 
 
 
Yield: 1.3 g, 9 mmol, 62% 
Appearance: clear liquid 
1H NMR (500 MHz, CDCl3): δ 5.83 (ddt, J = 17.6, 11.0, 1.9 Hz, 1H), 5.71 (dd, J = 17.5, 2.2 Hz, 
1H), 5.56 (dd, J = 11.0, 2.2 Hz, 1H), 4.87 (d, J = 2.0 Hz, 2H), 3.84 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 155.58, 128.86, 116.52, 86.14, 83.15, 56.40, 55.49. 
GC/MS: m/z [M]+ calcd for C7H8O3: 140.0; found: 140.1. 
IR: 3014, 2958, 2235, 1749, 1712, 1602, 1444, 1413, 1375, 1263, 1199, 1168, 1107, 1018, 950, 













O 2.5 mol % Pd2(dba)35 mol% Ligand








entry Ligand starting 
material
dienylation propargylation
1 XantPhos 2% 14% 62%
2 dppe 3% 94% 3%
3 dppm 28% 42% 27%
4 dppb 2% 85% 13%











(R)-SEGPHOS 5% 0% 76% 23%
8 tri-otolylphosphine 48% 3% 41% 9%
9 rac-BINAP 4% 1% 70% 24%
10 (R)-C3-tunephos 1% 0% 86% 13%
11 XPhos 11% 1% 36% 53%
12 dppbz 3% 0% 93% 3%
13b SPhos 13% 2% 24% 60%
14b (R)-DM-BINAP 3% 1% 80% 17%
15b tri-1-nap phosphine 52% 3% 37% 9%
16b Ligand 1 44% 1% 48% 7%
17b JohnPhos 45% 20% 2% 33%
18b Cy-JohnPhos 56% 4% 15% 25%
19b tBu-MePhos 22% 29% 2% 47%
20b tBu-XPhos 43% 18% 7% 37%
21b MePhos 11% 3% 19% 67%
0.3 mmol 1 eq










a Determined by GC/MS analysis.









Solvent Screen:  
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Experimental Procedure for the dienylation and propargylation of tertiary nitriles:  
In an oven or flamed dried Biotage microwave reaction vial (part no. 354624) equipped with a 
magnetic stir bar, catalyst (Pd2(dba)3, 0.0137 g,  5 mol %), ligand (dppe, 0.012 g, 10 mol % or  
MePhos, 0.011 g, 10 mol %), and diaryl acetonitrile (0.3 mmol if solid) were added under an argon 
atmosphere in a glovebox. The solid mixture was dissolved in 2 mL anhydrous DMF followed by 
addition of diaryl acetonitrile (0.3 mmol if liquid) and propargyl carbonate (0.6 mmol). The vessel 
was sealed, removed from the glovebox, and placed in a preheated oil bath at 80 oC for 1 hr. After 
reaction completion, the vessel was unsealed and solid lithium hydroxide (0.6 mmol) was added to 
the solution followed by 1 mL distilled water. The resulting mixture was stirred for an additional 
hour. The crude product was diluted with DCM (50 mL) and the organic layer was washed with 
distilled water (50 mL x 3) then brine (50 mL) before being dried over sodium sulfate.  The 
organic phase was concentrated via rotary evaporation and purified via column chromatography in 
0-5% ethyl acetate in hexane.  
 
 86 
Characterization of Dienylated and Propargylated Tertiary Nitriles: 
 
 
Yield: 66 mg, 0.27 mmol, 89%  
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.48 (m, 10H), 6.46 (dd, J = 17.6, 11.2 Hz, 1H), 5.79 (s, 1H), 5.55 
(d, J = 17.5 Hz, 1H), 5.33 (d, J = 11.2 Hz, 1H), 4.82 (s, 1H).  
13C NMR (126 MHz, CDCl3): δ 145.87, 138.35, 135.07, 128.99, 128.91, 128.51, 122.39, 120.51, 
118.55, 56.94.  




Yield: 64 mg, 0.23 mmol, 77% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.38 (m, 5H), 7.26 (m, 2H), 6.91 (m, 2H), 6.35 (m, 1H), 5.67 (s, 
1H), 5.45 (d, J = 17.5 Hz, 1H), 5.23 (d, J = 11.2 Hz, 1H), 4.72 (s, 1H), 3.83 (s, 3H).  
13C NMR (126 MHz, CDCl3): δ 159.59, 146.11, 138.67, 135.10, 130.30, 130.11, 128.95, 128.81, 
128.43, 122.55, 120.21, 118.45, 114.27, 56.28, 55.61. 
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Yield: 76 mg, 0.29 mmol, 96% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.42 (m, 6H), 7.14 (m, 2H), 6.95 (td, J = 7.9, 1.7 Hz, 1H), 6.36 
(dd, J = 17.5, 11.2 Hz, 1H), 5.70 (s, 1H), 5.52 (d, J = 17.5 Hz, 1H), 5.25 (d, J = 11.1 Hz, 1H), 4.83 
(s, 1H).  
13C NMR (126 MHz, CDCl3): δ 160.75 (d, J = 252.4 Hz), 144.05, 136.89, 134.77, 131.06 (d, J = 
8.5 Hz), 130.57 (d, J = 2.2 Hz), 129.15, 128.79, 128.60, 126.36 (d, J = 11.3 Hz), 124.43 (d, J = 3.7 
Hz), 120.81, 119.25, 118.49, 117.00 (d, J = 21.7 Hz), 52.94.  




Yield: 74 mg, 0.25 mmol, 83% 
Appearance : yellow oil  
 88 
1H NMR (500 MHz, CDCl3): δ 7.87 (m, 2H), 7.80 (m, 2H), 7.52 (m, 3H), 7.40 (m, 5H), 6.39 (dd, 
J = 17.5, 11.2 Hz, 1H), 5.73 (s, 1H), 5.48 (d, J = 17.5 Hz, 1H), 5.24 (d, J = 11.2 Hz, 1H), 4.77 (s, 
1H).  
13C NMR (126 MHz, CDCl3): δ 145.77, 138.35, 135.72, 135.13, 133.29, 133.09, 129.08, 129.05, 
128.86, 128.70, 128.62, 128.16, 127.91, 127.20, 126.97, 126.52, 122.41, 120.74, 118.70, 57.12. 




Yield: 84 mg, 0.26 mmol, 86% 
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.53 (m, 2H), 7.38 (m, 5H), 7.24 (m, 2H), 6.33 (dd, J = 17.5, 11.2 
Hz, 1H), 5.69 (s, 1H), 5.44 (d, J = 17.5 Hz, 1H), 5.24 (d, J = 11.2 Hz, 1H), 4.71 (s, 1H). 
13C NMR (126 MHz, CDCl3): δ 145.44, 137.82, 137.56, 134.79, 132.17, 130.64, 129.15, 128.78, 
128.75, 122.84, 121.91, 120.80, 118.89, 56.50. 






Yield: 72 mg, 0.24 mmol, 81%  
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 8.15 (m, 1H), 7.91 (m, 2H), 7.47 (m, 8H), 7.13 (m, 1H), 6.43 (dd, 
J = 17.4, 11.1 Hz, 1H), 5.80 (s, 1H), 5.63 (d, J = 17.5 Hz, 1H), 5.28 (d, J = 11.1 Hz, 1H), 4.87 (s, 
1H).  
13C NMR (126 MHz, CDCl3): δ 145.33, 138.25, 135.22, 134.88, 133.84, 130.89, 130.43, 129.33, 
129.20, 128.99, 128.79, 128.65, 126.57, 126.48, 126.16, 124.90, 122.21, 119.70, 118.30, 55.91. 
GC/MS: m/z [M]+ calcd for C22H17N: 295.1; found: 295.2. 
IR: 3087, 3060, 3029, 2925, 2248, 2239, 1591, 1487, 1448, 1398, 1076, 1010, 914, 815, 757, 734, 




Yield: 75 mg, 0.23 mmol, 77% 
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.38 (m, 8H), 7.28 (m, 1H), 6.33 (dd, J = 17.5, 11.2 Hz, 1H), 5.70 
(s, 1H), 5.44 (d, J = 17.6 Hz, 1H), 5.25 (d, J = 11.2 Hz, 1H), 4.72 (s, 1H).  
 90 
13C NMR (126 MHz, CDCl3): δ 145.35, 140.43, 137.66, 135.09, 134.77, 130.24, 129.18, 129.03, 
128.87, 128.81, 127.21, 121.84, 120.91, 118.92, 56.63. 




Yield: 71 mg, 0.25 mmol, 82% 
Appearance : orange oil 
1H NMR (500 MHz, CDCl3): δ 7.82 (m, 1H), 7.47 (m, 2H), 7.29 (m, 5H), 7.17 (m, 1H), 6.18 (dd, 
J = 17.4, 11.1 Hz, 1H), 5.60 (s, 1H), 5.35 (d, J = 17.4 Hz, 1H), 5.11 (d, J = 11.1 Hz, 1H), 4.75 (s, 
1H).   
13C NMR (126 MHz, CDCl3): δ 150.00, 144.88, 136.96, 134.53, 132.85, 132.36, 131.32, 130.30, 
129.21, 128.90, 128.37, 126.38, 119.70, 119.47, 118.97, 55.33. 




Yield: 17 mg, 0.070 mmol, 23% 
Appearance : orange-red oil  
 91 
1H NMR (500 MHz, CDCl3): δ 8.72 (ddd, J = 4.8, 1.9, 0.9 Hz, 1H), 7.72 (td, J = 7.8, 1.9 Hz, 1H), 
7.39 (m, 6H), 7.28 (m, 1H), 6.36 (dd, J = 17.6, 11.2 Hz, 1H), 5.69 (s, 1H), 5.39 (d, J = 17.6 Hz, 
1H), 5.20 (d, J = 11.2 Hz, 1H), 4.73 (s, 1H).  
13C NMR (126 MHz, CDCl3): δ 157.66, 150.07, 145.30, 137.51, 137.39, 135.06, 129.09, 128.85, 
128.67, 123.52, 123.27, 121.53, 120.67, 118.45, 59.39. 
GC/MS: m/z [M]+ calcd for C17H14N2: 246.1; found: 246.2. 





Yield: 9.6 mg, 0.04 mmol, 13% 
Appearance : orange-red oil  
1H NMR (500 MHz, CDCl3) major isomer: δ 8.85 (d, J = 4.9 Hz, 2H), 7.52 (m, 2H), 7.39 (m, 
4H), 6.38 (dd, J = 17.6, 11.3 Hz, 1H), 5.70 (s, 1H), 5.31 (d, J = 17.6 Hz, 1H), 5.17 (d, J = 11.3 Hz, 
1H), 4.85 (s, 1H).  
13C NMR (126 MHz, CDCl3) major isomer: δ 167.30, 158.13, 144.90, 136.43, 135.05, 129.04, 
128.80, 128.76, 120.78, 120.53, 120.29, 118.03, 60.83. 




Yield: 59 mg, 0.23 mmol, 75% 
Appearance : orange oil  
1H NMR (500 MHz, CDCl3): δ 7.44 (m, 3H), 7.32 (m, 2H), 6.51 (dd, J = 17.6, 11.3 Hz, 1H), 5.88 
(s, 2H), 5.72 (s, 1H), 5.63 (d, J = 17.5 Hz, 1H), 5.39 (d, J = 11.2 Hz, 1H), 4.68 (s, 1H), 2.11 (s, 
6H).  
13C NMR (126 MHz, CDCl3): δ 144.35, 136.94, 134.35, 131.55, 129.78, 129.22, 128.77, 120.69, 
119.77, 118.76, 109.86, 66.92, 16.76. 
GC/MS: m/z [M]+ calcd for C18H18N2: 262.1; found: 262.2. 
IR: 3099, 3062, 3029, 2960, 2927, 2898, 1712, 1593, 1523, 1492, 1450, 1375, 1271, 1186, 1064, 




Yield: 91 mg, 0.28 mmol, 94% 
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.64 (m, 5H), 7.45 (m, 10H), 6.40 (dd, J = 17.5, 11.2 Hz, 1H), 
5.73 (s, 1H), 5.50 (d, J = 17.5 Hz, 1H), 5.27 (d, J = 11.1 Hz, 1H), 4.80 (s, 1H).  
 93 
13C NMR (126 MHz, CDCl3): δ 145.80, 141.32, 140.31, 138.30, 137.34, 135.04, 129.35, 129.17, 
129.05, 128.89, 128.57, 127.99, 127.62, 127.37, 122.35, 120.55, 118.65, 56.70. 




Yield: 99 mg, 0.3 mmol, 99% 
Appearance : orange-red oil  
1H NMR (500 MHz, CDCl3): δ 7.37 (m, 5H), 7.22 (m, 2H), 6.90 (m, 2H), 6.35 (dd, J = 17.5, 11.2 
Hz, 1H), 5.66 (s, 1H), 5.45 (d, J = 17.5 Hz, 1H), 5.21 (d, J = 11.2 Hz, 1H), 4.73 (s, 1H), 3.87 (m, 
4H), 3.20 (m, 4H).  
13C NMR (126 MHz, CDCl3): δ 150.94, 146.10, 138.73, 135.11, 129.73, 128.99, 128.87, 128.78, 
128.33, 122.54, 120.05, 118.32, 115.29, 67.05, 56.21, 48.89. 
GC/MS: m/z [M]+ calcd for C22H22N2O: 330.2; found: 330.2. 
IR: 2962, 2910, 2893, 2854, 2827, 2235, 1608, 1514, 1490, 1448, 1380, 1263, 1238, 1184, 1122, 






Yield: 33 mg, 0.13 mmol, 42% 
Appearance : light yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.37 (m, 10H), 6.03 (m, 1H), 5.94 (dq, J = 15.8, 6.5 Hz, 1H), 5.54 
(s, 1H), 4.53 (s, 1H), 1.73 (dd, J = 6.4, 1.5 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 145.70, 138.64, 130.31, 129.41, 128.97, 128.93, 128.41, 122.66, 
118.37, 57.33, 18.91. 




Yield: 41 mg, 0.12 mmol, 41% 
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3) major isomer: δ 7.37 (m, 10H), 6.00 (m, 1H), 5.90 (dt, J = 15.8, 6.8 
Hz, 1H), 5.55 (s, 1H), 4.56 (s, 1H), 2.04 (m, 2H), 1.25 (m, 8H), 0.88 (t, J = 7.2 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 145.80, 138.69, 135.96, 129.00, 128.90, 128.38, 128.14, 122.64, 
118.47, 57.28, 33.31, 31.96, 29.23, 28.96, 22.91, 14.43. 
GC/MS: m/z [M]+ calcd for C24H27N: 329.2; found: 329.2. 
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Yield: 49 mg, 0.21 mmol, 70%  
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.22 (m, 15H), 6.69 (d, J = 16.2 Hz, 1H), 6.60 (d, J = 16.2 Hz, 
1H), 5.68 (s, 1H), 4.63 (s, 1H).   
13C NMR (126 MHz, CDCl3): δ 145.55, 138.49, 136.82, 132.85, 129.06, 128.99, 128.88, 128.57, 
128.40, 127.05, 126.75, 122.53, 119.83, 57.40. 
GC/MS: m/z [M]+ calcd for C24H19N: 321.2; found: 321.2. 
IR: 3082, 3060, 3028, 2927, 2250, 2237, 1639, 1633, 1598, 1492, 1448, 1334, 1074, 1031, 962, 




Yield: 60 mg, 0.22 mmol, 74% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.35 (m, 10H), 6.48 (dd, J = 15.6, 10.5 Hz, 1H), 6.32 (dt, J = 
17.0, 10.3 Hz, 1H), 6.19 (d, J = 15.6 Hz, 1H), 5.70 (s, 1H), 5.24 (d, J = 16.9 Hz, 1H), 5.15 (d, J = 
9.9 Hz, 1H), 4.68 (s, 1H). 
 96 
13C NMR (126 MHz, CDCl3): δ 145.34, 138.44, 136.94, 133.60, 130.76, 129.03, 128.98, 128.56, 
122.46, 119.54, 119.46, 57.35. 




Yield: 45 mg, 0.15 mmol, 51%  
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): product 5f only: δ 7.38 (m, 10H), 5.82 (m, 1H), 5.43 (s, 1H), 4.85 
(s, 1H), 2.43 (m, 2H), 2.33 (m, 2H), 1.74 (m, 2H), 1.62 (m, 2H).   
13C NMR (126 MHz, CDCl3): product 5f only: δ 151.24, 145.39, 138.68, 129.05, 128.85, 128.38, 
122.79, 118.61, 118.25, 59.29, 35.49, 32.11, 27.01, 25.77.  






Yield: 63 mg, 0.14 mmol, 93% 
Appearance : off-white solid 
1H NMR (500 MHz, CDCl3): δ 7.31 (m, 20H), 6.20 (d, J = 15.8 Hz, 1H), 5.78 (dt, J = 15.9, 7.2 
Hz, 1H), 5.56 (s, 1H), 4.64 (s, 1H), 3.14 (dd, J  = 7.3, 1.4 Hz, 2H).  
13C NMR (126 MHz, CDCl3): δ 144.73, 139.76, 138.19, 133.45, 129.12, 129.00, 128.83, 128.42, 
128.17, 127.91, 127.20, 122.27, 122.00, 121.11, 56.83, 52.03, 43.69. 




Yield: 64 mg, 0.26 mmol, 86% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.39 (m, 10H), 3.21 (q, J = 2.5 Hz, 2H), 1.76 (t, J = 2.51 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 139.62, 129.05, 128.40, 127.40, 122.30, 81.08, 73.56, 51.94, 
31.54, 3.86. 





Yield: 55 mg, 0.20 mmol, 67% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.38 (m, 7H), 6.91 (m, 2H), 3.82 (s, 3H), 3.17 (q, J = 2.5 Hz, 2H), 
1.76 (t, J = 2.5 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 159.49, 139.98, 131.62, 129.01, 128.66, 128.33, 127.33, 122.50, 
114.32, 81.00, 73.68, 55.60, 51.27, 31.72, 3.89. 
GC/MS: m/z [M]+ calcd for C19H17NO: 275.1; found: 275.2.  
IR: 3002, 2956, 2920, 2839, 2237, 1608, 1583, 1512, 1494, 1461, 1448, 1299, 1255, 1184, 1033, 




Yield: 53 mg, 0.20 mmol, 67% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.63 (td, J = 7.9, 1.7 Hz, 1H), 7.37 (m, 6H), 7.25 (td, J = 7.6, 1.3 
Hz, 1H), 7.07 (ddd, J = 11.5, 8.2, 1.3 Hz, 1H), 3.28 (m, 2H), 1.75 (t, J = 2.5 Hz, 3H).  
 99 
13C NMR (126 MHz, CDCl3): δ 160.64 (d, J = 251.1 Hz), 138.79, 130.91 (d, J = 8.7 Hz), 129.02, 
128.91 (d, J = 2.8 Hz), 128.49, 126.76, 126.42 (d, J = 10.8 Hz), 124.51 (d, J = 3.6 Hz), 120.94, 
117.13 (d, J = 21.7 Hz), 81.35, 73.31, 48.92, 30.50 (d, J = 2.2 Hz), 3.86.  
19F (376 MHz, CDCl3): δ -108.8 (s, 1F). 
GC/MS: m/z [M]+ calcd for C18H14FN: 263.1; found: 263.2. 





Yield: 74 mg, 0.25 mmol, 84% 
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 8.02 (d, J = 2.1 Hz, 1H), 7.87 (m, 3H), 7.55 (m, 2H), 7.42 (m, 
6H), 3.31 (q, J = 2.5 Hz, 2H), 1.75 (t, J = 2.5 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 139.60, 136.80, 133.26, 133.03, 129.16, 129.12, 128.68, 128.54, 
127.93, 127.57, 127.12, 127.03, 126.37, 125.26, 122.30, 81.32, 73.55, 52.12, 31.48, 3.96. 
GC/MS: m/z [M]+ calcd for C22H17N: 295.1; found: 295.2.  






Yield: 68 mg, 0.23 mmol, 78% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.89 (m, 4H), 7.59 (t, J = 7.8 Hz, 1H), 7.35 (m, 7H), 3.43 (dq, J = 
16.4, 2.5 Hz, 1H), 3.28 (dq, J = 16.4, 2.5 Hz, 1H), 1.80 (t, J = 2.5 Hz, 3H).  
13C NMR (126 MHz, CDCl3): 140.70, 135.03, 132.71, 130.69, 130.51, 129.37, 129.11, 128.27, 
126.65, 126.61, 126.04, 125.90, 125.80, 124.94, 121.96, 81.60, 73.67, 50.37, 33.63, 3.94. 
GCMS: m/z [M]+ calcd for C22H17N: 295.1. Found: 295.2. 
IR: 3085, 3055, 3029, 2918, 2237, 1600, 1510, 1490, 1448, 1434, 1398, 1161, 1031, 910, 796, 




Yield: 64 mg, 0.23 mmol, 75% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.37 (m, 9H), 3.18 (p, J = 2.5 Hz, 2H), 1.76 (t, J = 2.5 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 141.62, 138.94, 135.08, 130.32, 129.30, 128.78, 128.76, 127.79, 
127.38, 125.79, 121.80, 81.63, 73.14, 51.72, 31.53, 3.90. 
GC/MS: m/z [M]+ calcd for C18H14ClN: 279.1; found: 279.2. 
 101 
IR: 3062, 3029, 2920, 2852, 2239, 1593, 1573, 1492, 1475, 1448, 1421, 1190, 1168, 1089, 999, 




Yield: 81 mg, 0.28 mmol, 94% 
Appearance : orange oil  
1H NMR (500 MHz, CDCl3): δ 8.00 (dd, J = 8.0, 1.3 Hz, 1H), 7.74 (m, 2H), 7.58 (td, J = 7.7, 1.3 
Hz, 1H), 7.32 (m, 5H), 3.40 (m, 2H), 1.76 (t, J = 2.5 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 150.17, 137.55, 132.52, 131.49, 130.89, 130.19, 128.98, 128.78, 
126.96, 126.15, 120.40, 82.40, 73.05, 50.31, 32.30, 3.85. 
GC/MS: m/z [M]+ calcd for C18H14N2O2: 290.1; found: 290.1. 
IR: 3062, 2920, 2852, 2241, 1749, 1600, 1577, 1535, 1492, 1448, 1440, 1359, 1031, 912, 854, 




Yield: 54 mg, 0.22 mmol, 74% 
Appearance : orange-red oil 
1H NMR (500 MHz, CDCl3): δ 8.55 (m, 1H), 7.39 (m, 8H), 3.33 (m, 2H), 1.61 (m, 3H).  
 102 
13C NMR (126 MHz, CDCl3): δ 157.52, 149.58, 138.71, 137.47, 129.06, 128.45, 126.96, 123.28, 
122.80, 121.80, 80.30, 73.95, 54.42, 30.55, 3.87. 
GC/MS: m/z [M]+ calcd for C17H14N2: 246.1; found: 246.1.  
IR: 3058, 2920, 2854, 2241, 1587, 1573, 1494, 1467, 1448, 1431, 1298, 1153, 1054, 1033, 993, 




Yield: 67 mg, 0.27 mmol, 89% 
Appearance : red oil 
1H NMR (500 MHz, CDCl3): δ 8.79 (d, J = 4.9 Hz, 2H), 7.56 (m, 2H), 7.32 (m, 4H), 3.61 (dq, J = 
16.5, 2.5 Hz, 1H), 3.32 (dq, 16.4, 2.5 Hz, 1H), 1.70 (t, J = 2.5 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 166.79, 158.01, 137.59, 129.15, 128.67, 126.66, 120.88, 120.40, 
80.25, 73.69, 56.75, 30.42, 3.88. 
GC/MS: m/z [M]+ calcd for C16H13N3: 247.1; found: 247.2. 
IR: 3087, 3060, 3039, 3960, 2920, 2854, 2244, 1566, 1494, 1450, 1434, 1409, 1058, 1033, 912, 





Yield: 87 mg, 0.27 mmol, 89% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.62 (m, 4H), 7.44 (m, 10H), 3.26 (q, J = 2.5 Hz, 2H), 1.78 (t, J = 
2.5 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 141.28, 140.38, 139.61, 138.60, 129.17, 129.14, 128.50, 127.97, 
127.90, 127.73, 127.44, 127.39, 122.31, 81.22, 73.58, 51.76, 31.57, 3.92. 
GC/MS: m/z [M]+ calcd for C24H19N: 321.2; found: 321.2. 
IR: 3058, 3029, 2918, 2239, 1598, 1487, 1448, 1434, 1407, 1006, 910, 833, 763, 730, 696, 675, 




Yield: 54 mg, 0.20 mmol, 68%  
Appearance : dark yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.55 (m, 2H), 7.44 (m, 4H), 7.37 (m, 3H), 7.32 (m, 1H), 6.91 (d, J 
= 16 Hz, 1H), 6.39 (d, J = 16 Hz, 1H), 3.02 (q, J = 2.5 Hz, 2H), 1.80 (t, J = 2.5 Hz, 3H).   
13C NMR (126 MHz, CDCl3): δ 138.38, 135.95, 132.76, 129.27, 129.02, 128.72, 128.65, 127.78, 
127.14, 126.78, 120.99, 81.10, 73.08, 49.38, 31.91, 3.91. 
GC/MS: m/z [M]+ calcd for C20H17N: 271.1; found: 271.1. 
IR: 3060, 3028, 2918, 2852, 2239, 1714, 1577, 1494, 1448, 1434, 1157, 1072, 1029, 966, 748, 





Yield: 18 mg, 0.063 mmol, 21% 
Appearance : orange oil 
1H NMR (500 MHz, CDCl3) major isomer: δ 7.83 (m, 1H), 7.55 (m, 3H), 7.42 (m, 5H), 3.62 (dq, 
J = 16.6, 2.5 Hz, 1 H), 3.34 (dq, J = 16.6, 2.5 Hz, 1H), 1.76 (t, 3H). 
13C NMR (126 MHz, CDCl3) major isomer: δ 161.44, 151.52, 140.81, 135.09, 129.52, 129.50, 
126.54, 126.37, 125.32, 121.06, 118.03, 111.50, 81.51, 72.30, 49.55, 31.17, 3.95. 
GC/MS: m/z [M]+ calcd for C19H14N2O: 286.1; found: 286.2. 




Yield: 78 mg, 0.3 mmol, 99% 
Appearance : clear yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.40 (m, 10H), 3.22 (t, J = 2.4 Hz, 2H), 2.12 (qt, J = 7.4, 2.3 Hz, 
2H), 1.06 (t, J = 7.5 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 139.61, 128.99, 128.38, 127.46, 122.26, 87.19, 73.91, 51.95, 
31.54, 14.04, 12.65. 
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GC/MS: m/z [M]+ calcd for C19H17N: 259.1; found: 259.2. 
IR: 3060, 2975, 2935, 2920, 2237, 1598, 1585, 1494, 1448, 1319, 1033, 1002, 754, 698, 651, 624, 




Yield: 96 mg, 0.29 mmol, 97% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.39 (m, 10H), 3.24 (t, J = 2.4 Hz, 2H), 2.11 (tt, J = 7.0, 2.4 Hz, 
2H), 1.31 (m, 10H), 0.92 (t, J = 7.2 Hz, 3H).  
13C NMR (126 MHz, CDCl3): δ 139.64, 129.01, 128.37, 127.48, 122.30, 85.93, 74.51, 52.02, 
32.03, 31.63, 29.09, 28.87, 28.84, 22.96, 18.92, 14.43. 
GC/MS: m/z [M]+ calcd for C24H27N: 329.2; found: 329.2. 
IR: 3060, 2954, 2927, 2856, 2237, 1598, 1494, 1465, 1448, 1434, 1330, 1033, 1002, 754, 698, 




Yield: 27 mg, 0.084 mmol, 28%  
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.33 (m, 15H), 3.56 (t, J = 2.4 Hz, 2H), 3.33 (t, J = 2.4 Hz, 2H).  
13C NMR (126 MHz, CDCl3): δ 139.48, 136.80, 129.15, 128.67, 128.49, 128.12, 127.50, 126.73, 
122.31, 83.09, 76.98, 51.97, 31.75, 25.33. 




Yield: 81 mg, 0.3 mmol, 99% 
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.39 (m, 10H), 3.20 (d, J = 2.0 Hz, 2H), 1.15 (m, 1H), 0.68 (m, 
2H), 0.55 (m, 2H).  
13C NMR (126 MHz, CDCl3): δ 139.56, 128.97, 128.38, 127.44, 122.19, 88.98, 69.63, 51.96, 
31.58, 8.33, -0.23. 
GC/MS: m/z [M]+ calcd for C20H17N: 271.1; found: 271.2. 





Yield: 90 mg, 0.3 mmol, 99% 
Appearance : yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.39 (m, 10H), 3.23 (d, J = 2.2 Hz, 2H), 2.56 (m, 1H), 1.79 (m, 
2H), 1.63 (m, 2H), 1.51 (m, 4H).  
13C NMR (126 MHz, CDCl3): δ 139.64, 128.95, 128.35, 127.51, 122.26, 90.42, 74.19, 52.04, 
33.89, 31.65, 30.38, 24.97. 




Yield: 93 mg, 0.3 mmol, 99%  
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.39 (m, 10H), 3.24 (d, J = 2.2 Hz, 2H), 2.34 (br m, 1H), 1.65 (br 
m, 2H), 1.57 (br m, 2H), 1.31 (m, 6H).  
13C NMR (126 MHz, CDCl3): δ 139.62, 128.97, 128.36, 127.53, 122.29, 90.05, 74.71, 52.09, 
32.63, 31.65, 29.04, 26.15, 24.68.  
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GC/MS: m/z [M]+ calcd for C23H23N: 313.2; found: 313.3. 




Yield: 54 mg, 0.20 mmol, 67% 
Appearance : yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.41 (m, 10H), 5.73 (m, 1H), 5.16 (dq, J = 16.9, 1.8 Hz, 1H), 5.04 
(dq, J = 10.0, 1.7 Hz, 1H), 3.29 (t, J = 2.3 Hz, 2H), 2.91 (dp, J = 4.3, 2.1 Hz, 2H).   
13C NMR (126 MHz, CDCl3): δ 139.51, 132.43, 129.10, 128.47, 127.46, 122.26, 116.36, 82.08, 
77.13, 51.93, 31.64, 23.23. 





Yield: 52 mg, 0.19 mmol, 63% 
Appearance : clear yellow oil  
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1H NMR (500 MHz, CDCl3): δ 7.49 (m, 2H), 7.27 (m, 8H), 3.24 (m, 1H), 1.65 (d, J = 2.3 Hz, 
3H), 1.46 (m, 2H), 1.00 (t, J = 7.3 Hz, 3H).    
13C NMR (126 MHz, CDCl3): δ 139.68, 139.37, 129.13, 128.71, 128.12, 128.03, 127.92, 127.25, 
121.56, 82.22, 77.54, 57.70, 42.42, 25.37, 12.71, 3.92. 
GC/MS: m/z [M]+ calcd for C20H19N: 273.2; found: 273.2. 




Yield: 77 mg, 0.28 mmol, 92% 
Appearance : clear light yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.51 (m, 2H), 7.38 (m, 2H), 7.26 (m, 6H), 3.52 (qt, J = 6.8, 2.2 
Hz, 1H), 2.01 (m, 2H), 1.23 (d, J = 6.9 Hz, 3H), 0.93 (t, J = 7.5 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 139.45, 139.11, 129.09, 128.62, 128.16, 128.05, 127.99, 127.31, 
121.26, 87.21, 79.39, 58.13, 34.75, 18.61, 14.05, 12.66.  
GC/MS: m/z [M]+ calcd for C20H19N: 273.2; found: 273.2.  
IR: 3060, 3033, 2977, 2937, 2918, 2877, 2237, 1598, 1494, 1450, 1377, 1319, 1033, 1002, 914, 




Yield: 74 mg, 0.26 mmol, 87% 
Appearance : clear yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.40 (br m, 10H), 4.84 (m, 1H), 4.76 (m, 1H), 3.28 (t, J = 2.4 Hz, 
2H), 2.84 (m, 2H), 1.67 (m, 3H). 
13C NMR (126 MHz, CDCl3): δ 140.68, 139.55, 129.13, 128.48, 127.48, 122.31, 111.92, 82.66, 
76.86, 51.98, 31.70, 27.80, 22.32. 




Yield: 14 mg, 0.054 mmol, 18% 
Appearance : clear yellow oil  
1H NMR (500 MHz, CDCl3): δ 7.40 (br m, 10H), 5.71 (ddt, J = 17.5, 11.0, 2.0 Hz, 1H), 5.55 (dd, 
J = 17.6, 2.2 Hz, 1H), 5.43 (dd, J = 11.1, 2.2 Hz, 1H), 3.38 (d, J = 2.0 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 139.41, 129.15, 128.58, 127.68, 127.47, 122.08, 117.05, 84.65, 
84.12, 51.73, 32.08. 
GC/MS: m/z [M]+ calcd for C19H15N: 257.1; found: 257.2. 
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Yield: 16 mg, 0.054 mmol, 18% 
Appearance : clear yellow oil 
1H NMR (500 MHz, CDCl3): δ 7.40 (m, 15H), 3.49 (s, 2H).  
13C NMR (126 MHz, CDCl3): δ 139.44, 131.96, 129.14, 128.59, 128.53, 128.48, 127.53, 123.08, 
122.13, 85.53, 84.17, 51.80, 32.17. 
GC/MS: m/z [M]+ calcd for C23H17N: 307.1; found: 307.2 
IR: 3060, 3031, 2954, 2923, 2852, 2239, 1596, 1583, 1490, 1448, 1313, 1031, 912, 756, 694, 655, 







































































































































































































































Chapter 3. Palladium-Catalyzed Decarboxylative Propargylation and 1,3-Dienylation 
 
3.1 Introduction to Metal-Catalyzed Decarboxylation  
 Chapter 2 of this dissertation presented methods developed for the intermolecular 
dienylation and propargylation of α,α-diaryl acetonitrile pronucleophiles (Scheme 3.1).1 
However, the substrate scope was limited to weakly stabilized α,α-diaryl acetonitriles with a pKa 
similar to that of methanol (pKa = < 17). In order to expand the substrate scope to less stable 
nucleophiles (pKa > 17) we envisioned the development of an intramolecular variant that would 
generate the activated nucleophile in situ via decarboxylation (Scheme 3.2).2,3,4,5,6,7 
 
 
In standard transition metal-catalyzed cross-coupling methods both activation of the 
nucleophile and electrophile are required prior to bond formation (Scheme 3.3).8 Activation is 
typically achieved using an external base or preformed organometallic species. The employed 
reagents are often expensive, toxic or highly basic. Further, a necessary result of these standard 
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decarboxylative cross-coupling reactions possess significant advantages (Scheme 3.3).8 For 
example, the required starting materials can be easily and efficiently synthesized from readily 
available reagents and irreversible decarboxylation can drive the formation of reactive 
intermediates while generating CO2 as the only byproduct. Despite these significant advantages, 
only a handful of methods have been developed for decarboxylative propargylation, which will be 
presented in the following sections of this dissertation. 
 
 
3.2 Decarboxylative Propargylation Methods 
 In 1994, Bienaymé reported that decarboxylative propargylation of substituted 
propargylic carbonates could be achieved using Pd(PPh3)4 (Scheme 3.4).9 However, the method 
was not optimized for selective product formation and contamination by the allenyl isomer was 
frequently observed. Further, product ratios were largely affected by the substitution patterns on 
the starting carbonate. Specifically, terminal acetylene derivatives were found to favor the 
propargyl isomer while the addition of substituents, such as TMS or Ph, favored the allenyl 
isomer. The observed selectivity was suggested to arise from a change in the favored palladium-
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bound intermediate from an η1-propargylpalladium species to an η1-allenylpalladium species 
which avoids unfavorable steric interactions with R3 (Scheme 3.4). Lastly, in addition to the 
reported lack in selectivity, only poor to moderate yields of the product mixtures were obtained.  
 
 In 2011, Stoltz and coworkers reported a single example of the enantioselective 
decarboxylative propargylation of a cyclohexanone derivative (Scheme 3.5).10 However, only a 
brief ligand screen was reported which resulted in poor enantiomeric excess and produced only 
moderate yields. Further, the reported product was not isolated and observed yields were 











R1 R2 R3 yield selectivity (2 / 3)
Me Me H 59 36 / 64
H H H 64 0 / 100
Me Me TMS 30 63 / 37
Me Me Ph 90 100/ 0
2 3















































 Later, in 2014, Altman and coworkers reported the copper-catalyzed decarboxylative 
trifluoromethylation of propargylic electrophiles to access substituted propargyl and allenyl 
products (Scheme 3.6).11 However, like the method reported by Bienaymé, selective formation of 
the propargyl isomer was not obtained and reactions suffered from competitive formation of the 
allenyl isomer. Additionally, the propargyl products could not be successfully purified and were 
isolated in poor ratios with the allenyl isomer.     
 
 Through use of a cationic copper complex and chiral ligand, Xu12 and Hu13 were able to 
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R1 R2 % Yield A : B
Scheme 3.6: Cu-Catalyzed Decarboxylative Trifluoromethylation
A B
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and secondary amines (Scheme 3.7). Overall, good yields and enantioselectivities were observed. 
However, the methods were restricted to 1-aryl propargylic carbonates and, as discussed 
previously in Chapter 1, limited to terminal acetylene derivatives that enable formation of the 
copper-acetylide and copper-allenylidene intermediates in situ.  
 
 Lastly, Wu recently demonstrated the gold(I)-catalyzed decarboxylative propargylation 
of oxygen-centered nucleophiles (Scheme 3.8).14 Substrates were once again limited to 1-aryl 
propargylic carbonates although 1,1-disubstituted propargylic carbonates were also tolerated and 
resulted in moderate isolated yields. Further, 3-substituted propargylic carbonates with either 
alkyl or aryl substituents resulted in low yields of the propargylated product, unless the aryl 
moiety was ortho-substituted. The ortho-substituent is proposed to perturb coordination of the 
gold catalyst to the π-bond and promote σ-activation resulting in the propargylated product 
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 In the following, ongoing efforts to develop a generalized and selective method for the 
palladium-catalyzed decarboxylative propargylation and dienylation of acetonitrile derivatives 
will be presented. Development of such methods is necessary to provide facile, efficient, and 
selective access to propargyl and dienyl functionalities for application as synthetic intermediates 
in complex molecule synthesis.  
 
3.3 Decarboxylative Propargylation and Dienylation of Acetonitrile Pronucleophiles 
 Decarboxylative cross-coupling minimizes the use of additives and provides efficient 
access to reactive intermediates via irreversible decarboxylation. As a result, these methods 
provide an environmentally friendly and atom-economic alternative to commonly employed 
coupling methods. Initially, we hypothesized that we could adopt decarboxylation as a way to 
expand on our previously developed methods for propargylation and dienylation of acetonitrile 
pronucleophiles in which substrates were limited to those with a pKa of < 17. We proposed that 
the source of this limitation was in pronucleophile activation by liberated methoxide, which 
would necessitate that the pronucleophile have a pKa similar to that of methanol (Figure 3.1). 
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Scheme 3.8: Gold(I)-Catalyzed Decarboxylative Propargylation of Oxygen-Centered Nucleophiles.
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nucleophile would be generated in situ, after decarboxylation thus potentially providing access to 
a larger range of nucleophiles for coupling to the butadiene synthon (Scheme 3.9).   
 
 
 To begin, we subjected but-2-yl 2-cyano-2-phenylpropanoate to the reaction conditions 
developed for intermolecular dienylation of acetonitrile derivatives at elevated reaction 
temperatures (Table 3.1, entry 3).1 Disappointingly, we observed only minimal reaction 
conversion in favor of the protonated product. Screening studies revealed that monomeric 
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Scheme 3.9: Decarboxylative Activation of Pronucleophiles:
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could be increased after extended reaction times (Table 3.1 entry 4). However, only poor yields of 
the isolated product were obtained after purification via column chromatography.  
 
Next, we evaluated the potential decarboxylative dienylation reaction pathway in order to 
optimize isolated yields of the dienylated product (Figure 3.2). Initially, we envisioned that 
palladium(0) would undergo oxidative addition to generate an η3-propargylpalladium 
intermediate and activated nucleophile. As previously proposed, the activated nucleophile would 
then regioselectively attack the center carbon of the palladium complex to generate a pallada-

















cat. mol % ligand mol % additive solvent mL temp time sm % A% B% C% and D%
Pd(dba)2 10 MePhos 10 --- DMF 0.5
0.15 mmol
40 1h 37 18 22 23
Pd(dba)2 2.5 MePhos 2.5 --- DMF 0.5 80 1h 58 20 6 16
Pd2(dba)3 5 dppe 10 --- DMF 0.5 100 1h 83 15 3 0
10 dppe 10 --- DMF 0.5 100 6h 0 5 83 12
Pd(dba)2 2.5 dppe 2.5 --- DMF 0.5 100 6h 88 11 1 0
Pd(dba)2 10 dppe 10 --- DMF 1 150mw 10m 0 17 69 14
Pd(dba)2 10 dppe 10 --- DMF 1 150mw 4m 0 15 71 14
Pd(dba)2 10 dppe 10 --- DMF 1 150mw 1m 0 13 73 14
Pd(dba)2 10 dppe 10 --- DMF 1 100mw 5m 72 11 16 2
Pd(dba)2 10 dppe 10 --- DMF 1 120mw 1m 0 5 86 10
Pd(dba)2 10 dppe 10 DMF 1 120mw 1m 23 7 62 8




--- -- DMF 0.25 120mw 1m 68 10 13 9
Pd(dba)2 10 dppe 10 morpholine 1 DMF 1 100 4h only protonated material
Pd(dba)2 10 dppe 10 Bu2NH 1 DMF 1 100 4h 0 77 23 0
Pd(dba)2 10 dppe 10 Bn2NH 1 DMF 1 100 4h 0 74 23 2
Pd(dba)2 10 dppe 10 pyrrolidine 1 DMF 1 100 4h 0 61 39 0
Pd(dba)2 10 dppe 10 azocane 1 DMF 1 100 4h 0 65 14 21
Pd(dba)2 10 dppe 10 i-Pr2NH 1 DMF 1 100 4h 0 8 92 0
Pd(dba)2 10 dppe 10 TBD 1 DMF 1 100 4h 0 94 6 0
Pd(dba)2 10 dppe 10 K2HPO4 1 DMF 1 100 4h 0 5 95 0
Pd(dba)2 10 dppe 10 NaHCO3 1 DMF 1 100 4h 0 11 89 0
Pd(dba)2 10 dppe 10 mesitol 1 DMF 1 100 4h 0 40 60
Pd(dba)2 10 dppe 10 2-nitroethanol 1 DMF 1 100 4h 62 38 0 0
Pd(dba)2 10 dppe 10 2,2,2-trifluoroethanol1 DMF 1 100 4h very Very messy
Pd(dba)2 10 dppe 10 1 DMF 1 100 4h 0 23 5 71
Pd(dba)2 10 dppe 10 propofol 1 DMF 1 100 4h 0 35 5 60
Pd(dba)2 10 dppe 10 benzoic acid 1 DMF 1 100 4h 48 47 0 5
Pd(dba)2 10 dppe 10 MeOH 1 DMF 1 100 4h 0 22 54 14
Pd(dba)2 10 dppe 10 H2O 1 DMF 1 100 4h 0 61 39 0
Pd(dba)2 10 dppe 10 tert-butanol 1 DMF 1 100 4h 0 8 92 0
Pd(dba)2 10 dppe 10 tert-butanol 1 DMF 1 100 3h 0 50 50 0
Pd(dba)2 10 dppe 10 K2HPO4 1 DMF 1 100 3h 59 19 22 0
Table 3.1:Optimization of Decarboxylative Dienylation





































Ratios were determined by GC/MS analysis.
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a molecule of methanol or substrate, neither is possible in the decarboxylation pathway since both 
compounds are absent from the reaction media. Therefore, we proposed that a proton source 
could be needed. Further, the proton source would also have to act as a competent base to 
deprotonate intermediate C (Scheme 3.2) for optimal product formation.    
 
We next screened a variety of proton sources (Table 3.1) and found that K2HPO4 
provided the optimal conversion to the diene product after 4 h. However, significantly decreased 
yields of the isolated product were still obtained compared to the suggested product formation by 
GC/MS analysis using mesitylene as an internal standard. It was next proposed that although 
acetonitrile derivatives are readily activated via decarboxylation in allylation-type chemistry,8 
activation utilizing propargylic esters might be more problematic. Further, if deprotonation of 
intermediate C (Scheme 3.10) occurred by the activated nitrile instead of the conjugate base of 



































but-2-yn-1-yl-2-cyano-2-(4-nitrophenyl)propanoate which could stabilize the in situ generated 
anionic charge more efficiently and potentially lower the pKa of the protonated product enough 
for reintroduction back into the catalytic cycle for dienylation. Gratifyingly, decarboxylative 
dienylation occurred using 10 mol % of Pd(dba)2, 9.5 mol % dppe, in DMF at 80 °C after 1 h and 
moderate yields of the isolated product were obtained (Scheme 3.10, 2.1b). We then screened 
other electron-deficient aryl substituents and found that a para-carbomethoxy derivative could be 
obtained in similar yield (2.1c). However, when meta-substituted electron-deficient aryl moieties 
were screened, a decrease in yield was observed (2.1d, 2.1e, 2.1f). Similarly, the reaction was 
tolerant of a para-chloro pyridine derivative (2.1g), and increased steric bulk of the α-substituted 
alkyl group (2.1h). Unfortunately, a further decrease in isolated yield of the diene product was 
observed when an ethyl group was incorporated at the 3-position of the propargylic substituent 
(2.1i) and with electron-donating substituents on the aryl moiety (2.1j).              
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 In addition to the successfully isolated products obtained from decarboxylative 
dienylation, we have also encountered limitations to the developed method (Scheme 3.11). When 
an allyl functionality was incorporated into the starting material, mostly unreacted starting 
material was observed (Scheme 3.11, 2.2a, 2.2b). Such a result is expected if the formation of a 
palladium π-allyl intermediate out-competes the formation of η3-propargylpalladium complex, 





R2 Pd(dba)2 (10 mol %)dppe (9.5 mol %)



























a propargyl ester (0.3 mmol), Pd(dba)2 (10 mol %), dppe (9.5 mol %), DMF (2 mL), 80 oC, 1 h, 
isolated yields are reported.
b run with K2HPO4 (2.1 mmol).
c Pd(dmdba)2 (10 mol %) used.
CN
OMe








substituted aryl moiety was subjected to the optimized reaction conditions (2.2c). In this case, we 
proposed that oxidative addition of the aryl–bromine bond occurs in lieu of oxidative addition of 
the propargylic ester, which would also halt desired product formation. Alternatively, when the 
aryl ring contained an ortho-chloro substituent, minor conversion to the diene product was 
observed (18% by GC/MS) (2.2d). However, a higher relative percentage of the protonated 
product was present at 24% with 58% remaining as starting material. Lastly, increased steric bulk 
at the 3-position of the propargyl functionality also perturbed diene formation; only a 26% 
conversion of starting material 2.2e was observed by GC/MS. 
 
 As previously presented, decarboxylative dienylation is currently restricted to electron-
deficient aryl rings in order to obtain moderate yields. However, it should be mentioned that the 
developed method provides access to a broader range of nucleophiles than were previously 
successful in the palladium-catalyzed intermolecular dienylation using nitriles and propargyl 
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 Due to the fact that the substrate scope of the decarboxylative dienylation reaction is 
somewhat limited, we aimed to expand the application of our method through a sequential 
dienylation/cyclization pathway to provide facile and efficient access to polycyclic cores.16,17 A 
brief reaction optimization study evaluated the effects of temperature, additives, solvent, and 
reaction duration for the sequential reaction. Eventually, it was found that, after diene formation 
addition of 20 mol % ZnBr2 and 2 equivalents of N-phenylmaleimide lead to the cyclized product 
in 47% isolated yield after 3 hours (Scheme 3.13).18,19,20 Further, evaluation of the cyclized 
product by 1H and 13C NMR spectroscopies suggests that only one stereoisomer is formed of the 
Diels-Alder product, however, current efforts to obtain crystallographic information is ongoing in 
the laboratory. Additionally, efforts are also being put forth to further optimize the yield of the 
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Scheme 3.13: One-Pot, Sequential Decarboxylative Dienylation and Diels-Alder Cyclization
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 We next explored the capacity for the decarboxylative dienylation method to be diverted 
toward decarboxylative propargylation of acetonitrile derivatives from propargylic esters 
(Scheme 3.14). Beginning with methyl 4-(2-cyanohex-4-yn-2-yl)benzoate, which was an optimal 
substrate for the dienylation pathway, we once again changed the denticity of the coordinating 
ligand from bidentate (dppe) to monodentate (MePhos) and were able to obtain a 60% isolated 
yield of the propargylated product (Scheme 3.14, 2.5a). Altering the para-carbomethoxy 
substituent to a para-nitro moiety also produced the propargylated product in moderate yield 
(2.5b). Interestingly, when steric bulk was increased at the 3-position of the propargylic 
substituent, an increase in yield was observed (2.5d, 2.5e). However, when the arene contained a 
strongly electron-withdrawing substituent in the meta-position as opposed to the para-position, a 
significant decrease in yield was observed (2.5c). Lastly, the reaction was tolerant of alkyl 
variation to either allyl (2.5f) or benzyl (2.5g) substituents, which resulted in moderate yields of 
the isolated product.          
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 Unfortunately, in addition to the substrates listed above that lead to successful isolation of 
the decarboxylative propargylic species, many substrates have been unsuccessful under the 
developed reaction conditions (Scheme 3.15). When a simple aryl substituent was employed, 
moderate reaction conversion to the propargylated product was observed by GC/MS but efforts to 
isolate the pure product have been unsuccessful (2.6a). Instead, the product has been obtained 
with significant contamination by the unreacted starting material. Further, when the aryl moiety 
contained a para-bromo (2.6b) or ortho-chloro (2.6d) substituent, only minor reaction conversion 
was observed. Again, this is potentially due to competitive oxidative addition of the aryl—
halogen bond or unfavorable steric interactions by the ortho-substituted derivative. In general, 
when meta-substituted aryl functionalities were employed, predominate formation of the 
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Scheme 3.14: Scope of Decarboxylative Propargyation.a
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dienyl isomers (2.6c, 2.6e, 2.6f). Alternatively, when heteroaryl moieties were employed, equal 
formation of protonation and propargylation products along with unreacted starting material was 
observed by GC/MS (2.6g). Lastly, despite the moderate yield of the propargylated product 
obtained from a simple allyl substituent, incorporation of a cinnamyl substituent stopped 
reactivity (2.6h).  
 
 Given the apparent limitation of decarboxylative propargylation to para-substituted 
electron-withdrawing aryl substituents, we next aimed to develop a potential rational for this 
observation. Initially, we envision that oxidation addition of the propargylic ester to palladium(0) 
would occur to generate a palladium-bound intermediate (Figure 3.3). As initially proposed in 
chapter 2 for the intermolecular variant (Figure 3.4), propargylation is proposed to arise from 
inner-sphere nucleophilic attack of the η1-allenylpalladium species over other palladium-bound 
intermediates.21,22,23,24 Rational for this intermediate is twofold: 1) our observations of an increase 





R2 Pd(dba)2 (10 mol %)MePhos (10 mol %)






















Method A:  propargyl ester (0.3 mmol), Pd(dba)2 (10 mol %), MePhos (9.5 mol %), DMF (2 mL), 80 oC, 1 h.

















Scheme 3.15 Unsuccessful Decarboxylative Propargylation Scope.a
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substituent and 2) the known coordination of weakly stabilized nitrile intermediates to 




























































FIgure 3.4: Intermolecular Propargylation of Diaryl Acetonitrile Derivatives
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 Alternatively, the rational for increased protonation and competitive product formation of 
meta-substituted derivatives is as follows. In contrast to the stabilizing effects of para-substituted 
electron-withdrawing aryl moieties, it is proposed that meta-substituted derivatives would be less 
efficient at anionic stabilization resulting in competitive formation of non-nitrile coordinated and 
nitrile coordinated palladium intermediates (Scheme 3.16). Lack of intermediate preference could 
then account for a mix of allenyl (1.4G), dienyl (1.4E), and propargyl (1.4F) isomers, however, 
the proton source that gives rise to protonated nitrile is currently unknown.     
 
3.4 Conclusion:  
 In chapter 3 of this dissertation a regiodivergent method for decarboxylative dienylation 











































Scheme 3.16: Proposed Source of Compettive Product Formation with 
Meta-Substituted α-Aryl Nitriles.
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in situ, we have been able to expand the substrate scope to compounds that were previously 
unsuccessful for the intermolecular variant present in chapter 2. Additionally, although we are 
aware of limitations in both the dienylation and propargylation method, further studies are 
currently underway to expand the reaction scopes and provide support for the respective 
mechanistic pathways. Future direction will focus on the evaluation of diverse electron-
withdrawing functional groups beyond nitriles and electron-deficient arenes and substitution 
effects at both the 1-position and 3-position of the propargylic moiety. Lastly, it would be 
beneficial to extend the application of the developed dienylation and propargylation methods to 
both inter- and intramolecular one-pot cyclization protocols to efficiently access polycyclic cores. 
In particular, further studies should focus on cyclization reactions that generate a single 
stereoisomer as eluted to previously in chapter 3. 
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Purified compounds, unless otherwise stated, were obtained by column chromatography using 60 
Å porosity, 230 x 400 mesh standard grade silica gel from Sorbent Technologies. TLC analysis 
was preformed on silica gel HL TLC plates w/UV254 from Sorbent Technologies. Gas 
chromatography/mass spectrometry data was obtained using a Shimadzu GCMS-QP2010 SE. 
NMR spectra were obtained on a Bruker Advance 500 DRX equipped with a QNP cryoprobe. 1H 
and 13C spectra were normalized using residual undeuterated solvent signals as a reference 
(CDCl3 = 7.28 ppm for 1H and 77.36 ppm for 13C).1 19F NMR spectra were referenced to α,α,α-
trifluorotoluene (purchased from Sigma Aldrich) at -62.7 ppm.   
 
N,N-Dimethylformamide (DMF) and nitromethane were purchased from Sigma Aldrich and 
stored in a glove box. Dichloromethane (DCM) and toluene were either purified by an Innovative 
Technology Pure SolvTM solvent purification system or purchased from Sigma Aldrich and stored 
in a glove box. Tetrahydrofuran (THF) was purified in a solvent still with sodium and 
benzophenone and obtained after relux. Bis(dibenzylideneacetone)palladium(0) (Pd(dba)2) was 
purchased from Strem as were ethylenebis(diphenylphosphine) (dppe) and 2-
dicyclohexylphosphino-2’-methylbiphenyl (MePhos). Bis(3,5,3’,5’-dimethoxydibenzyli-
deneactone)palladium(0) was obtained from Alfa Aesar. All were stored in a glove box. 
Acetonitrile derivatives were purchased from Sigma Aldrich, Alfa Aesar, VWR, and Acros 
Organics and used without further purification. N,N'-Carbonyldiimidazole (CDI) was purchased 
from Matrix Scientific and 2-Butyn-1-ol was purchased from Acros Organics. Both were used 
without further purification.     
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Synthesis of Starting Materials: 
Synthesis of but-2-yn-1-yl 1H-imidazole-1-carboxylate.1 
 
General procedure:  
 In a 500 mL flame-dried Schlenk flask under an atmosphere of argon, CDI was dissolved 
in dry THF and cooled to 0 °C. Next, 2-butyn-1-ol was added dropwise and the mixture was 
allowed to warm to room temperature and stirred overnight. Upon reaction completion, saturated 
ammonium chloride (75 mL) was added to quench the reaction and the mixture was diluted with 
distilled water (100 mL) and extracted with ethyl acetate (100 mL x 2) and washed with brine (50 
mL). The organic layer was dried over sodium sulfate and concentrated before purification by 
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1H NMR (500 MHz, CDCl3): δ 7.58 – 7.52 (m, 2H), 7.46 – 7.37 (m, 3H), 4.73 (q, J = 2.2 Hz, 
2H), 1.99 (s, 3H), 1.83 (t, J = 2.4 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 167.78, 135.71, 129.52, 129.26, 126.15, 119.54, 84.87, 72.09, 
55.69, 48.57, 25.26, 4.00 
HRMS TAPSI: [M+H] calcd for C14H14NO2: 228.1025. Found: 228.1014.  
IR: 3063, 2995, 2945, 2922, 2245, 1747, 1599, 1585, 1492, 1448, 1381, 1224, 1155, 1099, 1078, 




1H NMR (500 MHz, CDCl3): δ 7.34 (t, J = 8.1 Hz, 1H), 7.11 (ddd, J = 7.8, 1.9, 0.8 Hz, 1H), 7.06 
(t, J = 2.2 Hz, 1H), 6.92 (ddd, J = 8.3, 2.5, 0.9 Hz, 1H), 4.73 (q, J = 2.4 Hz, 2H), 3.84 (s, 3H), 
1.97 (s, 3H), 1.83 (t, J = 2.4 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 167.66, 160.38, 137.14, 130.55, 119.49, 118.30, 114.57, 112.16, 
84.88, 72.12, 55.72, 48.53, 25.26, 3.99. 
HRMS TAPSI: [M+H] calcd for C15H16NO3: 258.1130. Found: 258.1135.  
 249 
IR: 3001, 2943, 2922, 2839, 2245, 1755, 1747, 1602, 1585, 1492, 1454, 1435, 1381, 1369, 1319, 
1294, 1261, 1224, 1155, 1105, 1091, 1066, 1043, 949, 561, 474, 430, 418.  
 
TL5-246 
1H NMR (500 MHz, CDCl3): δ 8.11 – 8.07 (m, 2H), 7.65 – 7.61 (m, 2H), 4.74 (qd, J = 2.4, 0.9 
Hz, 2H), 3.94 (s, 3H), 2.00 (s, 3H), 1.82 (t, J = 2.4 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 167.21, 166.53, 140.31, 131.14, 130.75, 126.36, 119.01, 85.12, 
71.89, 55.94, 52.73, 48.63, 25.24, 3.99. 
HRMS TAPSI: [M+H] calcd for C16H16NO4: 286.1079. Found: 286.1067. 
IR: 2999, 2953, 2924, 2848, 2245, 1755, 1749, 1726, 1610, 1510, 1454, 1435, 1411, 1381, 1371, 




1H NMR (500 MHz, CDCl3): δ 8.28 (d, J = 8.5 Hz, 2H), 7.75 (d, J = 8.9 Hz, 2H), 4.95 – 4.58 
(m, 2H), 2.02 (s, 3H), 1.87 – 1.65 (m, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.62, 148.42, 142.23, 127.52, 124.61, 118.41, 85.30, 71.66, 
56.17, 48.47, 25.20, 3.91. 
HRMS TAPSI: [M+H] calcd for C14H13N2O4: 273.0875. Found: 273.0869.  
 250 
IR: 3115, 3084, 2999, 2949, 2924, 2858, 2245, 1766, 1755, 1747, 1732, 1714, 1608, 1599, 1519, 
1494, 1446, 1435, 1411, 1384, 1367, 1348, 1323, 1296, 1222, 1157, 1118, 1095, 1064, 1014, 947, 




1H NMR (500 MHz, CDCl3): δ 8.40 (t, J = 2.0 Hz, 1H), 8.28 (ddd, J = 8.2, 2.1, 1.0 Hz, 1H), 
7.95 (ddd, J = 7.9, 2.0, 1.0 Hz, 1H), 7.66 (t, J = 8.0 Hz, 1H), 4.77 (qq, J = 15.0, 7.3, 2.4 Hz, 2H), 
2.05 (s, 3H), 1.83 (t, J = 2.4 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.80, 148.98, 137.82, 132.58, 130.69, 124.42, 121.52, 118.52, 
85.48, 71.67, 56.23, 48.28, 25.22, 3.97. 
HRMS TAPSI: [M+H] calcd for C14H13N2O4: 273.0875. Found: 273.0871.  
IR: 3090. 2997, 2951, 2924, 2852, 2245, 1747, 1693, 1614, 1531, 1504, 1479, 1435, 1381, 1352, 




1H NMR (500 MHz, CDCl3): δ 7.81 – 7.75 (m, 2H), 7.70 – 7.65 (m, 1H), 7.63 – 7.53 (m, 1H), 
4.76 (qq, J = 15.1, 10.1, 2.3 Hz, 2H), 2.01 (s, 3H), 1.82 (td, J = 2.4, 1.0 Hz, 3H). 
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13C NMR (126 MHz, CDCl3): δ 167.12, 136.83, 130.18, 129.82, 126.29 (q, J = 3.7 Hz), 123.08 
(q, J = 3.8 Hz), 118.86, 85.20, 71.77, 55.98, 48.41, 25.31, 3.88. 
HRMS TAPSI: [M+H] calcd for C15H13F3NO2: 296.0898. Found: 296.0889.  
IR: 3070. 2997, 2949, 2926, 2858, 2245, 1747, 1616, 1597, 1492, 1440, 1383, 1369, 1329, 1288, 
1224, 1170, 1130, 1080, 1016, 1003, 949, 927, 900, 869, 536, 491, 430.  
 
TL6-174 
1H NMR (500 MHz, CDCl3): δ 7.59 – 7.51 (m, 2H), 7.46 – 7.40 (m, 2H), 4.73 (q, J = 2.3 Hz, 
2H), 1.97 (s, 3H), 1.83 (t, J = 2.4 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 167.35, 134.74, 132.66, 128.77, 127.95, 123.63, 119.08, 85.09, 
71.93, 55.89, 48.18, 25.12, 4.01. 
HRMS TAPSI: [M+H] calcd for C14H13NO2Br: 306.0130. Found: 306.0128.  
IR: 2993, 2945, 2922, 2852, 2243, 1747, 1589, 1489, 1454, 1400, 1381, 1369, 1224, 1157, 1095, 




1H NMR (500 MHz, CDCl3): δ 8.17 – 8.03 (m, 2H), 7.70 – 7.59 (m, 2H), 4.75 (qt, J = 15.1, 5.4, 
2.2 Hz, 2H), 3.94 (s, 3H), 2.19 (qt, J = 7.5, 2.2 Hz, 2H), 2.00 (s, 3H), 1.10 (t, J = 7.5 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 167.18, 166.52, 140.35, 131.13, 130.74, 126.36, 119.02, 90.77, 
72.05, 55.94, 52.74, 48.62, 25.24, 13.74, 12.73. 
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HRMS TAPSI: [M+H] calcd for C17H18NO4: 300.1236. Found: 300.1215.  
IR: 2980, 2953, 2879, 2845, 2243, 1753, 1724, 1610, 1437, 1410, 1369, 1317, 1282, 1222, 1192, 
1151, 1112, 1097, 1018, 964, 943, 750, 547, 501, 472, 437. 
 
TL6-272 
1H NMR (500 MHz, CDCl3): δ 8.11 – 8.07 (m, 2H), 7.65 – 7.60 (m, 2H), 4.76 (qt, J = 15.1, 7.9, 
2.2 Hz, 2H), 3.94 (s, 3H), 2.17 (tt, J = 7.1, 2.2 Hz, 2H), 2.00 (s, 3H), 1.50 – 1.40 (m, 2H), 1.37 – 
1.19 (m, 8H), 0.89 (t, J = 7.0 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.83, 166.17, 140.03, 130.79, 130.41, 126.03, 118.69, 89.29, 
72.33, 55.65, 52.38, 48.30, 31.70, 28.74, 28.24, 24.91, 22.63, 18.68, 14.10. 
HRMS TAPSI: [M-H] calcd for C22H28NO4: 370.2018. Found: 370.1997.  
IR: 2953, 2929, 2856, 2241, 1749, 1728, 1610, 1435, 1411, 1379, 1369, 1317, 1282, 1222, 1192, 




1H NMR (500 MHz, CDCl3): δ 7.45 – 7.38 (m, 1H), 7.35 (ddd, J = 7.9, 1.9, 1.0 Hz, 1H), 7.25 
(dt, J = 9.8, 2.1 Hz, 1H), 7.10 (tdd, J = 8.2, 2.5, 1.0 Hz, 1H), 4.74 (qd, J = 2.4, 1.7 Hz, 2H), 1.98 
(s, 3H), 1.83 (t, J = 2.4 Hz, 3H). 
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13C NMR (126 MHz, CDCl3): δ 167.28, 163.25 (d, J = 248.1 Hz), 137.98 (d, J = 7.5 Hz), 131.15 
(d, J = 8.5 Hz), 121.99 (d, J = 3.2 Hz), 119.06, 116.43 (d, J = 21.2 Hz), 113.74 (d, J = 24.0 Hz), 
85.12, 71.92, 55.90, 48.29 (d, J = 1.9 Hz), 25.21, 3.96.  
HRMS TAPSI: [M+H] calcd for C14H13FNO2: 246.0930. Found: 246.0922.  
IR: 3078, 2997, 2947, 2924, 2856, 2359, 2339, 2245, 1764, 1755, 1747, 1614, 1593, 1489, 1442, 




1H NMR (500 MHz, CDCl3): δ 8.60 (dd, J = 2.8, 0.7 Hz, 1H), 7.85 (dd, J = 8.4, 2.8 Hz, 1H), 
7.42 (dd, J = 8.5, 0.7 Hz, 1H), 4.80 – 4.72 (m, 2H), 2.02 (s, 3H), 1.84 (t, J = 2.4 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.75, 152.72, 147.74, 137.01, 130.70, 124.93, 118.12, 85.51, 
71.67, 56.29, 46.34, 25.04, 4.01. 
HRMS TAPSI: [M+H] calcd for C13H12ClN2O2: 263.0587. Found: 263.0580.  
IR: 3093, 3063, 2997, 2949, 2922, 2877, 2856, 2324, 2245, 1747, 1732, 1714, 1697, 1680, 1668, 





1H NMR (500 MHz, CDCl3): δ 8.13 – 8.08 (m, 2H), 7.71 – 7.66 (m, 2H), 7.35 – 7.22 (m, 5H), 
6.60 (d, J = 15.8 Hz, 1H), 6.11 (dt, J = 15.7, 7.4 Hz, 1H), 4.75 (p, J = 2.3 Hz, 2H), 3.94 (s, 3H), 
3.32 (ddd, J = 14.0, 7.7, 1.2 Hz, 1H), 3.03 (ddd, J = 13.9, 7.1, 1.3 Hz, 1H), 1.76 (t, J = 2.3 Hz, 
3H). 
13C NMR (126 MHz, CDCl3): δ 166.53, 166.48, 138.64, 136.95, 136.63, 131.24, 130.73, 128.88, 
128.33, 126.87, 126.81, 121.26, 117.65, 85.14, 71.91, 55.91, 54.77, 52.74, 42.20, 3.91. 
HRMS TAPSI: [M+H] calcd for C24H22NO4: 388.1549. Found: 388.1543.  
IR: 3082, 3061, 3028, 3003, 2953, 2922, 2850, 2243, 1747, 1728 1716, 1610, 1575, 1496, 1435, 





























Experimental procedure for the dienylation and propargylation of cyanopropanoate derivatives: 
 
In an oven or flamed dried Biotage microwave reaction vial (part no. 354624) equipped 
with a magnetic stir bar, catalyst (10 mol % Pd(dba)2), ligand (10 mol % dppe or 10 mol % 
MePhos) were added under an argon atmosphere in a glovebox. The solid mixture was dissolved 
in 2 mL anhydrous DMF followed by addition of cyanopropanoate (0.3 mmol). The vessel was 
sealed, removed from the glovebox, and placed in a preheated oil bath at 80 oC for 1 hr. After 
reaction completion, the vessel was unsealed and the crude product was placed directly on silica 
gel for purification via column chromatography in 1%-10% EtOAc:Hexane.   
 
Characterization of dienylated and propargylated tertiary nitriles: 
 
TL7-091 
1H NMR (500 MHz, CDCl3): δ 7.46 – 7.30 (m, 5H), 6.09 (dd, J = 17.5, 11.2 Hz, 1H), 5.56 (s, 
1H), 5.46 (s, 1H), 5.33 (d, J = 17.0 Hz, 1H), 5.11 (d, J = 11.1 Hz, 1H), 1.86 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 145.59, 139.59, 134.32, 129.31, 128.31, 126.34, 122.64, 118.41, 







Pd(dba)2 (10 mol %)
ligand (10 mol %)









1H NMR (500 MHz, CDCl3): δ 8.27 – 8.22 (m, 2H), 7.66 – 7.59 (m, 2H), 6.09 (dd, J = 17.5, 
11.2 Hz, 1H), 5.64 (s, 1H), 5.52 (s, 1H), 5.26 (d, J = 17.5 Hz, 1H), 5.14 (d, J = 11.2 Hz, 1H), 1.89 
(s, 3H). 
13C NMR (126 MHz, CDCl3): δ 147.86, 146.86, 144.26, 133.82, 127.44, 124.58, 121.43, 119.16, 
117.17, 45.62, 27.67. 
HRMS: [M+H]+ calcd for C13H13N2O2: 229.0977. Found: 229.0977.  
IR: 3109, 3082, 2991, 2943, 2858, 2237, 1633, 1604, 1595, 1531, 1519, 1494, 1462, 1454, 1427, 





1H NMR (500 MHz, CDCl3): δ 8.10 – 8.00 (m, 2H), 7.56 – 7.46 (m, 2H), 6.07 (dd, J = 17.7, 
11.0 Hz, 1H), 5.58 (s, 1H), 5.47 (s, 1H), 5.27 (d, J = 17.5 Hz, 1H), 5.10 (d, J = 11.2 Hz, 1H), 3.92 
(s, 3H), 1.86 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.66, 144.86, 144.58, 134.05, 130.21, 126.38, 121.98, 118.71, 
116.38, 52.55, 45.71, 27.54. 
HRMS: [M+H]+ calcd for C15H15NO2: 242.1181. Found: 242.1162.  
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IR: 3095, 2991, 2953, 2926, 2848, 2237, 1728, 1714, 1633, 1608, 1597, 1575, 1454, 1435, 1410, 




1H NMR (500 MHz, CDCl3): δ 8.24 (t, J = 2.0 Hz, 1H), 8.21 (ddd, J = 8.1, 2.2, 1.0 Hz, 1H), 
7.85 (ddd, J = 7.8, 2.0, 1.0 Hz, 1H), 7.61 (t, J = 8.0 Hz, 1H), 6.09 (dd, J = 17.5, 11.2 1H), 5.65 (s, 
1H), 5.54 (s, 1H), 5.30 (d, J = 17.5 Hz, 1H), 5.15 (d, J = 11.2 Hz, 1H), 1.92 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 149.01, 144.32, 142.04, 133.70, 132.66, 130.50, 123.55, 121.52, 
121.40, 119.24, 117.12, 45.53, 27.53. 
HRMS TAPSI: [M+H] calcd for C13H13N2O2: 229.0977. Found: 229.0972.  
IR: 3091, 3076, 2989, 2928, 2874, 2237, 1631, 1612, 1593, 1583, 1531, 1479, 1456, 1433, 1352, 




1H NMR (500 MHz, CDCl3): δ 7.69 – 7.63 (m, 2H), 7.62 – 7.57 (m, 1H), 7.53 (tt, J = 7.7, 0.8 
Hz, 1H), 6.08 (dd, J = 17.5, 11.1 Hz, 1H), 5.62 (s, 1H), 5.50 (s, 1H), 5.30 (d, J = 17.4 Hz, 1H), 
5.14 (d, J = 11.1 Hz, 1H), 1.89 (s, 3H). 
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13C NMR (126 MHz, CDCl3): δ 144.80, 140.85, 133.92, 131.82 (q, J = 32.6 Hz), 129.96, 129.93 
(d, J = 1.4 Hz), 125.37 (q, J = 3.8 Hz), 124.08 (q, J = 273.0 Hz), 123.12 (q, J = 3.8 Hz), 121.91, 
118.95, 116.54, 45.66, 27.62.    
HRMS: [M+H]+ calcd for C15H13F3NO2: 296.0898. Found: 296.0868.  
IR: 3102, 2990, 2936, 2851, 2500, 2241, 1599, 1493, 1441, 1329, 1287, 1202, 1169, 1128, 1072, 




1H NMR (500 MHz, CDCl3): δ 7.37 (td, J = 8.0, 5.9 Hz, 1H), 7.28 – 7.24 (m, 1H), 7.11 (dt, J = 
10.0, 2.2 Hz, 1H), 7.03 (tdd, J = 8.2, 2.5, 0.9 Hz, 1H), 6.09 (dd, J = 17.5, 11.2 Hz, 1H), 5.58 (s, 
1H), 5.47 (s, 1H), 5.33 (d, J = 17.5 Hz, 1H), 5.13 (d, J = 11.2 Hz, 1H), 1.86 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 163.02 (d, J = 247.5 Hz), 144.74, 141.89 (d, J = 7.2 Hz), 
133.73, 130.60 (d, J = 8.3 Hz), 121.79, 121.77, 118.38, 115.76, 115.11 (d, 20.9 Hz), 113.37 (d, 
23.5 Hz), 45.25, 27.20.    
HRMS TAPSI: [M+H] calcd for C13H13FN: 202.1032. Found: 202.1024.  
IR: 3091, 3063, 2989, 2926, 2852, 2237, 1614, 1591, 1487, 1440, 1392, 1379, 1273, 1251, 1172, 






1H NMR (500 MHz, CDCl3): δ 8.45 (dd, J = 2.8, 0.7 Hz, 1H), 7.70 (dd, J = 8.4, 2.7 Hz, 1H), 
7.36 (dd, J = 8.5, 0.8 Hz, 1H), 6.09 (dd, J = 17.3, 11.0 Hz, 1H), 5.62 (s, 1H), 5.49 (s, 1H), 5.32 (d, 
J = 17.5 Hz, 1H), 5.18 (d, J = 11.2 Hz, 1H), 1.89 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 151.69, 147.91, 144.14, 137.13, 134.57, 133.56, 124.82, 121.20, 
119.40, 116.87, 43.57, 27.37. 
HRMS TAPSI: [M+H] calcd for C12H12ClN: 219.0684. Found: 219.0677.  
IR: 3095, 3055, 2989, 2926, 2850, 2237, 1633, 1583, 1562, 1462, 1456, 1371, 1141, 1111, 1016, 





1H NMR (500 MHz, CDCl3): δ 8.00 – 7.96 (m, 2H), 7.34 – 7.29 (m, 2H), 7.25 – 7.14 (m, 3H), 
6.92 – 6.87 (m, 2H), 6.09 (dd, J = 17.5, 11.2 Hz, 1H), 5.66 (s, 1H), 5.55 (s, 1H), 5.33 (d, J = 17.4 
Hz, 1H), 5.12 (d, J = 11.2 Hz, 1H), 3.93 (s, 3H), 3.55 (d, J = 12.9 Hz, 1H), 3.28 (d, J = 12.9 Hz, 
1H). 
13C NMR (126 MHz, CDCl3): δ 166.77, 144.45, 142.42, 134.52, 134.18, 130.84, 130.24, 130.21, 
128.30, 127.78, 127.43, 120.45, 118.81, 116.57, 52.58, 52.29, 44.23. 
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HRMS TAPSI: [M+H] calcd for C21H20NO2: 318.1494. Found: 318.1479.  
IR: 3063, 3032, 2951, 2359, 2341, 2239, 1732, 1714, 1681, 1633, 1608, 1573, 1496, 1454, 1435, 




1H NMR (500 MHz, CDCl3): δ 8.08 – 8.02 (m, 2H), 7.54 – 7.48 (m, 2H), 5.85 – 5.71 (m, 2H), 
5.46 (s, 1H), 5.33 (s, 1H), 3.93 (s, 3H), 1.85 (s, 3H), 1.64 (d, J = 5.5 Hz, 3H). 
13C NMR: 
HRMS TAPSI: [M+H] calcd for C16H18NO2: 256.1338. Found: 256.1328.  
IR: 3059, 3989, 253, 2887, 2850, 2237, 1766, 1726, 1608, 1573, 1508, 1435, 1410, 1371, 1315, 




Impure with 23% methyl 4-acetylbenzoate 
1H NMR (500 MHz, CDCl3): δ 8.09 – 8.04 (m, 2H), 7.61 – 7.53 (m, 2H), 3.93 (s, 3H), 2.75 (qq, 
J = 16.6, 7.6, 2.5 Hz, 2H), 1.83 (s, 3H), 1.78 (t, J = 2.5 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.74, 144.43, 130.41, 128.53, 126.14, 122.80, 80.97, 73.00, 
52.61, 42.51, 33.18, 26.07, 3.82. 
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HRMS TAPSI: [M+H] calcd for C15H16NO2: 242.1181. Found: 242.1172.  
IR: 2989, 2953, 2922, 2850, 2239, 1728, 1716, 1693, 1612, 1573, 1435, 1410, 1315, 1282, 1192, 





1H NMR (500 MHz, CDCl3): δ 8.29 – 8.24 (m, 2H), 7.71 – 7.65 (m, 2H), 2.80 (q, J = 2.5 Hz, 
2H), 1.85 (s, 3H), 1.77 (t, J = 2.5 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 147.95, 146.49, 127.30, 124.33, 122.25, 81.53, 72.49, 42.47, 
33.13, 26.11, 3.79. 
HRMS TAPSI: [M+H] calcd for C13H13N2O2: 229.0977. Found: 229.0967.  
IR: 3082, 2987, 2939, 2922, 2856, 2239, 1693, 1604, 1599, 1519, 1496, 1454, 1435, 1410, 1379, 




1H NMR (500 MHz, CDCl3): δ 8.36 (t, J = 2.0 Hz, 1H), 8.24 (ddd, J = 8.2, 2.2, 1.0 Hz, 1H), 7.90 
(ddd, J = 7.9, 2.0, 1.0 Hz, 1H), 7.62 (t, J = 8.04 Hz, 1H), 2.81 (q, J = 2.5 Hz, 2H), 1.88 (s, 3H), 
1.78 (t, J = 2.5 Hz, 3H). 
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13C NMR (126 MHz, CDCl3): δ 148.78, 141.66, 132.60, 130.26, 123.65, 122.34, 121.20, 81.75, 
72.52, 42.13, 33.32, 25.96, 3.81. 
GC/MS: calc: 228.3. Found 228.1.  





1H NMR (500 MHz, CDCl3): δ 8.09 – 8.03 (m, 2H), 7.59 – 7.53 (m, 2H), 3.92 (s, 3H), 2.78 (qt, 
J = 16.6, 3.0, 2.4 Hz, 2H), 2.11 (tt, J = 7.1, 2.4 Hz, 2H), 1.82 (s, 3H), 1.42 (p, J = 6.9 Hz, 2H), 
1.34 – 1.17 (m, 8H), 0.88 (t, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.69, 144.43, 130.34, 130.27, 126.17, 122.76, 85.74, 73.84, 
52.56, 42.53, 33.19, 32.03, 29.08, 28.99, 28.92, 26.04, 22.93, 18.88, 14.39. 
HRMS TAPSI: [M-H] calcd for C21H28NO2: 326.2120. Found: 326.2104.  
IR: 2953, 2929, 2856, 2239, 1732, 1714, 1681, 1612, 1575, 1512, 1454, 1435, 1410, 1379, 1315, 




1H NMR (500 MHz, CDCl3): δ 8.12 – 7.99 (m, 2H), 7.62 – 7.52 (m, 2H), 3.93 (s, 3H), 2.76 (qt, 
J = 16.5, 4.6, 2.4 Hz, 2H), 2.14 (qt, J = 7.5, 2.4 Hz, 2H), 1.83 (s, 3H), 1.08 (t, J = 7.5 Hz, 3H). 
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13C NMR (126 MHz, CDCl3): δ 166.73, 144.41, 130.35, 130.30, 126.18, 122.76, 87.03, 73.27, 
52.58, 42.51, 33.19, 25.94, 14.19, 12.63. 
HRMS TAPSI: [M+H] calcd for C16H18NO2: 256.1338. Found: 256.1326.  
IR: 3061, 2980, 2953, 2939, 2918, 2879, 2847, 2239, 1934, 1805, 1732, 1714, 1612, 1575, 1552, 





1H NMR (500 MHz, CDCl3): δ 8.11 – 8.04 (m, 2H), 7.60 – 7.51 (m, 2H), 5.65 (dddd, J = 17.1, 
10.2, 7.5, 6.9 Hz, 1H), 5.25 – 5.10 (m, 2H), 3.93 (s, 3H), 2.96 – 2.69 (m, 4H), 1.76 (t, J = 2.5 Hz, 
3H). 
13C NMR (126 MHz, CDCl3): δ 166.75, 142.65, 131.28, 130.34, 130.32, 126.76, 121.45, 121.22, 
81.20, 72.76, 52.60, 47.68, 43.17, 31.06, 3.83. 
HRMS TAPSI: [M+H] calcd for C17H18NO2: 268.1338. Found: 268.1330.  
IR: 3080, 2953, 2922, 2852, 2239, 1728, 1714, 1643, 1612, 1435, 1410, 1317, 1284, 1247, 1193, 





78% pure isolated with 22% protonated pdt 
1H NMR (500 MHz, CDCl3): δ 8.07 – 8.02 (m, 2H), 7.49 – 7.44 (m, 2H), 7.26 – 7.20 (m, 3H), 
7.06 – 7.01 (m, 2H), 3.95 (s, 3H), 3.42 (d, J = 13.5 Hz, 1H), 3.27 – 3.22 (m, 1H), 2.90 (qq, J = 
16.6, 6.6, 2.6 Hz, 2H), 1.81 (t, J = 2.5 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 166.78, 142.60, 134.41, 130.62, 130.56, 130.15, 128.56, 127.89, 
127.02,121.49, 81.43, 73.02, 52.59, 49.08, 45.33, 30.15, 3.89. 
HRMS TAPSI: [M+H] calcd for C21H20NO2: 318.1494. Found: 318.1489.  
IR: 3063, 3032, 3005, 2953, 2922, 2854, 2241, 1722, 1716, 1610, 1573, 1496, 1454, 1454, 1435, 
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Chapter 4. Activation of Alcohols with Carbon Dioxide: Intermolecular Allylation 
of Weakly Acidic Pronucleophiles1 
 
 
4.1 Introduction to Allylation:  
 
As mentioned in chapters 1-3 of this dissertation, incorporation of allylic moieties consisting 
of a three-carbon subunit (C–C=C) have been the subject of extensive research over the past four 
decades.2-9 One potential reason for such extensive research lies in the ability of alkenes to serve 
as diverse functional handles for other chemoselective transformations.10 Further, unlike 
asymmetric reactions involving a prochiral olefin or carbonyl moieties where asymmetric 
induction relies on facial differentiation, asymmetric allylic alkylations can arise from numerous 
methods of asymmetric induction.7 Specifically, incorporation of chiral elements can occur about 
the nucleophile, electrophile, or both. Lastly, allylic alkylations can also form numerous types of 
bonds making them attractive considerations in total synthesis.7 
In general, allylic substituents can be incorporated into synthetic intermediates as 
nucleophiles (allylic anion)11-14 or as most commonly is observed, electrophiles (allyl cation).2-9,15  
The most highly utilized method for catalytic electrophilic allylic alkylation, known as the Tsuji-
Trost reaction, involves the use of palladium, activated allylic electrophile (allyl acetate or allyl 
carbonate), and a stabilized nucleophile. In contrast to simple substitution reactions with allylic 
halides, the Tsuji-Trost reaction uses more readily available alcohols and the use of palladium can 
control the regio- and stereochemical outcome of product formation.  
 
4.2 Development and Application of the Tsuji-Trost Reaction. 
First reported in 1965 by Tsuji and coworkers, the ability for palladium to promote allylic 
alkylation of carbon-centered nucleophiles was accomplished in the presence of sodium ethoxide 
(Scheme 4.1).16 Although a mixture of allylated and diallylated products was observed using 
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stoichiometric palladium(allyl)chloride dimer, Tsuji and coworkers revealed the importance of 
palladium π-allyl intermediates for successful allylic alkylation.    
 
 Over the next couple of years, it was revealed that not only could palladium π-allyl 
intermediates be generated from allylic electrophiles equipped with a good leaving group in the 
presence of a palladium(0) catalyst, but also that the amount of palladium could be reduced and 
used catalytically (Scheme 4.2).17 In general, the mechanism of the Tsuji-Trost allylation reaction 
begins with coordination of an allylic electrophile to palladium(0) (Scheme 4.3).7 Then, 
ionization occurs via oxidative addition to palladium to form a cationic palladium π-allyl 
intermediate. Lastly, nucleophilic substitution by an activated nucleophile will yield the allylated 
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 As it pertains to material that will be presented later in the chapter, in 1980 Tsuji18 and 
Saegusa19 expanded the scope of allylic alkylation methods to include the in situ generation of 
enolate nucleophiles from the palladium(0)-catalyzed decarboxylation of β-ketocarboxylates. 
Although Nesmeyanov and coworkers had previously demonstrated that metal β-ketocarboxylates 
readily undergo decarboxylation to generate metal enolates,20 application in the Tsuji-Trost 
reaction, as presented by Tsuji and Saegusa, allowed for both activation of the electrophile and 
nucleophile in situ. Specifically, in situ activation of various nucleophiles could bypass the 
previously existing pKa limits of the reaction and significantly expand the functional group 
compatibility.9 Importantly, a single example demonstrated by Saegusa and coworkers revealed 
that an acetonitrile derivative was also a compatible starting material for the decarboxylative 
allylation reaction despite minor contamination with the diallylated species (Scheme 4.4).19  
Subsequent studies conducted by Tunge and coworker in 2009 further revealed that the 
decarboxylative allylation of nitriles was regiospecific when conducted in the presence of much 
more acidic α-protons (Scheme 4.5).21 Their studies demonstrated the application of 








































 In addition to the decarboxylative activation of nitriles for allylic substitution, it is also 
necessary to briefly discuss advances in the decarboxylative allylation of nitroalkanes. Along 
with providing additional examples of the decarboxylative allylation of nitriles (in which 
allylation was observed in competition with protonation), in 1987 Tsuji and coworkers reported 
that nitroalkanes were viable substrates for decarboxylative allylic coupling to form a new C—C 
bond (Scheme 4.6).22 However, the reaction was significantly effected by competing O-allylation 
even at reduced reactions temperatures (Scheme 4.6).      
 
 
 To expand the scope of decarboxylative allylation to nitroalkanes, in 2010 Tunge and 
coworker optimized reaction conditions that resulted in predominately C-allylation (Scheme 
4.7).23 Further, it was determined that O-allylation is fast and reversible as opposed to C-
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Scheme 4.6: Competitive C- vs. O-Allylation of Nitroalkanes.
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allylation, which was irreversible. Therefore, in cases where aldehyde products (presumably 
formed as a result of elimination of O-allylation products) were formed competitively with C-
allylation products, reactions could be conducted under more concentrated conditions to facilitate 
higher yields of C-allylation products. 
 
 
4.3 Regioselectivity of the Tsuji-Trost Allylic Alkylation.  
 In addition to the development of various methods for nucleophilic activation, substantial 
research has been conducted on the mode of nucleophilic attack once generated (Scheme 4.8).24-26 
Starting from a chiral allylic acetate or carbonate, palladium(0) will undergo oxidative addition of 
the allylic electrophile to generate a palladium π-allyl intermediate with inversion of 
stereochemistry. For soft, stabilized nucleophiles like malonates (pKa = <18), nucleophilic attack 
will occur with inversion at the π-allyl ligand to displace palladium resulting in a formal retention 
of stereochemistry. Alternatively, hard nucleophiles (pKa = >25), will first undergo 
transmetalation at the palladium center followed by reductive elimination to yield retention of 





























Scheme 4.8. Regioselectivity and Stereoselectivity of the Tsuji-Trost Reaction.
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4.4 Activation of Allylic Alcohols for the Allylation of Carbon-Centered Nucleophiles.  
 The Tsuji-Trost reaction is an extremely valuable method for allylic incorporation into 
molecular scaffolds as demonstrated by its prevalent use over the last four decades. However, 
application of this method requires preactivation of alcohols, which possess a poor leaving group 
to form a better leaving group (typically converting the allylic alcohol to an allylic acetate or 
carbonate). Therefore, a logical improvement of the Tsuji-Trost reaction would be to develop 
methods that utilize allylic alcohols directly for the allylation of carbon-centered nucleophiles. 
Development of such a method would significantly increase the atom economy and efficiency of 
allylation reactions.  
 
 In 1964, Tsuji and coworkers demonstrated that allylic alcohols could be esterified using 
1 atm of carbon monoxide in ethanol in the presence of palladium chloride (Scheme 4.9).27,28 
However, compared to allylic acetate derivatives, allylic alcohols required extended reaction 
times, higher temperatures, and resulted in lower overall yields. Fifteen years later, in 1979, 
Commereuc and coworkers reported that a single substrate, diethyl acetamidomalonate, could be 
allylated in the presence of allyl alcohol, Pd(OAc)2, PPh3 and PhONa (Scheme 4.10).29 Further, 
under similar reaction conditions Sas30 and Bergbreiter31 reported the allylation of nitroalkanes 
(Scheme 4.11),30 nitriles (Scheme 4.12),31 and β-ketoesters (Scheme 4.13),31 however, the 
reported methods suffered from extended reaction times, high temperatures, or lacked product 







105 oC, 40 h
EtOH 42%
80%












 In 2011, Tunge and coworker reported that allylic alcohols could be activated in situ by 
ketone pronucleophiles for successful C-allylation (Scheme 4.14).32 The mechanism proceeds via 
deacylative allylation where a retro-Claisen rearrangement occurs to generate allyl acetate in situ 
along with an activated nucleophile. Allyl acetate would then undergo activation by palladium(0) 
to ultimately generate the allylated product. In contrast to palladium-catalyzed reactions that 
attempted to couple allylic alcohols directly, Tunge and coworker demonstrated that their method 
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Scheme 4.10. Allylation of Diethyl Acetamidomalonate.
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Scheme 4.13. Allylation of b-Ketoesters with Allylic Alcohols.
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nucleophiles. The retro-Claisen allylation was also applicable to a diverse range of substituted 
allylic alcohols.   
 
 In addition to deacylative allylation as developed by Tunge and coworkers, numerous 
other methods have been developed toward the activation of allylic alcohols for allylic alkylation 
of carbon nucleophiles. A brief review of allylation methods utilizing catalysts such as Lewis and 
Brønsted acids, hydrogen-bond donors, and catalysts based on ligand design will be presented in 
the following sections.  
 
4.5 Lewis Acid-Catalyzed Allylic Alcohol Activation.   
 A common method for the activation of allylic alcohols is through the employment of 
Lewis acids that coordinate to the alcohol functionality and weaken the C—O bond in situ, rather 
than proceeding through a prior functional group manipulation. In 1993, Kočovsky and 
coworkers reported the first use of BPh3 to activate allyl alcohol in the palladium(0) catalyzed 
allylation of lithium diethylmalonate (Scheme 4.15).33 The reaction was tolerant of several 
substituted allylic alcohols , but the scope of the nucleophile was not examined. Further, refluxing 



















Scheme 4.14. Deacylative Allylation: Allylic Alkylation via Retro-Claisen Activation.
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 Subsequent reports beginning in 2000 by Tamaru and coworkers began to further 
investigate alkylboranes as a source of in situ allylic alcohol activation (Scheme 4.16).4,34,35 After 
reaction optimization, Tamaru and coworkers reported that Et3B activated various allylic alcohol 
for successful allylic alkylation of active methylene compounds in moderate yields. However, the 
reaction required superstoichiometric Et3B, NaH and extended reaction times when more 
sterically encumbered allylic alcohols were used.  
 
 
4.6 Brønsted Acid-Catalyzed Activation of Allylic Alcohols. 
 In addition to trialkylborane Lewis acids, As2O3,36 Ti(OiPr)3,37 SnCl2,38 and B2O3,39 have 
also been employed most often in stoichiometric quantities. As an alternative, Brønsted acid-
catalysis has been developed to minimize the production of waste by reducing the amount of 
catalysts employed. In 2003, Kobayashi and coworker reported that palladium tetrakis with 10 
Ph OH
i) BuLi (1 equiv.), THF, rt, 5 min.
ii) Ph3B (1.1 equiv.), rt, 10 min
iii) LiCH(CO2Et)2 (1.5 equiv.),
     Pd(PPh3)4 (5 mol %)
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Scheme 4.16: Et3B Promoted Allylic Alcohol Activation.
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mol% of 1-adamantanecarboxylic acid efficiently catalyzed the allylation of various nucleophiles 
equipped with two electron-withdrawing groups (EWG’s) (Scheme 4.17).40 Despite the fact that 
the reaction could be conducted in water absent of any organic solvents or stoichiometric 
additives, refluxing reaction conditions are a significant limitation along with the narrow 
substrate scope for substituted allylic alcohols.     
 
 
 In 2011, List and coworkers employed the use of Pd(PPh3)4 with chiral Brønsted acid and 
benzhydryl amine to facilitate both allylic alcohol activation and chiral induction in the 
asymmetric allylation of aldehyde derivatives (Scheme 4.18).41 Although the developed method 
produced adequate yields and high ee’s, the substrate scope was limited to carbonyl 
functionalities that could generate an imine in situ. Further, the use of transition metal, Brønsted 
acid, and amine catalysts deviates from the overall objective to develop an atom-economical 












Pd(PPh3)4 (0.5-5 mol %)
10 mol %
73% - >99% yield
80 oC - reflux
H2O
Scheme 4.17: Carboxylic Acid-Assisted Allylation with Allylic Alcohols in Water.
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 In attempt to minimize the number of requisite additives and expand the substrate scope 
of asymmetric allylic alkylations, in 2013 Gong and coworkers reported the use of palladium(0) 
with chiral phosphoric acid and a chiral phosphoramidite ligand in the asymmetric allylation of 
pyrazol-5-ones (Scheme 4.19).42 The method was found to be functional group tolerant and 
resulted in high yields and ee’s. However, chiral induction is largely based on the presence of 
hydrogen bonding in the transition-state, which limits the scope of the nucleophile.    
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Scheme 4.19. Palladium-Catalyzed Asymmetric Allylic Alkylation of Pyrazol-5-ones.
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 In effort to further minimize the amount of additives required for the in situ activation of 
allylic alcohols, Reek and coworkers reported that simple diethylurea could be utilized as a HBD 
catalyst in only 3 mol % for allylic alkylation of carbon nucleophiles (Scheme 4.20).43 However, 
the developed method was only successful for simple allyl alcohol. When substituted derivatives 
were employed, significantly decreased yields were observed or the allylation reaction was shut 
down completely. Lastly, the scope of the nucleophile appeared to be limited to indole-type 
derivatives.  
 
4.8 Allylic Alcohol Activation via Ligand Design. 
 One last method of allylic alcohol activation was demonstrated by Ozawa and workers in 
2002 through the use of sp2-hydridized phosphorous ligands (Scheme 4.21).44 Unlike the methods 
presented previously, allylic alcohol activation occurred absent of any additional additives 
beyond catalytic palladium and ligand. The active catalytic species is proposed to be a palladium-
hydride intermediate which will facilitate a proton transfer to generate a palladium(0) 
intermediate and activated allylic species for nucleophilic attack.44 However, both the scope of 
the nucleophile and allylic alcohol were extremely limited. Further, a large excess of the starting 
































4.9 Activation of Allylic Alcohols with CO2. 
 As demonstrated in sections 1.4 – 1.8 of chapter 4, a variety of methods have been 
developed for the in situ activation of allylic alcohols using various additives or specifically 
designed ligands. However, the developed methods are limited to non- or weakly basic 
nucleophiles. More strongly basic nucleophiles would be incompatible under Brønsted or Lewis 
Acid catalysis. Additionally, these methods often suffer from diminished yields or failed reactions 
when substituted allylic alcohols are employed. The use of additives also deviates from the goal 
of achieving an atom-economical alternative to the Tsuji-Trost allylic alkylation reaction since 





R = H, C3H7, Ph2 equiv.
(DPCB)Pd(allyl)OTf (2 mol %)
pyridine (10 mol %)
MgSO4 (1 equiv.) 































Scheme 4.21. Palladium-Calalyzed Allylic Activation via Ligand Design.
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inspired to develop an environmentally benign method to activate both allylic alcohols and a large 
class of nucleophiles in situ for allylic alkylation of carbon-centered nucleophiles.  
 In 1995, Yamamoto and coworkers reported that CO2 could be used at high pressure to 
catalyze the allylation of acidic β-dicarbonyl compounds in the presence of allylic alcohols 
(Scheme 4.22).45 At the time, it was initially proposed that CO2 reversibly inserts into allylic 
alcohols to form allyl carbonic acids in situ which then undergo activation by palladium. Then in 
2001,46 and in subsequent reports,47-48 Eckert and coworkers demonstrated that alkylcarbonic 
acids form in situ from the addition of CO2 to alcohols (Scheme 4.23). Based on these initial 
reports, we sought to expand the application of CO2 activation of allylic alcohols to a broader 
substrate class beyond highly stabilized malonate-type derivatives as reported Yamamoto 































Scheme 4.22. CO2-Catalyzed Allylation of Carbon Nucleophiles at High Pressures
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By employing CO2 as an in situ activator of allylic alcohols, we envisioned expanding the 
known method to weakly acidic pronucleophiles, such as nitroalkanes, nitriles, and aldehydes 
(Scheme 4.24). Beginning with nucleophilic attack of allyl alcohol on CO2, allylic carbonate 
would be generated in situ and sufficiently activated for oxidative addition by palladium(0) to 
yield a palladium π-allyl intermediate along with bicarbonate. Subsequent decarboxylation of 
bicarbonate could then form a strong hydroxide base (pKa = 30 in DMSO) necessary for 
pronucleophile activation and generate water as the only stoichiometric by-product. Lastly, 
nucleophilic attack on the palladium π-allyl intermediate would occur to yield the allylated 
product and regenerate the active palladium(0) catalyst.    
 
 Initial studies were conducted by Simon Lang using relatively acidic nitroalkane 




































Scheme 2.24. CO2-Activation of Alcohols for Intermolecular Allylation.
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obtained when a sealed vial containing nitroalkane, allyl alcohol, and Pd(PPh3)4 in DMSO under 
1 atm of CO2 was heated at 80 oC overnight (Scheme 2.25). Further, when argon replaced CO2, 
1H NMR spectroscopy of the crude reaction mixture indicated that no appreciable amount of 
allylated product formed (Scheme 2.25).    
 
 Next, Simon examined the scope of nitroalkanes using the developed allylation reaction 
in which he found that both cyclic and acyclic nitroalkanes were well tolerated (Scheme 2.26). 
Further, upon examination of the functional group tolerance of the reaction, it was found that 
olefins (1a, 1c, 1h), α,β-unsaturated esters (1l), ethers (1e, 1f), and indole (1d) were well 
tolerated. Additionally, β-methallyl alcohol also lead to a high isolated yield of the allylated 
nitroalkane (1j). However, prenyl and crotyl alcohols were unsuccessful under the optimized 
reaction conditions. Lastly, successful allylation of nitroalkane derivatives could also occur under 
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 Next, Simon evaluated the ability of various aldehyde derivatives to undergo CO2-
catalyzed allylic alkylation from allylic alcohols despite the fact that aldehydes can be prone 
dimerization (Scheme 2.27). Gratifyingly, under the standard reaction conditions developed for 
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a) Nitroalkane (0.3 mmol) and allyl alcohol (0.45 mmol) in 1.75 mL DMSO under 1 atm 
CO2. b) Isolated yields.  c) Ar replaced CO2 (% conversion via crude 1H NMR).  d) Allyl 
alcohol (0.9 mmol), 160  oC, 20 min. in a microwave reactor.
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nitroalkanes, both cyclic (2a-2g, 2j-3l) and acylic (2h-2i) aldehyde derivatives were successfully 
allylated in good to high overall yields. In regards to α-aryl aldehydes, both electron-withdrawing 
(2c, 2e) and electron-donating functionalities (2b, 2d) were tolerated on the aryl ring along with 
2-napthyl and biaryl motifs (2f, 2g). Further, aldehydes containing a protected amino aldehyde 
(2j) and benzyl substituents (2k, 2l) also resulted in good to high yields of the allylated products.      
 
 In order to probe to identity of the in situ generated base and examine how weakly acidic 
the nucleophile coupling partner could be, we next extended the nucleophile scope beyond 


















































































2a 2b 2c 2d
Scheme 2.27. Scope of the Allylation of Aldehydesa,b
2e 2f 2g 2h
2i 2j 2k 2l
a) Aldehyde (0.30 mmol) and alcohol (0.45 mmol) in 2.0 mL DMSO under 1 atm
of CO2. b) Isolated yields. c) Ar replaced CO2 (% conversion via GC/MS).
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slight contrast to the method developed for the allylation of aldehydes and nitroalkanes, 
optimized reaction conditions for the allylation of nitriles resulted in lowered catalyst loading, 
more concentrated solutions, and slightly elevated reaction temperatures. However, as found with 
both nitroalkanes and aldehydes, the CO2-catalyzed allylation of nitriles resulted in good to high 
yields of the allylated products. This result suggests that pronucleophile activation occurs from a 
hydroxide/carbonate mixture generated in situ instead of bicarbonate which is not a sufficient 
base for nitrile activation.  
Upon examining the substrate scope of the nitrile coupling partner, it was found that the 
reaction was tolerant of halogens (3b-3c), aryl ether (3d), ketone (3f), and indole substituents 
(3h). However, allylation of a sterically congested ortho-disubstituted nitrile was unsuccessful 
under the optimized reaction conditions. Further, yields of the allylated products were 
significantly higher than when the same reactions conducted under argon. Presumably, since 
nitriles are known to undergo hydrolysis to form carboxylic acids, the observed minor reaction 




 Lastly, we examined the scope of the reaction utilizing substituted allylic alcohols with 
tertiary nitriles and aldehydes (Scheme 2.29). In general, comparable yields were observed as 
those resulting from allylation reactions with simple allyl alcohol (4a-4o). Both 2-methyl and 2-
phenyl-2-propen-1-ol were well tolerated by both nitriles and aldehydes resulting in good to high 
isolated yields of the allylated product (4a, 4b, 4j). Further, as typically observed in palladium-
catalyzed allylation reactions, the linear regioisomer was predominately favored over the 
branched isomer. For nitrile derivatives a trend was observed where the ratio of the 
linear:branched isomers increased with an increase in steric bulk on the substituted allylic alcohol 
Scheme 2.28. Scope of the Allylation of nitriles.a,b
R1
HNC OH
2.5 mol % Pd(PPh3)4
CO2 (1 atm)
DMSO (0.6 M)
































a) Nitrile (0.3 mmol) and allyl alcohol (0.6 mmol) in 0.5 mL DMSO under





(4c-4f). Selectivity is proposed to arise from an outer-sphere C-allylation mechanism.48,49 When 
comparing cinnamyl alcohol and α-vinylbenzyl alcohol, which result in the same palladium π-
allyl intermediate in situ, comparable selectivity was observed, resulting in a >95:5 
linear:branched ratio (4f, 4g). However, the overall isolated yield of the allylated products was 
slightly lower using the cinnamyl reactant (4f, 4g). Unfortunately, employment of prenyl alcohol 
failed to produce any of the desired product, presumably due to the increased steric hindrance at 
the terminal position of the allylic alcohol (4i). Lastly, for aldehyde derivatives, ether and 
substituted aryl moieties were well tolerated on the allylic alcohol resulting in good yields and 








































































































































































 The development of a CO2-catalyzed method for the in situ activation of allylic alcohols  
enabled the allylation of weakly acidic nitroalkanes, nitriles, and aldehydes under mild conditions 
with water as the only stoichiometric byproduct. Further, the presented method provides an atom-
economic alternative to the Tsuji-Trost allylic alkylation absent of stoichiometric or catalytic 
additives that require removal upon reaction completion.  
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 All reactions were run in oven or flame dried 2.0 – 5.0 mL microwave vials from 
Biotage.  DMSO was purchased from Sigma Aldrich and stored in a glove box.  Allyl alcohol 
was purchased from Sigma Aldrich and stored over 3 Å mol sieves. 2-Phenylprop-2-en-1-ol was 
prepared according to a literature procedure.1 Palladium tetrakis(triphenylphosphine) was 
purchased from Strem, stored in a glovebox, and used as received. CO2 was dispensed through a 
Matheson 3040 series regulator attached to a cylinder purchased from Lindweld.  
 TLC analysis was performed with silica gel HL TLC plates w/UV254 from Sorbent 
Technologies.  60 Å porosity, 230 x 400 mesh standard grade silica gel from Sorbent 
Technologies was used for column chromatography.  GC/MS data was obtained using a 
Shimadzu GCMS-QP2010 SE. Microwave experiments were run in a Biotage Initiator.  1H, 13C, 
and 19F NMR spectra were obtained on a Bruker Advance 500 DRX equipped w ith a QNP 
cryoprobe or a Bruker Advance 400.  19F NMR spectra were referenced to trifluoromethyltoluene 
while 1H and 13C NMR spectra were referenced to residual protio solvent signals.  
 
Nitroalkanes were prepared according to literature procedures:  
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Procedure A (synthesis of 2-(4-chlorophenyl)propanenitrile, 2-(4-fluorophenyl)-
propanenitrile ):11 
 
To a glass sleeve, the respective phenylacetonitrile (16.5 mmol) was added with dimethyl 
carbonate (25 mL, 16 equiv.), and K2CO3 (4.5 g, 2 equiv.). The sleeve was placed in a stainless 
steel Parr reactor, sealed, heated to 160 oC and stirred for 3 hr. The reaction was then quenched 
by turning off the heating source and allowing the apparatus to cool to room temperature. After 
removal of the glass sleeve, the contents were subjected to a water workup (200 mL), extracted 
with EtOAc (100 mL), and purified by flash chromatography over silica in 2% EtOAc:Hexanes.  
 
Procedure B (synthesis of 2-(4-methoxyphenyl)-3-phenylpropanenitrile):12 
 
In a 100 mL flame-dried Schlenk flask under Ar dry THF (13 mL) was added. The solvent was 
then place in a dry ice/acetone bath and cooled to -78 oC. n-BuLi (8.0 mL, solution 1.6 M/Hex 
from Aldrich) was added dropwise and the solution was stirred for 10 min. The solution was then 
warmed to room temperature, stirred for 5 minutes then cooled to -78 oC. Next, commercially 
available 4-methoxyphenylacetonitrile (1.85 g, 12.6 mmol) was added dropwise over 10 minutes. 
The solution was stirred for 1 hr before benzyl bromide (2.15 g ,1 equiv) was added dropwise. 
The resulting solution was stirred for 30 min., warmed to room temperature, and stirred 
overnight. The reaction was quenched with aq. NH4Cl (20 mL), subjected to a water workup (2 x 
50 mL), and extracted with EtOAc (50 mL) and dried over MgSO4. The solution was then filtered 
and concentrated via rotary evaporation to yield a light yellow oil that solidified upon standing. 
The solid was then purified via recrystallization by heating the solid in 50 mL EtOH until 
dissolved then placed in the freezer. The product was collected via vacuum filtration as an off-
white solid.       
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Procedure C (synthesis of substrate 3-(1-methyl-1H-indol-3-yl)-2-phenylpropanenitrile):13   
 
A 100 mL round bottom flask was charged with benzyl cyanide (.94 g, 8.0 mmol), 1-
methylindole-3-carboxaldehyde (1.27 g, 8 mmol), sodium methoxide (0.04 g, 0.8 mmol) and 
EtOH (12 mL) and stirred at room temperature overnight. The reaction mixture was then 
concentrated in vacuo followed by an aqueous workup in water (2 x 50 mL), extracted with 
EtOAc (100 mL), and dried over MgSO4. After concentration via rotary evaporation, the crude 
product was heated until dissolved in 20 mL EtOH to yield 4-(1-methyl-1H-indol-3-yl)-2-
phenylbut-3-enenitrile as an orange solid (1.25 g, 4.8 mmol). The solid was then dissolved in 
THF (5 mL) and cooled to 0 oC followed by the addition of NaBH4 (0.2 g, 4.8 mmol). The 
solution was allowed to warm to room temperature and stirred overnight followed by quenching 
with NH4Cl (10 mL), aqueous workup (3 x 20 mL), extraction with EtOAc (20 mL), and 
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Representative procedure for the CO2 catalyzed activation of allyl alcohol towards 
allylation of nitroalkanes: 
 A 2.0 – 5.0 mL microwave vial (Biotage #351521) dried in an oven is charged with a stir 
bar and taken into a glove box.  Pd(PPh3)4 (10 mol %, 0.035 g) is added along with DMSO ( 2.0 
mL) and the vial is capped using a vial cap (Biotage #352298) and a manual cap crimper (Biotage 
#353671).  The vial is removed from the glovebox and substrate (0.30 mmol) and allyl alcohol 
(0.45 mmol, 0.026 g) are added sequentially via syringe.  CO2 is then bubbled through the solvent 
using a 20G needle connected to a balloon and a separate 25.5G needle to vent.  After 6 mins the 
vent needle was removed followed by the CO2 needle and the top of the vial is wrapped in 
parafilm “M”.  The vial was then placed in an oil bath at room temperature and heated/stirred at 
80 oC for 14 hours. 
 After 14 hours the vial is removed from the bath, and allowed to cool to room 
temperature.  The contents were taken up in EtOAc (10 mL) and transferred to a separatory 
funnel and were washed with 30 mL DI water 3x.  The organic layer was dried over MgSO4, 
filtered, and the solvent evaporated in vacuo followed by purification via silica gel column 






dr = 95:5 ; Stereochemistry assigned by inference. See Ref. 11. 
 
1H NMR Spectra (500 MHz, CDCl3): 
(major diastereomer) G 7.47 (d, J = 7.43 Hz, 2H), 7.37 (t, J = 7.40 Hz, 2H), 7.30 (m, 1H), 6.54 
(dd, J = 5.66, 3.22 Hz, 1H), 6.26 (dd, J = 5.67, 2.82 Hz, 1H), 5.57 (m, 1H), 5.04 (dt, J = 10.2, 
0.95 Hz 1H), 4.90 (dq, J = 16.9 Hz, 1.50 Hz, 1H), 3.52 (d, J = 2.63 Hz, 1H), 3.41 (s, 1H), 3.12 (s, 
1H), 2.29 (ddt, J = 15.0, 6.97, 1.20 Hz, 1H), 2.05 (d, J = 9.60 Hz, 1H), 1.95 (dd, J = 15.0, 7.60 
Hz, 1H), 1.85 (dq, J = 9.56, 2.07 Hz, 1H). 
13C NMR (126 MHz, CDCl3):  
(major diastereomer) G 139.79, 138.18, 135.82, 130.21, 127.45, 126.06, 118.66, 100.40, 52.03, 
47.13, 45.67, 44.58, 42.14. 











1H NMR Spectra (500 MHz, CDCl3): 
G 7.99 (d, J = 8.66 Hz, 1H), 7.87 (d, J = 8.08 Hz, 1H), 7.80 (d, J = 8.40 Hz, 1H), 7.44 (m, 2H), 
7.51 (t, J = 7.65 Hz, 1H), 7.26 (d, J = 6.22 Hz, 1H), 5.71 (m, 1H), 5.21 (m, 2H), 3.78 (d, J = 14.7 
Hz, 1H), 3.71 (d, J = 14.6 Hz, 1H), 3.02 (dd, J = 14.2, 6.86 Hz, 1H), 2.57 (dd, J = 14.2, 7.76 Hz, 
1H), 1.43 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
G 133.91, 132.66, 131.15, 130.92, 129.01, 128.47, 128.38, 126.27, 125.67, 125.38, 123.63, 
120.93, 92.43, 44.36, 41.09, 21.31. 
GC/MS data: 255.1 (M+, 8 %), 141.1, base peak. 
 
dr > 95:5; Stereochemistry assigned by inference. See Ref. 11. 
1H NMR Spectra (500 MHz, CDCl3): 
G 7.23 (m, 3H), 7.11 (m, 2H), 5.63 (m, 1H), 5.14 (m, 2H), 3.47 (d, J = 6.82 Hz, 1H), 2.85 (dd, J = 
14.1, 6.81 Hz, 1H), 2.64 (m, 3H), 2.34 (m, 2H), 1.75 (d, J = 10.9 Hz, 6H). 
13C NMR (126 MHz, CDCl3):  
G 140.27, 130.99, 128.47, 128.27, 127.53, 124.40, 123.72, 120.64, 92.98, 46.8, 41.80, 36.6, 33.35, 
19.36, 18.30. 
GC/MS data: 225.2 (M – NO2, 8%), 183.1, base peak. 
 359 
 
1H NMR Spectra (500 MHz, CDCl3): 
G 7.53 (dt, J = 7.97, 0.92 Hz, 1H), 7.30 (dt, J = 8.31, 0.91 Hz, 1H), 7.23 (ddd, J = 8.18, 6.99, 1.11 
Hz, 1H), 7.13 (ddd, J = 7.99, 6.94, 1.08 Hz, 1H), 6.84 (s, 1H), 5.74 (m, 1H), 5.19 (m, 2H), 3.75 
(s, 3H), 3.49 (d, J = 14.8 Hz, 1H), 3.24 (d, J = 14.8 Hz, 1H), 2.92 (dd, J = 14.2, 7.05 Hz, 1H), 
2.57 (dd, J = 14.1, 7.62 Hz, 1H), 1.51 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
G 136.62, 131.19, 128.48, 128.45, 121.69, 120.50, 119.32, 118.74, 109.37, 107.48, 92.63, 44.04, 
35.61, 32.78, 21.50. 




dr = 88:12;  Relative stereomchemistry assigned via x-ray structure of corresponding amine salt. 
1H NMR Spectra (500 MHz, CDCl3): 
(major diastereomer) G 7.30 (m, 8H), 7.18 (m, 2H), 5.62 (m, 1H), 5.04 (m, 2H), 4.86 (s, 1H), 4.44 
(d, J = 11.5 Hz, 1H), 4.20 (d, J = 11.5, 1H), 3.01 (dd, J = 14.5, 6.63 Hz, 1H), 2.53 (dd, J = 14.6, 
7.89 Hz, 1H), 1.33 (s, 3H). 
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13C NMR (126 MHz, CDCl3):  
(major diastereomer) G 136.19, 134.15, 130.31, 127.82, 127.43, 127.40, 127.33, 126.88, 119.34, 
93.20, 83.66, 70.43, 39.01, 16.74. 
GC/MS data: 221.1 (M – toluene, 1%), 91.1, base peak. 
 
dr = 88:12; Relative stereochemistry assigned based on the x-ray structure of the 1e salt. 
1H NMR Spectra (500 MHz, CDCl3): 
(major diastereomer) G 7.35 (m, 3H), 7.27 (m, 2H), 5.71 (m, 1H), 5.13 (m, 2H), 4.73 (s, 1H), 3.26 
(s, 3H), 3.09 (dd, J = 14.1, 6.75 Hz, 1H), 2.56 (dd, J = 14.5, 7.90 Hz, 1H), 1.38 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
(major diastereomer) G 135.17, 131.41, 128.75, 128.37, 128.22, 120.32, 94.18, 87.23, 57.84, 
39.83, 17.85. 
GC/MS data: 121.1 base peak. 
 
1H NMR Spectra (500 MHz, CDCl3): 
G 7.27 (m, 1H), 7.07 (m, 3H), 5.70 (m, 1H), 5.20 (m, 2H), 3.33 (d, J = 14.3 Hz, 1H), 3.25 (d, J = 
14.2 Hz, 1H), 2.89 (dd, J = 14.1, 6.93 Hz, 1H), 2.53 (dd, J = 14.2, 7.68 Hz, 1H), 1.48 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
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G 161.27 (d, JCF = 246 Hz), 131.82 (d, JCF = 3.91 Hz), 130.74, 129.47 (d, JCF = 8.32 Hz), 124.41 
(d, JCF = 3.60 Hz), 121.89 (d, JCF = 15.7 Hz), 120.87, 115.44 (d, JCF = 22.7 Hz), 91.65, 43.95, 
38.19, 20.78. 
19FNMR (376 MHz, CDCl3): 
G  -116.75. 
GC/MS data: 223.05 (M+ 0.1 %), 109.1, base peak. 
 
 
dr = 85:15; Stereochemistry assigned by inference. See Ref. 11. 
1H NMR Spectra (500 MHz, CDCl3): 
(major diastereomer) G 5.98 (m, 1H), 5.62 (m, 1H), 5.13 (m, 4H), 2.80 (dd, J = 15.1 Hz, 7.08 Hz, 
1H), 2.69 (dd, J = 14.1, 7.60 Hz, 1H), 2.55 (m, 1H), 2.23 (ddd, J = 13.8, 8.62, 3.78 Hz, 1H), 1.60 
(m, 8H). 
13C NMR (126 MHz, CDCl3):  
(major diastereomer) G 136.18, 130.72, 120.40, 118.15, 93.55, 48.66, 41.56, 29.62, 28.48, 22.09. 
GC/MS data: 149.2 (M – NO2, 5%), 81.1 (base peak). 
 
 
1H NMR Spectra (500 MHz, CDCl3): 
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G 5.63 (ddt, J = 17.3, 10.1, 7.30 Hz, 1H), 5.17 (m, 2H), 2.77 (dt, J = 7.30, 1.24 Hz, 2H), 2.01 (m, 
2H), 1.84 (dd, J = 6.8, 1.46 Hz, 2H), 0.87 (t, J = 7.45 Hz, 3H), 0.61 (m, 1H), 0.46 (m, 2H), 0.10 
(m, 2H). 
13C NMR (126 MHz, CDCl3):  
G 130.28, 118.98, 93.78, 39.02, 37.73, 28.68, 7.03, 4.61, 2.85, 2.78. 
GC/MS data:  154.1 (M – ethyl, 0.4 %), 55.1, base peak. 
 
 
 dr = 90:10; Stereochemistry assigned by inference. See Ref. 11. 
1H NMR Spectra (500 MHz, CDCl3): 
G 7.23 (m, 3H), 7.10 (m, 2H), 4.90 (t, J = 1.70 Hz, 1H), 4.65 (d, J = 1.05 Hz, 1H), 3.44  (d, J = 
7.17 Hz, 1H), 2.93 (d, J = 14.0 Hz, 1H), 2.69 (m, 3H), 2.36 (m, 2H), 1.75 (d, J = 13.6 Hz, 6H), 
1.63 (s, 3H).  
13C NMR (126 MHz, CDCl3):  
G 140.34, 139.64, 128.44, 128.32, 127.52, 124.27, 123.91, 116.68, 92.85, 47.33, 44.73, 37.19, 
32.61, 23.19, 19.35, 18.25. 




1H NMR Spectra (500 MHz, CDCl3): 
G 7.30 (m, 3H), 7.02 (dd, J = 7.52, 1.90 Hz, 2H), 5.63 (dddd, J = 17.1, 10.2, 7.61, 6.96 Hz, 1H), 
5.12 (m, 2H), 3.29 (d, J = 13.9 Hz, 1H), 2.98 (d, J = 13.9 Hz, 1H), 2.79 (dd, J = 14.2, 6.97 Hz, 
1H), 2.43 (dt, J = 14.2, 7.68, 1.07 Hz, 1H), 1.39 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
G 134.60, 130.88, 130.10, 128.54, 127.52, 120.80, 91.51, 45.62, 43.82, 21.29. 
GC/MS data: 159.1 (M- NO2, 4%), 91.1, base peak 
 
1H NMR Spectra (500 MHz, CDCl3): 
G 7.90 (s, 1H), 7.39 (m, 3H), 7.28 (m, 2H), 5.47 (m, 1H), 5.06 (m, 2H), 3.79 (s, 3H), 3.37 (d, J = 
16.5 Hz, 1H), 3.26 (d, J = 14.6 Hz, 1H), 2.73 (dd, J = 14.1, 6.78 Hz, 1H), 2.26 (dd, J = 14.2, 8.00 
Hz, 1H), 1.34 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
G 168.22, 143.67, 135.05, 130.78, 128.75, 128.67, 128.54, 127.88, 120.73, 90.46, 52.21, 43.85, 
35.50, 21.17. 
GC/MS data: 289.1 (M+, 1%), 115.1, base peak. 
Representative procedure for the CO2 catalyzed activation of allyl alcohol towards 
allylation of aldehydes: 
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 A 2.0 – 5.0 mL microwave vial (Biotage #351521) dried in an oven is charged with a stir 
bar and taken into a glove box.  Pd(PPh3)4 (5 mol %, 0.014 g) is added along with DMSO ( 2.0 
mL) and the vial is capped using a vial cap (Biotage #352298) and a manual cap crimper (Biotage 
#353671).  The vial is removed from the glovebox and substrate (0.30 mmol) and allyl alcohol 
(0.45 mmol, 0.026 g) are added sequentially via syringe.  CO2 is then bubbled through the solvent 
using a 20G needle connected to a balloon and a separate 25.5G needle to vent.  After 6 mins the 
vent needle was removed followed by the CO2 needle and the top of the vial is wrapped in 
parafilm “M”.  The vial was then placed in an oil bath at room temperature and heated/stirred at 
80 oC until the reaction was complete as shown by GC/MS. The reaction mixture was dry loaded 






1H NMR Spectra (500 MHz, CDCl3): 
G 9.52 (s, 1H), 7.39 (m, 2H), 7.30 (m, 1H), 7.26 (m, 2H), 5.55 (m, 1H), 5.04 (m, 2H), 2.70 (ddt, J 
= 14.2, 6.93, 1.32 Hz, 1H), 2.63 (ddt, J = 14.1, 7.72, 1.19 Hz, 1H), 1.45 (s, 3H).  
13C NMR (126 MHz, CDCl3):  







1H NMR Spectra (500 MHz, CDCl3): 
G 9.49 (s, 1H), 7.20 (m, 2H), 7.14 (m, 2H), 5.56 (m, 1H), 5.04 (m, 2H), 2.68 (ddt, J = 14.1, 6.91, 
1.13 Hz, 1H), 2.61 (ddt, J = 14.1, 7.67, 1.13 Hz, 1H), 2.35 (s, 3H), 1.43 (s, 3H). 
13C NMR (126 MHz, CDCl3):  






1H NMR Spectra (500 MHz, CDCl3): 
G 9.68 (d, J = 4.97 Hz, 1H), 7.30 (m, 2H), 7.18 (td, J = 7.58, 7.53, 1.35 Hz, 1H), 7.08 (ddd, J = 
11.8, 8.18, 1.33 Hz, 1H), 5.53 (m, 1H), 5.02 (m ,2H), 2.75 (dd, J = 14.0, 6.99 Hz, 1H), 2.63 (dd, J 
= 14.1, 7.77 Hz, 1H), 1.42 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
 366 
G 201.87 (d, J = 2.32 Hz), 161.85, 159.89, 132.74, 129.42 (d, J = 8.57 Hz), 128.62 (d, J = 4.95 
Hz), 127.87 (d, J = 13.1 Hz), 124.44 (d, J = 3.21 Hz), 118.84, 116.12 (d, J = 22.8 Hz), 51.85 (d, J 




1H NMR Spectra (500 MHz, CDCl3): 
G 9.46 (s, 1H), 7.17 (m, 2H), 6.92 (m, 2H), 5.55 (m, 1H), 5.04 (m, 2H), 3.80 (s, 3H), 2.66 (ddt, J 
= 14.1, 6.78, 1.37 Hz, 1H), 2.59 (dd, J = 14.2, 7.79, 1.21 Hz, 1H), 1.42 (s, 3H). 
13C NMR (126 MHz, CDCl3):  




1H NMR Spectra (300 MHz, CDCl3): 
G 9.51 (s, 1H), 7.28 (m, 2H), 7.23 (m, 2H), 5.52 (m, 1H), 5.06 (m, 2H), 2.67 (dd, J = 10.6, 6.93 
Hz, 1H), 2.62 (dd, J = 10.8, 7.62 Hz, 1H), 1.45 (s, 3H).  
13C NMR (126 MHz, CDCl3):  
 367 
G 201.41, 148.39 (d, J = 2.09 Hz), 138.14, 132.59, 128.68, 121.18, 120.5 (q, J = 257 Hz), 119.08, 
53.30, 40.68, 18.98. 
19FNMR (376 MHz, CDCl3): 
G  -58.86 




1H NMR Spectra (300 MHz, CDCl3): 
G 9.60 (s, 1H), 7.85 (m, 3H), 7.72 (d, J = 1.95 Hz, 1H), 7.51 (m, 2H), 7.37 (dd, J = 8.60, 1.96 Hz, 
1H), 5.57 (m, 1H), 5.06 (m, 2H), 2.83 (ddt, J = 14.2, 6.82, 1.29 Hz, 1H), 2.72 (ddt, J = 14.1, 7.74, 
1.10 Hz, 1H), 1.56 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
G 201.98, 136.80, 133.3, 133.13, 132.41, 128.60, 128.03, 127.55, 126.40, 126.30, 126.29, 125.00, 








1H NMR Spectra (500 MHz, CDCl3): 
G 9.56 (s, 1H), 7.61 (m, 4H), 7.45 (m, 2H), 7.35 (ddt, J = 16.9, 8.76, 1.71 Hz, 3H), 5.60 (m, 1H), 
5.08 (m, 2H), 2.74 (ddt, J = 14.1, 6.87, 1.29 Hz, 1H), 2.67 (ddt, J = 14.1, 7.78, 1.16 Hz, 1H), 1.49 
(s, 3H). 
13C NMR (126 MHz, CDCl3):  





1H NMR Spectra (500 MHz, CDCl3): 
G 9.63 (s, 1H), 7.54 (dt, J = 7.80, 0.99 Hz, 1H), 7.26 (m, 2H), 7.12 (ddd, J = 7.93, 6.77, 1.24 Hz, 
1H), 5.61 (m, 1H), 5.12 (dq, J = 17.0. 1.61 Hz, 1H), 5.03 (ddt, J = 10.1, 2.07, 1.10 Hz, 1H), 3.63 
(s, 3H), 2.90 (ddt, J = 14.7, 6.95, 1.41 Hz, 1H), 2.81 (t, J = 5.9 Hz, 2H), 2.69 (ddt, J = 14.8, 7.53, 
1.19 Hz, 1H), 1.97 (m, 4H). 
13C NMR (126 MHz, CDCl3):  
G 201.58, 137.85, 133.66, 131.42, 126.60, 122.07, 119.12, 118.44, 113.91, 108.94, 51.29, 38.09, 
31.25, 30.64, 21.24, 19.41. 





1H NMR Spectra (300 MHz, CDCl3): 
G 9.55 (s, 1H), 7.18 (m, 4H), 5.60 (m ,1H), 5.05 (m, 2H), 2.78 (t, J = 5.65 Hz, 2H), 2.63 (dd, J = 
7.22, 1.28 Hz, 2H), 2.09 (m, 1H), 1.83 (m, 3H). 
13C NMR (126 MHz, CDCl3):  
G 200.09, 138.65, 134.00, 133.69, 129.88, 128.29, 127.02, 126.37, 118.47, 53.04, 41.13, 29.88, 
27.84, 19.23. 




1H NMR Spectra (500 MHz, CDCl3): 
G 9.40 (s, 1H), 7.18 (m, 3H), 6.99 (d, J = 7.08 Hz, 2H), 5.53 (m, 1H), 5.04 (m, 2H), 4.99 (s, 1H), 
3.28 (d, J = 14.0 Hz, 1H), 3.0 (d, J = 14.0 Hz, 1H), 2.79 (dd, J = 14.5, 7.48 Hz, 1H), 2.45 (dd, J = 
14.4, 7.32 Hz, 1H), 1.38 (s, 9H). 
13C NMR (126 MHz, CDCl3):  
G 200.25, 154.54, 135.39, 131.19, 130.20, 128.34, 126.95, 119.89, 79.80, 66.01, 38.55, 37.75, 
28.34. 
 370 






1H NMR Spectra (500 MHz, CDCl3): 
G 9.60 (s, 1H), 7.28 (d, J = 8.28 Hz, 2H), 7.02 (d, J = 8.23 Hz, 2H), 5.74 (m, 1H), 5.11 (m, 2H), 
2.85 (d, J = 13.8 Hz, 1H), 2.72 (d, J = 13.7 Hz, 1H), 2.36 (ddt, J = 14.2, 7.14, 1.28 Hz, 1H), 2.18 
(dd, J = 14.2, 7.70, 1.25 Hz, 1H), 1.30 (s, 9H), 1.03 (s, 3H). 
13C NMR (126 MHz, CDCl3):  





1H NMR Spectra (500 MHz, CDCl3): 
G 9.57 (s, 1H), 6.71 (d, J = 7.90, 1H), 6.58 (d, J = 1.76 Hz, 1H), 6.54 (dd, J = 7.95, 1.76 Hz, 1H), 
5.92 (s, 3H), 5.72 (m, 1H), 5.11 (m, 2H), 2.81 (d, J = 13.9 Hz, 1H), 2.66 (d, J = 13.9 Hz, 1H), 
2.34 (ddt, J = 14.4, 7.32, 1.35 Hz, 1H) 2.17 (dd, J = 14.1, 7.73, 1.22 Hz, 1H), 1.02 (s, 3H). 
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13C NMR (126 MHz, CDCl3):  
G 206.00, 147.42, 146.26, 132.96, 130.25, 123.27, 118.92, 110.56, 108.03, 100.92, 50.18, 41.49, 
39.92, 29.72, 18.57. 













Representative procedure for the CO2 catalyzed activation of allylic alcohol towards 
allylation of nitriles: 
A 2.0 – 5.0 mL microwave vial (Biotage #351521) was flame dried and charged with the nitrile 
substrate (if solid, 0.3 mmol) and a stir bar. In the glove box, Pd(PPh3)4 (2.5 mol %, 0.009 g) was 
added along with DMSO (2 mL) and the vial was capped using a vial cap (Biotage #352298) and 
a manual cap crimper (Biotage #353671).  The vial was then removed from the glove box and 
substrate (if liquid, 0.3 mmol) and allyl alcohol (0.6 mmol, 0.035 g) were added sequentially via 
syringe.  CO2 was then bubbled through the solvent using a 20G needle connected to a balloon 
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and a separate 25.5G needle to vent.  After 5 minutes, the vent needle is removed followed by the 
CO2 needle and the top of the vial was wrapped in parafilm.  The vial was then placed in an oil 
bath at room temperature and heated/stirred at 90 oC for 14 hours. 
 After 14 hours the vial was removed from the bath, and allowed to cool to room 
temperature. An aliquot was then diluted in DCM and subjected to GC/MS analysis to determine 
conversion. The remaining solution was subjected to purification via silica gel column 











1H NMR Spectra (500 MHz, CDCl3): 
δ 7.44 (m, 2H), 7.38 (m, 2H), 7.30 (m, 1H), 5.70 (m, 1H), 5.15 (m, 2H), 2.67 (ddt, J = 13.9, 6.7, 
1.3 Hz, 1H), 2.60 (ddt, J = 13.9, 7.8, 1.0 Hz, 1H), 1.7 (s, 3H). 
13C NMR Spectra (126 MHz, CDCl3):  





1H NMR Spectra (500 MHz, CDCl3): 
δ 7.38 (m, 4H), 5.69 (dddd, J = 17.0, 10.2, 7.6, 6.9 Hz, 1H), 5.17 (m, 2H), 2.62 (m, 2H), 1.71 (s, 
3H). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 138.64, 134.09, 131.75, 129.31, 127.38, 122.99, 120.84, 46.50, 42.09, 26.82. 





1H NMR Spectra (500 MHz, CDCl3): 
δ 7.42 (m, 2H), 7.09 (m, 2H), 5.70 (dddd, J = 17.0, 10.2, 7.6, 6.9 Hz, 1H), 5.18 (m, 2H), 2.63 (m, 
2H), 1.71 (s, 3H). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 163.44, 161.48, 135.94, 135.92, 131.92, 127.77, 127.70, 123.29, 120.77, 116.18, 116.01, 46.75, 
41.96, 26.98. 
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GC/MS data: 189.1 (M+), 148.1 (base peak). 
 
3d 
1H NMR Spectra (500 MHz, CDCl3): 
δ 7.13 (m, 5H), 6.89 (m, 2H), 6.78 (m, 2H), 5.61 (dddd, J = 16.9, 10.2, 7.6, 6.5 Hz, 1H), 5.07 (m, 
2H), 3.72 (s, 3H), 3.12 (d, J = 13.5 Hz, 1H), 3.02 (d, J = 13.5 Hz, 1H), 2.68 (m, 2H). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 159.30, 135.23, 132.24, 130.69, 129.59, 128.34, 128.02, 127.53, 122.07, 120.38, 114.24, 55.58, 
48.91, 47.34, 43.95. 




1H NMR Spectra (500 MHz, CDCl3): 
δ 7.40 (m, 4H), 7.32 (m, 1H), 5.66 (m, 1H), 5.13 (m, 2H), 2.69 (ddt, J = 7.0, 2.0, 1.1 Hz, 2H), 
2.08 (m, 1H), 1.96 (m, 1H), 0.93 (t, J = 7.4 Hz, 3H). 
13C NMR Spectra (126 MHz, CDCl3):  






1H NMR Spectra (500 MHz, CDCl3): 
δ 7.87 (t, J = 1.9 Hz, 1H), 7.80 (m, 2H), 7.72 (m, 2H), 7.60 (m, 1H), 7.51 (m, 3H), 5.73 (ddt, J = 
17.3, 10.3, 7.2 Hz, 1H), 5.18 (m, 2H), 2.68 (m, 2H), 1.75 (s, 3H). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 196.29, 140.61, 138.46, 137.37, 133.03, 131.72, 130.28, 130.13, 129.91, 129.08, 128.66, 
127.00, 122.91, 120.86, 46.35, 42.34, 26.68. 
GC/MS data: 275.1 (M+), 234.10 (base peak). 
 
3h 
1H NMR Spectra (500 MHz, CDCl3):  
δ 7.45 (m, 2H), 7.36 (m, 2H), 7.29 (m, 3H), 7.19 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H), 7.03 (ddd, J = 
8.1, 6.9, 1.1 Hz, 1H), 6.85 (s, 1H), 5.68 (dddd, J = 17.1, 10.3, 7.6, 6.6 Hz, 1H), 5.12 (m, 2H), 3.73 
(s, 3H), 3.44 (d, J = 14.7 Hz, 1H), 3.34 (d, J = 14.6 Hz, 1H), 2.82 (m, 2H). 
13C NMR Spectra (126 MHz, CDCl3):  
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δ 138.66, 136.72, 132.47, 129.10, 129.05, 128.84, 128.12, 126.89, 122.82, 121.80, 120.23, 
119.39, 119.00, 109.48, 108.26, 50.20, 43.47, 37.39, 33.12. 




1H NMR Spectra (500 MHz, CDCl3):  
δ 7.45 (m, 4H), 7.39 (ddd, J = 7.8, 6.8, 1.3 Hz, 4H), 7.34 (m, 2H), 5.77 (ddt, J = 17.2, 10.2, 7.0 
Hz, 1H), 5.23 (m, 2H), 3.19 (dt, J = 7.1, 1.2 Hz, 2H). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 139.94, 132.00, 129.08, 128.17, 127.25, 122.19, 120.64, 51.94, 44.13. 
 
 
 4a  
 ref. 22 
1H NMR Spectra (500 MHz, CDCl3):  
δ 7.48 (m, 2H), 7.39 (m, 2H), 7.33 (m, 1H), 4.92 (p, J = 1.6 Hz, 1H), 4.77 (dq, J = 1.8, 1.0 Hz, 
1H), 2.64 (t, J = 1.0 Hz, 2H), 1.76 (s, 3H), 1.62 (m, 3H). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 140.37, 140.27, 129.07, 128.05, 125.89, 123.88, 116.94, 50.08, 42.03, 27.83, 23.84. 
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1H NMR Spectra (500 MHz, CDCl3):  
δ 7.41 (m, 2H), 7.28 (m, 3H), 5.39 (d, J = 1.1 Hz, 1H), 5.18 (q, J = 1.0 Hz, 1H), 3.12 (d, J = 1.0 
Hz, 2H), 1.67 (s, 3H). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 143.85, 141.74, 140.21, 128.98, 128.58, 128.04, 127.87, 126.81, 126.01, 123.33, 119.21, 47.46, 
43.13, 27.28. 
GC/MS data: 247.1 (M+), 139.1 (base peak). 
 
 
● linear Z diasteromer                        ■ = linear E diastereomer           ▲ = branched residues 
             residues                                                 residues                               (both diastereomers)                      
                                                                              
4c (l : b, 2 : 1) (cis : trans, 1 : 2.5) 
ref. 23 
1H NMR Spectra (500 MHz, CDCl3):  
δ 7.40 (m, 5H (Ph-Hlinear), 5H (Ph-Hbranched)), 5.89 (ddd, J = 16.6, 10.5, 8.8 Hz, 1H branched), 5.68 
(m, 1H cis-linear), 5.59 (m, 1H (trans-linear), 1H (branched)), 5.36 (m, 1H (cis-linear), 1H 
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(trans-linear)), 5.20 (m, 2H, branched), 5.01 (m, 2H, branched), 2.59 (m, (2H cis-linear), (2H 
trans-linear), (1H branched)), 1.66 (d, J  = 7.1 Hz, 3H, trans-linear), 1.57 (d, J = 7.1 Hz, 3H, cis-
linear), 1.17 (d, J = 6.8 Hz, 3H, branched), 0.94 (d, J = 6.8 Hz, 2H, branched). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 140.49, 140.36, 140.05, 139.26, 138.79, 138.16, 131.40, 129.23, 129.13, 128.85, 128.09, 
128.04, 126.74, 126.22, 125.98, 125.95, 124.71, 123.93, 123.70, 123.07, 122.34, 117.99, 117.63, 
48.69, 47.66, 47.04, 46.74, 45.60, 42.83, 42.59, 39.63, 26.77, 26.56, 24.57, 18.33, 17.21, 15.99, 
13.38. 












4d (l : b, 10.5 : 1) 
1H NMR Spectra (500 MHz, CDCl3): 
(Major linear diastereomer) δ 7.37 (m, 8H), 7.30 (m, 2H), 5.63 (dtt, J = 15.4, 6.5, 1.2 Hz, 1H), 
5.31 (dtt, J = 15.5, 7.1, 1.6 Hz, 1H), 3.07 (dq, J = 7.2, 1.1 Hz, 2H), 1.98 (m, 2H), 0.90 (t, J = 7.5 
Hz, 3H). 
13C NMR Spectra (126 MHz, CDCl3): 
(Major linear diasteromer) δ 140.33, 138.83, 129.08, 128.14, 127.47, 122.47, 122.32, 52.48, 
43.18, 25.96, 13.89. 
GC/MS data: 261.2 (M+), 193.1 (base peak).  
 
 
4e (l : b, 11.2 : 1) (cis : trans, 1 : 14.3) 
ref. 23 
1H NMR Spectra (500 MHz, CDCl3):  
(Major linear diastereomer) δ 7.38 (m, 8H), 7.30 (m, 2H), 5.58 (dtt, J = 15.0, 6.8, 1.3 Hz, 1H), 
5.32 (dtt, J = 15.4, 7.1, 1.4 Hz, 1H), 3.08 (dq, J = 7.1, 1.0 Hz, 2H), 1.94 (m, 2H), 1.31 (h, J = 7.3 
Hz, 2H), 0.81 (t, J = 7.4 Hz, 3H). 
13C NMR Spectra (126 MHz, CDCl3):  
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(Major linear diastereomer) δ 140.32, 137.14, 129.08, 128.13, 127.46, 123.47, 122.48, 52.46, 




1H NMR Spectra (500 MHz, CDCl3):  
δ 7.37 (m, 15H), 6.54 (dt, J = 15.7, 1.4 Hz, 1H), 6.10 (dt, J = 15.7, 7.2 Hz, 1H), 3.31 (dd, J = 7.4, 
1.3 Hz, 2H). 
13C NMR Spectra (126 MHz, CDCl3):  





 4g  
 ref. 25 
 
1H NMR Spectra (500 MHz, CDCl3):  
δ 7.37 (m, 15H), 6.54 (dt, J = 15.7, 1.4 Hz, 1H), 6.10 (dt, J = 15.7, 7.2 Hz, 1H), 3.31 (dd, J = 7.4, 
1.3 Hz, 2H). 
13C NMR Spectra (126 MHz, CDCl3):  
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                                          ■ = Major linear              ▲ = Branched residues 
                                                                 diastereomer residues     
4h (l : b, 1.4 : 1) (cis : trans, 1 : 4.6) 
 
1H NMR Spectra (500 MHz, CDCl3):  
δ 7.38 (m, 10H (Ph-Hlinear), 10H (Ph-Hbranched)), 5.84 (ddd, J = 17.1, 10.5, 7.6 Hz, 1H, branched), 
5.64 (m, 1H, linear), 5.34 (m, 1H, linear), 5.32 (m, 1H, linear diastereomer), 5.10 (m, 2H, 
branched), 3.45 (m, 1H, branched), 3.07 (dt, J = 7.3, 1.2 Hz, 2H, linear diatereomer) 2.98 (dt, J = 
7.0, 1.2 Hz, 2H, linear), 1.64 (dq, J = 6.7, 1.2 Hz, 3H, linear), 1.50 (ddt, J = 6.9, 1.87, 0.94 Hz, 
3H, linear diastereomer), 1.20 (d, J = 6.7 Hz, 3H, branched). 
13C NMR Spectra (126 MHz, CDCl3):  
δ 140.30, 139.63, 139.50, 138.53, 131.70, 129.24, 129.12, 129.10, 129.01, 128.20, 128.15, 
128.04, 127.94, 127.49, 127.42, 127.13, 124.49, 123.95, 122.50, 121.12, 117.85, 58.19, 52.48, 










1H NMR Spectra (300 MHz, CDCl3): 
G 9.54 (s, 1H), 7.38 (m, 2H), 7.29 (m, 3H), 4.81 (p, J = 1.57, 1.53 Hz, 1H), 4.62 (dq, J = 1.78, 
0.89 Hz, 1H), 2.69 (q, J = 13.9 Hz, 2H), 1.47 (s, 3H), 1.40 (s, 3H). 
13C NMR (126 MHz, CDCl3):  





linear product data reported 
1H NMR Spectra (500 MHz, CDCl3): 
G 9.45 (s, 1H), 7.30 (m, 2H), 7.19 (m, 3H), 5.42 (m, 1H), 5.09 (m, 1H), 2.53 (dd, J = 7.32, 1.16 
Hz, 2H), 1.87 (m, 2H), 1.34 (s, 3H), 0.83 (t, J = 7.46 Hz, 3H). 
13C NMR (126 MHz, CDCl3):  







86:14 linear to branched 
linear data reported 
1H NMR Spectra (500 MHz, CDCl3): 
G 9.55 (s, 1H), 8.11 (d, J = 8.76 Hz, 2H), 7.42 (dd, J = 8.24, 6.94 Hz, 2H), 7.35 (dd, J = 8.12, 6.89 
Hz, 3H), 7.28 (m, 2H), 6.44 (d, J = 15.8 Hz, 1H), 6.13 (ddd, J = 15.8, 7.93, 7.00 Hz, 1H), 2.88 
(ddd, J = 14.3, 7.01, 1.47 Hz, 1H), 2.81 (ddd, J = 14.3, 7.98, 1.28 Hz, 1H), 1.52 (s, 3H). 
13C NMR (126 MHz, CDCl3):  













84:16 trans:cis  
4m 
1H NMR Spectra (500 MHz, CDCl3): 
G 9.52 (s, 1H), 7.39 (m, 2H), 7.31 (m, 6H), 7.25 (m, 2H), 5.63 (dtt, J = 15.1, 6.17, 1.37 Hz, 1H), 
5.47 (dtt, J = 14.6, 7.43, 1.24 Hz, 1H), 4.40, (s, 2H), 3.91 (ddd, J = 6.27, 2.31, 1.23 Hz, 2H), 2.71 
(ddd, J = 14.3, 6.96, 1.34 Hz, 1H), 2.64 (ddd, J = 14.2, 7.70, 1.17 Hz, 1H), 1.46 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
G 201.88, 139.32, 138.24, 130.63, 128.91, 128.63, 128.36, 127.77, 127.58, 127.40, 127.17, 71.75, 
70.38, 53.76, 39.11, 18.93. 














linear product data reported 
ref. 27 
1H NMR Spectra (300 MHz, CDCl3): 
G 9.58 (s, 1H), 7.41 (m, 2H), 7.28 (m, 6H), 7.20 (m, 2H), 6.41 (dt, J = 15.7, 1.33 Hz, 1H), 5.94 
(dt, J = 15.2, 7.44 Hz, 1H), 2.81 (m, 2H), 1.50 (s, 3H). 
13C NMR (126 MHz, CDCl3):  




1H NMR Spectra (500 MHz, CDCl3): 
G 9.56 (s, 1H), 7.50 (d, J = 8.12 Hz, 2H), 7.42 (dd, J = 8.21, 6.96 Hz, 2H), 7.33 (m, 3H), 7.28 (dd, 
J = 8.37, 1.30 Hz, 2H), 6.41 (d, J = 16.0 Hz, 1H), 6.04 (ddd, J = 15.4, 7.93, 7.07 Hz, 1H), 2.86 
(ddd, J = 14.2, 7.06, 1.45 Hz, 1H), 2.79 (ddd, J = 14.2, 7.92, 1.27 Hz, 1H), 1.51 (s, 3H). 
13C NMR (126 MHz, CDCl3):  
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G 201.67, 140.58, 139.09, 132.30, 129.07 (q, J = 33.3 Hz), 129.02, 127.98, 127.58, 127.14, 
126.23, 125.43 (q, J = 3.88 Hz), 124.18 (q, J = 271.82 Hz), 54.08, 39.99, 18.87. 
 
Procedure for the reduction of compound 1e (Wurz, R. P.; Charette, A.B.; J. Org. Chem. 2004, 
69. 1262-1269) and formation of the corresponding amine salt. 
 In a 50 mL round bottom flask equipped with a stir bar, compound 1e  (0.185g, 0.59 
mmol) was dissolved in 12 mL isopropanol.  To this solution 1.5 M HCl (6.0 mL) and zinc dust 
(0.740 g, 11.3 mmol) were added and the solution was stirred at 50 oC for 2 hours.  Saturated aq 
K2CO3 (8.0 mL) was added after the solution cooled to rt.  The reaction mixture was filtered 
though a pad of celite and extracted 3x with 25 mL CHCl3 washes.  The combined organic layers 
were washed with 20 mL brine and dried over MgSO4. 
 The dried solution was filtered and concentrated in vacuo to afford the corresponding 
amine as a colorless oil (0.072 g, 43%).  2.0 M HCl in diethyl ether (5.0 mL) was added to the 
amine and the solvent removed in vaccuo to provide a white solid which was re-crystallized from 











Major diastereomer shown. 
1H NMR Spectra (500 MHz, CDCl3): 
Major diastereomer G 8.55 (s, 3H), 7.36 (m, 10H), 5.98 (ddt, J = 16.4, 11.4, 7.49 Hz, 1H), 5.19 
(m, 2H), 4.90 (s, 1H), 4.62 (d, J = 11.4 Hz, 1H), 4.33 (d, J = 11.4 Hz, 1H), 2.69 (dd, J = 14.6, 
7.02 Hz, 1H), 2.17 (dd, J = 14.6, 7.73 Hz, 1H), 1.31 (s, 3H).  
13C NMR (126 MHz, CDCl3):  
Major diasteromer G 137.67, 135.26, 130.92, 128.68, 128.56, 128.36, 128.33, 128.06, 127.58, 
127.46, 84.94, 71.25, 60.29, 37.61, 21.03. 
HRMS:  




Detailed description of x-ray crystal structure determination for [C19H24NO][Cl] :  
The alignment reflections for determining the preliminary unit cell for the crystal of 
[C19H24NO][Cl] (1) indexed quite well as a C-centered monoclinic lattice.  The crystal was 
therefore believed to utilize a monoclinic space group and intensity data were collected 
accordingly.  The monoclinic Rsym was 0.105 and the most probable space group appeared to be 
centrosymmetric C2/m.  When the structure would not solve in C2/m, the intensity data were 
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further analyzed and this indicated the possible presence of a c-glide.  The structure solved 
straightforwardly in the centrosymmetric space group C2/c with an asymmetric unit containing 
two [C19H24NO][Cl] cation/anion pairs.  When this structure failed to refine below R1 = 0.153, 
the possibility of it being a triclinic structure that was pseudomerohedrally twinned to look 
monoclinic was considered.  This turned out to be the case and the final centrosymmetric triclinic 
asymmetric unit has four nearly identical, but crystallographically-independent [C19H24NO][Cl] 
cation/anion pairs, related by non-crystallographic pseudosymmetry. The crystals utilize the 
centro-symmetric triclinic space group CC1 [a nonstandard setting of PC1 – Ci1 (No. 2)] with lattice 
constants at 100K of:  a =26.96214(19)Å, b = 12.68483(10)Å, c = 21.88641(18)Å, D = 
90.4219(6)q, β = 104.5435(4)q, J = 89.7970(4)q, V = 7245.3(1)Å3 and Z = 16 [C19H24NO][Cl] 
moieties.  The crystals are pseudomerohedrally (68%/32%) twinned with the two domains related 
by a 180q rotation about the b axis.  
The final centrosymmetric triclinic asymmetric unit contains four cation/anion pairs.  All 
nonhydrogen atoms were included in the structural model with variable anisotropic thermal 
parameters.  All twelve hydrogens for the protonated amine groups were located from difference 
Fourier syntheses and incorporated into the structural model as individual isotropic atoms whose 
parameters were allowed to vary in least-squares refinement cycles.  Mild restraints were applied 
to the anisotropic thermal parameters of two carbon atoms [C(78) and C(79)] and three of the 
ammonium hydrogens were fixed at values 1.2 times the equivalent isotropic thermal parameter 
of their nitrogen atom.  The remainder of the hydrogen atoms were placed at idealized sp2- or sp3-
hybridized positions with C-H bond lengths of 0.95 - 1.00 Å and isotropic thermal parameters 
fixed at values 1.20 (nonmethyl) or 1.50 (methyl) times the equivalent isotropic thermal 
parameter of the carbon atom to which they are bonded.  Methyl groups were placed at idealized 
“staggered” positions. The terminal ethylene group for the first cation is 57%/43% disordered 
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between two conformations and both of these were restrained to have metrical parameters similar 
to that group in the fourth cation.   
The final least-squares refinement cycles for 1 in space group CC1 utilized anisotropic thermal 
parameters for all nonhydrogen atoms, isotropic thermal parameters for all hydrogen atoms, 867 
variables, 51 restraints and 11861 reflections having 2T(CuKD)< 140.10q.  Final agreement 
factors at convergence for 1 are: R1(unweighted, based on F) = 0.078 for 10457 independent 
absorption-corrected “observed” reflections having 2T(CuKD) < 140.10q and I>2V(I);  
R1(unweighted, based on F) = 0.086 and wR2(weighted, based on F2) = 0.213 for all 11861 
independent absorption-corrected reflections having 2T(CuKD)< 140.10q. The largest shift/s.u. 
was 0.000 in the final refinement cycle.  The final difference map had maxima and minima of 
0.59 and -0.56 e-/Å3, respectively. 
 
 
 
 
